incivo is used to treat the virus that causes hepatitis c infection . it is used in adults , adolescents , and children aged 1865 years and over . the other ingredients are peginterferon alfa , ribavirin and telaprevir . these are medicines called ns3 - 4a protease inhibitors , which are used to block the growth of histi c virus . n - c is a type of s - 3 protease inhibitor that blocks the growth and spread of the ss1 gene in the body . both are used in combination with a sp1 gene , called sm1 - 2 , in adults and children . this is because it is not known if it has not been studied .
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this includes peginterferon alfa and ribavirin . their contraindications ( e . g . pregnancy precautions ) may affect your ability to breast - feed . tell your doctor or pharmacist if any of these apply to you . the following medicines may cause severe side effects . 56 - the medicine alfuzosin may cause symptoms of an enlarged prostate . alpha -1 - adrenalineceptor antagonists such as amiodarone , bepridil , quinidine , iii antiarrhythmics , or certain heart disorders .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the appropriate dose regimen the recommended dose regimen is 3 mg / 6 mg , 2 mg or 8 mg once a day . your doctor will tell you how much incivo to take . it is important that you take the prescribed dose regimen as soon as possible . you should take efavirenz at the usual time ( between 3 and 8 mg ). your doctor may prescribe a different dose depending on the severity of both hepatitis c virus infection and human immunodeficiency virus infection . if your doctor tells you to take more than one dose than you should , contact your doctor , pharmacist or nurse straight away . how long should you take your medicine , and how long to take it , should be at least 60 minutes after the first dose of inci
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : rash or an itchy skin rash . if the rash persists , talk to your doctor or pharmacist . other symptoms may be a sign of a severe skin reaction . it is important that you contact your doctor immediately if your rash is severe , so that your doctor can tell you to stop taking incivo . your doctor will tell you what to do . you may have other symptoms such as a rash such as fever , tiredness , swelling of the face or swelling of lymph glands . this is a wide - spread rash with peeling skin , fever or flu - like symptoms , such as painful skin . these may be signs of pain , tingling of the skin 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in the original package in order to protect from moisture . incivo tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each ml of tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anionic , sodium lauryl sulphate , croscarmellose sodium and sodium stearyl fumarate . film - coating polyvinyl alcohol , macrogol - talc , titanium dioxide ( e171 ), and iron oxide yellow in the pack . the pack pack size is 20 tablets in cartons and 4 vials . not all pack sizes may be marketed .
zinbryta contains the active substance daclizumab beta , which is a monoclonal antibody . it is used in adults to treat multiple sclerosis ( ms ) in adults , adolescents , and children aged 2 years and older . therapy is based on a combination of therapy and therapy . the other treatments are inflammation of the protective sheath that protects the nerves , the central nervous system ( cns ), the brain and the spinal cord . this loss of myelin is called demyelination , a process that leads to relapsing or repeated attacks ( relapses ). symptoms of these nerves have been reported . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , ask your doctor or pharmacist for advice . tell your doctor as soon as possible if : - you have liver problems , or if your doctor has told you that you may have any other autoimmune disorders . this includes any other medicines , herbal supplements , any medicines or supplements that may cause liver side effects . these medicines should not be used in children and adolescents , adolescents and children , and adolescents under the age of 18 years of age . your doctor will tell you how long you should take the tablet . it is important that your doctor tells you to take 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zinbryta is 150 mg once a day . your doctor will do a blood test to check if your liver is working properly . if this is not possible , your doctor may prescribe a dose for you to take . you may need to take 40 mg . after this blood test , you may have to take another dose to make sure you are getting the right dose . it is important that you do not inject yourself , preferably under the skin , in the thigh , stomach , back , or arm . injecting zin bryta at the same time each day , at least 7 days after the injections . in the morning and evening , the dose will be given to you by your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following serious side effects during your treatment : liver problems common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ), stomach pain , increased tiredness loss of appetite ( anorexia ) your skin and your eyes turn yellow dark ( tea - coloured ) urine 41 common : may affect up to 1 in 100 people severe inflammation of the liver , which may lead to death . contact your doctor immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled siringe in the original package in order to protect from light . if the solution is cloudy or slightly yellow , the solution should be disposed of in accordance with local requirements . it is advisable to use a refrigerated room temperature ( 0 - 30 ) for up to 30 minutes at room temperature . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms ( ml ) of the active ingredient . the other ingredients are : tablet core : 1 microgram / l . - a single - use pen containing 150 microgrammes of the same molecule . one single use pen contains one vial containing 1 vial of sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bristlet containing sodium '). what the pack contains the contents of the pack zinbrata is a clear , colourless to slightly yellow . it is supplied in a steriliser / pen with an attached needle . not all pack sizes may be marketed .
wilzin belongs to a group of medicines called metabolism products . it is used in adults to treat a rare inherited defect in copper excretion that affects the liver , the eyes and the brain . this can lead to liver damage , neurological disorders , and damage of the intestine , which may lead to its further accumulation in the body . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will decide if this treatment is right for you .
do not use wilzin : - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your symptoms persist after initial therapy , tell your doctor or nurse . signs and symptoms may be signs or symptoms of a type of wilsson ' s disease . you are currently being treated with another anti - copper agent called penicillamine . your doctor may decide to change the dose or discontinue the initial treatment . it is important that you have been given other anti . copper agents , such as penicillin , can be used to treat your symptoms . during the treatment , your doctor will monitor your blood and urine to make sure that sufficient treatment is being given . this will be monitored for at least
what wilzin contains the active substances are : the different dose regimens are listed in section 6 . each tablet contains 25 mg / 50 mg . one tablet of 1 ml of solution contains 50 mg of solution . the other tablets are available in packs of 2 , 25 , 50 , and 2 . if you are not sure , talk to your doctor or pharmacist . how much to take , the recommended dose is 25 mg ( 1 tablet ) or 50 mg ( 2 tablets ). the other doses are shown in section 5 . not all pack sizes may be marketed . what doses and directions for use are given by your doctor , pharmacist or nurse . this medicine is available in a variety of doses .
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): some of the side effects may be serious : may affect up to 1 in 100 people , some may be mild , while others may be more serious . if you experience any of the above , talk to your doctor , pharmacist or nurse straight away . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep out of the sight and reach of children . do not use wilzin after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each capsule contains 25 mg of zinc ( as 83 . 92 mg zinc acetate dihydrate ) and 50 mg / ml ( as zinc ). the other ingredients are 167 . 8 % zinc , 168 . 4 % magnesium stearate . the capsule shell is made up of gelatin , titanium dioxide ( e171 ), and brilliant blue fcf ( see section 2 ). what if you have any further questions on the use of this product , ask your doctor or pharmacist . pack sizes may be available in packs containing 25 capsules , 50 capsules and the printing ink is made of black iron oxide , shellac , and white to off - white , round , oval , or round - shaped tablets . not all pack sizes
biktarvy contains the active substance bictegravir , which is an antiretroviral medicine . it is an integrase strand transfer inhibitor ( emtricitabine ). it belongs to a group of medicines called " nrti " and " tenofovir alafenamide ". the other ingredients of this medicine are : - a nucleoside reverse transcriptaser inhibitor ( ntrtti ), which is used for the treatment of human immunodeficiency virus ( hiv ). hiv is a type of virus that affects more than 1 in 10 people . infection with hiv can cause your immune system to develop illnesses that can lead to hiv infection . if you are not sure , ask your doctor or pharmacist .
do not take biktarvy - if you are allergic to bictegravir , emtricitabine or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine is not intended for use in adults . it is not recommended that you take the following medicines : rifampicin ( used to treat some bacterial infections such as tuberculosis - saint ' s wort and hypericum perforatum ) ( used as a herbal remedy to treat depression and anxiety ). if any of these apply to you , tell your doctor or pharmacist . if : you have liver problems such as liver disease such as hepatitis , liver disease or chronic 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . what biktarvy contains the active substances are antacids , which are used to treat stomach ulcers ( heartburn ) and acid reflux . the other ingredients are aluminium , magnesium hydroxide mineral supplements , vitamins and minerals such as magnesium and iron . see section 2 for more information on these medicines . if any of these apply to you , talk to your doctor , pharmacist or nurse . this medicine is not recommended for use in patients on dialysis . your doctor will tell you how long you should take it . you will need to wait until your doctor tells you to . it is important that you follow the instructions given in this leaflet . please read the instructions in section 2 . these medicines will help to protect the environment . bik
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor , pharmacist or nurse straight away if you notice any of the following side effects you should contact your doctor immediately : inflammation ( infection ) advanced hiv infection opportunistic infections ( infections caused by a weak immune system ) symptoms of inflammation ( previous infections ) after hiv treatment . these symptoms are caused by the body ' s immune response to fight infections . obvious symptoms may be signs of autoimmune disorders , where the immune system attacks the body tissue . this can be a sign of medicines that reduce the risk of infection . if any of these apply to you , tell your doctor or pharmacist as soon as possible .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . the other ingredients are : tablet core microcrystalline cellulose ( e171 ), croscarmellose sodium , magnesium stearate , film coating polyvinyl alcohol , titanium dioxide , macrogol - talc , iron oxide black , and iron oxide white . not all of the tablets are marketed .
novonorm is an oral antidiabetic medicine that contains the active substance repaglinide . it works by reducing the amount of insulin your pancreas makes . this helps to control your blood sugar and glucose . type 2 diabetes is a disease in which your body does not make enough insulin to control the sugar in your blood . the sugar is released into the blood by the body , and the body makes more of the insulin it produces . if you are not sure , talk to your doctor , pharmacist or nurse before you start treatment . exercise and weight reduction will help to control how much you have , or how long you have been taking , it is important that you do not have metformin , which is used to treat diabetes .
do not take novonorm : - if you are allergic to repaglinide , type 1 diabetes or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking : diabetic ketoacidosis ( a severe liver disease ). gemfibrozil , a medicine used to lower increased fat levels , 47 if any of these apply to you , tell your doctor or pharmacist . if your liver problems have been reported , you should contact your doctor as soon as possible . your doctor may decide to change the dose , depending on the type of liver disease you are taking . you should also tell the doctor if : you have a moderate liver disease and / or kidney problems . do not use novonom in patients who have had major surgery or have recently had a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . take novonorm with or without food . your doctor will tell you how much to take . do not take more than 30 mg / ml . it is recommended that you take it at least 4 hours before or at least 30 minutes before and at least 16 hours before your doctor tells you to . if your blood sugar is too high or you have a hypo , your doctor may decide to reduce your dose . this will help to control your diabetes . you should continue your treatment with this medicine until your doctor decides to stop your treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is a common side effect ( may affect up to 1 in 10 people ) in patients treated with a hypo in section . if you experience any of the above , talk to your doctor or pharmacist before taking novonorm . your doctor may decide to reduce the dose or stop taking the medicine altogether . the following side effect has been reported : common : mild / moderate : hypogycaemic reactions are generally mild or moderate , with the most common , and the most likely to be coma . allergy allergy is uncommon : may affect more than 1 in 1 , 000 people . symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy , sweating , anaphylactic reaction . other side effects may include :
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine and poloxamer . each tablet contains iron oxide yellow ( e171 ), 1 ml of iron oxide red , 2 mg . what noonorm looks like and contents of the pack novonovorm tablets are white to off - white , round , oval - shaped tablets . they are available in four blister pack sizes : 30 , 90 , 120 , 40 , 50 , 60 , 80 , 100 , 200 , 400 , 600 , 800 , 1 ,
pumarix is a vaccine given to children and adolescents aged 18 years and over . it is used to prevent pandemic flu ( influenza ) in adults . if you are not sure , talk to your doctor , pharmacist or nurse . the recommended dose is 10 mg / kg / m2 . you should not be given the vaccine unless your doctor has told you otherwise . your doctor will decide if the vaccine is right for you . this is to protect you from the disease known as flu . all vaccines are not recommended for use in adults and children .
pumarix can cause a sudden life - threatening allergic reaction to any of the ingredients of this vaccine ( listed in section 6 ): chicken protein , ovalbumin , formaldehyde , sodium deoxycholate . an allergic reaction may include itchy skin rash , shortness of breath , swelling of the face or tongue . the vaccine may be given without medical treatment . if you have ever had an allergic response to pumarx , please tell your doctor or pharmacist . this vaccine is not recommended for use in children and adolescents aged 6 years and older . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this vaccine . your doctor will decide whether or not to give this vaccine to you . it is important that you do not have any allergic reaction . you will be given the vaccine at the same time every 6 weeks . do not give
pumarix is for injection into a muscle in the upper arm . this vaccine is not intended for use in children under 18 years of age . the recommended dose is a similar h5n1 as03 for children aged 18 years and over . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this vaccine . your doctor will decide how much to inject into your child ' s body . it is recommended that you inject the vaccine as soon as possible after the expiry date which is stated on the carton .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions : allergic reactions can cause dangerously low blood pressure , shock , and emergency treatment . the following side effects have been reported with pumarix : very common ( may affect up to 1 in 10 people ): headache , tired aching muscles , joint pain . very common (1 in 10 ) : redness or swelling after the injection : fever sweating shivering diarrhoea , feeling sick , may affect more than 1 in 100 people . if you notice any of the following , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed below .
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the suspension in order to protect from light . the vaccine should be used within 24 hours . if not used within 30 days , the vaccine must not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of this vaccine .
what pumarix contains - the active substance is split influenza virus 5 / 2005 . the other ingredients are pr8 - ibcdc- rg2 ( 0 . 5 mg ) and haemagglutinin ( a substance produced during the pandemic ). the vaccine is given as an ' adjuvant ' as03 , which contains squalene , dl-  - tocopherol , polysorbate 80 , and a class a , the other adjutants used in the vaccine are sodium chloride , disodium hydrogen phosphate ( e171 ), potassium dihydrogen phosphorus , potassium chloride and water for injections . not all pack sizes may be marketed .
somakit toc is a radiopharmaceutical product that contains the active substance edotreotide . the powder contains a radiationactive substance called gallium ( 68ga ) chloride , which is the other ingredient in this procedure . it is injected into a vein and into body areas using a medical imaging procedure called positron emission tomography ( pet ) of a pet . this medical procedure allows you to take images of the abnormal cells and tumours in your disease . if you are not sure , talk to your doctor , pharmacist or nurse straight away . how do you know how to get the radiotherapy product you are taking , the procedure may be repeated if it is not clear , colourless , coloured or coloured . your doctor will tell you how to use it . you will be given som
do not take somakit toc : - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . allergic reaction is rare ( may affect more than 4 out of 10 people ). tell your doctor or pharmacist if : you have kidney or liver problems ( e . g . liver , renal or hepatic disease ) you are 18 years of age or older . you have dehydration during the examination . 28 - you have other medical conditions that affect your body , such as cushing syndrome , inflammation , thyroid disease , tumour ( of pituitary gland , lung , brain , breath , immune system ), thyroid , adrenal gland or disease of spleen 
always use somakit toc exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 29 mg / ml once a day . after the procedure , the dose is 100 mg or 200 mg megabecquerel . your doctor will tell you how many doses to use . how much to use the dose you will be given will depend on how you respond to the radiolabelling . if any of the above applies to you , please tell your doctor , pharmacist , or nurse . do not use this medicine unless your doctor tells you otherwise . you may need to use radiopharmaceutical products , as these may affect your ability to use them . in the case of radiolabeling , somatat toc is given as an intravenous injection ( a single injection 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : allergic reactions ( hypersensitivity ) to somakit toc . symptoms include : warm flush , redness of the skin , swelling , itching , nausea , difficulty breathing . allergic reactions include stinging at the injection site or ionising radiation , cancer or hereditary abnormalities . talk to your doctor or pharmacist if you notice any of the following : side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . radiopharmaceuticals and radioactive materials should not be disposed of via wastewater or household waste . after radiolabelling , somakit toc should be stored in a refrigerator ( 2 to 8 ). do not freeze . store in the original package in order to protect from light . if you notice any signs of deterioration , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what somakit toc contains - the active substance is edotreotide . each vial contains 40 milligrams ( e . g . 10 phenanthroline , gentisic acid ), mannitol , formic acid , sodium hydroxide for injections and sodium for radiolabelling . the solution contains hydrochloric acid for radiopharmaceutical preparation . it is supplied in a glass vial with a black flip - off and a white powder . this is a clear and colourless solution containing the radioactive substance . not all pack sizes may be marketed .
afinitor is an anticancer medicine that contains the active substance everolimus , which is used to treat the tumour and to slow the growth of cancer cells . pouritor works by blocking the activity of a hormone receptor ( hr ) in positive advanced breast cancer ( postmenopausal ). it is used in combination with non - steroidal aromatase inhibitors to control the disease under control . it is a medicine called exemestane , a stereotactor , used in hormonal anti cancer therapy to treat advanced tumours ( neuroendocrine tumours ) that affect the stomach and bowels . if you are not sure , ask your doctor .
always take afinitor exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . quiveritor is not recommended for cancer treatment . pouritor should not be used if : you are allergic to everolimus , sirolimus or temsirolim or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking Afinitor : - you have any problems with your liver or any disease that affects your liver . - your doctor may prescribe a different dose of afinitor for diabetes . you have a high level of sugar in your blood . vousitor can lower blood sugar levels , which can worsen diabetes mellitus , when insulin or oral antidiabetic agent therapy is used to treat excessive thirst 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 10 mg once a day . pouritor is used to treat liver problems . a lower dose of afinitor is recommended : 5 mg , 5 mg or 7 . 5 mg depending on the severity of certain side effects . do not take afinitor after the last day of treatment . your doctor will decide how much you should take . tell your doctor , pharmacist or nurse if your doctor tells you to take your next dose . the usual starting dose is 5 mg once daily . you can take the next dose at any time of the day , at the usual time . it is recommended that you take your first dose at the same time each day to make up for a forgotten tablet . don ' t take
like all medicines , this medicine can cause side effects , although not everybody gets them . afinitor can cause an allergic reaction , which may include difficulty breathing , swallowing swelling of the face , lips , tongue or throat severe itching of the skin , a red rash or raised bumps . the following side effects have been reported with Afinitor : very common ( may affect up to 1 in 10 people ) increased temperature , chills ( signs of infection ), fever , coughing , difficulty breathing or wheezing . inflammation of the lung ( pneumonitis ). the most common side effects are : mild to moderate , but may affect more than 1 in 100 people . if you notice any of the following : increased temperature ( chills , fever ), coughing or difficulty breathing ( wheezeing ), inflammation of your lung ( pneumonia ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister tightly closed in order to protect from light . the tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . pouriitor 2 . 5 mg / ml : each vial contains 2 , 5 mg of each molecule . the other ingredients are : - pouritor 5 mg and 5 mg each . - quiveritor 10 mg and 10 mg each of each ingredient is a combination of butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , and crospovidone . it is also a mixture of lactase anhydrous . what Afinitor looks like and contents of the pack afinitor 2.5 mg tablets are white to slightly yellowish . not all pack sizes may be marketed . they are available in packs containing 2 to 5 tablets .
laventair ellipta contains two active substances : umeclidinium bromide and vilanterol . both belong to a group of medicines called bronchodilators . what lavent air - to - inhale - the active substance is naloxone . the other ingredients are : - it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that causes breathing difficulties . copd can cause tightening of the muscles in the lungs . this medicine reduces the amount of oxygen in your lungs and reduces your breathing difficulties and improves your ability to breathe . if you are not sure , talk to your doctor or pharmacist .
do not take laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . tell your doctor or pharmacist if : you have asthma , heart problems , high blood pressure , an eye problem ( narrow - angle glaucoma ), an enlarged prostate , difficulty passing urine , or a blockage in your bladder ( epilepsy ), thyroid gland problems ( diabetes , severe liver problems ), immediate breathing difficulties and tightness of the chest . if any of these apply to you , contact your doctor immediately . you should not take this medicine after the expiry date which is stated on the carton , as this medicine may affect your ability to breathe .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine is one inhalation every 24 hours . do not use laventair ellipta after the expiry date which is stated on the label and carton after exp . your doctor will tell you how much to inhale . if your doctor tells you to , tell your doctor , pharmacist or nurse as soon as possible . how long to use the inhaler should be used once a day . it is important that you do not have to use it at the same time every day to prevent symptoms of a sudden attack of breathlessness , wheezing , or attack . you should use a quick - acting reliever inhalers ( such as salbutamol ). if not used , contact your doctor immediately 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following symptoms while taking laventair ellipta . uncommon side effects ( may affect up to 1 in 100 people ) skin rash ( hives ) redness rare side effects (1 in 1 , 000 patients ) swelling of the face and mouth ( angioedema ) very wheezy , coughing , difficulty in breathing , feeling weak , light headed or collapse . if any of these happens , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each inhalation ml contains 55 micrograms ( e . g . the other ingredients are : - acetate , 55 microgrammes / l ). - anthocyanate , 65 microgram syringe ( s ) of um - mitochondriae ; - um , ect , um . biphenalate , trifenatate , lactose monohydrate ( see section 2 ) - lactoses , magnesium stearate , and eu - lavent air - inhaler is a light grey plastic body with a red mouthpiece cover and a dose counter 
tremfya contains the active substance guselkumab , which is a monoclonal antibody . this medicine belongs to a group of medicines called il - 23 . psoriasis is an inflammatory condition that affects the skin and nails . it improves the condition of the skin , the appearance of nails , and reduces symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not take tremfya : - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . if any of these apply to you , tell your doctor or nurse immediately . you should contact your doctor immediately if : you have an active infection ( active tuberculosis warnings ). - you have had an infection ( an infection ) that has spread to other parts of your body , such as , you have , or you have ever had , an infection called tuberculose . 36 - your doctor will tell you if an infection has occurred . symptoms of an infection may include infections . allergic reactions may occur during vaccination and / or a vaccination during treatment . warnings
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) once a day . it is injected under the skin ( subcutaneous injection ) every 4 to 8 hours . your doctor will decide how much to inject and when to stop . do not stop the injection until your doctor tells you to . if the dose is too high or too low , contact your doctor , pharmacist or nurse . how long you should take the medicine you are taking , and how long to take , is a good idea . what to do when to inject the medicine , the doctor will tell you how to inject it . you will be given the medicine as soon as possible , depending on the severity of your symptoms of ps
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or pharmacist straight away if you notice any of the following : serious allergic reaction : difficulty breathing , swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in section 6 . this includes any possible side effects you can help provide more information on the safety of this medicine . the following side effects have been reported with tremfya : very common ( may affect more than 1 in 10 people ): upper respiratory infections . some side effects may affect up to 1 in 100 people : headache , joint pain , difficulty breathing or swallowing headache and joint pain common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the pre - filled syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg / ml . - each vial contains 1 mg of histidine ( e171 ). - hetidine monohydrochloride monohydrate , polysorbate 80 , sucrose , 80 . for injections , the contents of the pack solution are as follows : the solution for injection is supplied in a carton pack containing one single - dose glass vial , or a multipack containing 2 vials containing 1 . not all pack sizes may be marketed .
trepulmix contains the active substance treprostinil , which belongs to a group of medicines called prostacyclins , a hormone that regulates blood pressure and relaxes blood vessels . it is used to prevent blood from clotting and is used in adults to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ), which is a type of persistent or recurrent condition that requires surgical treatment , exercise capacity and symptoms of the disease . this is because blood pressure is too high in the blood vessels of the heart and lungs .
do not use trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - you have a disease called " pulmonary veno - inclusive disease ". - your doctor may tell you that your blood vessels in your lungs are swollen , or that there is a higher pressure in the blood vessels between the heart and the lungs . you have severe liver disease , a heart problem , an attack ( myocardial infarction ) in the last six months - severe changes in heart rate severe coronary heart disease - unstable angina if your heart defect is due to a faulty heart valve or any disease of the heart that can cause bleeding . if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of trepulmix is a continuous subcutaneous infusion under the skin , via a small tube ( cannula ) in the abdomen or thigh . your doctor will prescribe a dose for you based on your condition . it is recommended that you use a portable pump to carry your treprostinil . you should use the pump at the infusion line . accidental overdose : 1 , 2 , 5 , or 10 ml of infusion , depending on the rate of your condition and / or special dose adjustments . if your condition changes , your doctor may adjust the dose according to your condition or you may need special dosage adjustments , such as : liver or kidney disease , if the in
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur with trepulmix : very common ( may affect more than 1 in 10 people ): widening of blood vessels pain caused by the infusion site reaction . this may be due to a variety of factors , including : the injection site bleeding , bruising , or swelling at the site of infusion . headaches , nausea , diarrhoea jaw pain common : may affect up to 1 out of 10 people dizziness , light - headedness or fainting , low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgie ) and swelling of feet , ankles . these may be signs of a number of side effects not known . warnings and precaution
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep a trepulmix vial in the original package in order to protect from light . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what trepulmix contains - the active substance is treprostinil . each ml contains 1 mg of trepr . the other ingredients are sodium salt ( see section 6 ). - each 10 mg / 10 mg tablet contains 1 . 5 mg . - every 10 mg tablets contain one . 25 mg , one 2.5 g tablet contains one 2.5 mg tablet containing one g . tablet contains two 25 g tablets containing two gs . one 25 mg tablets contains one - gms / 100 mg tablets , each containing 1 gbs , the other 2 , 5 mg or 50 mg tablets are also available . not all pack sizes may be marketed , but some tablets may be sold .
what thorinane contains - the active substance is enoxaparin sodium , which is a low molecular weight heparin ( lmwh ). the other ingredients are : 1 , stopping existing blood clots , 2 , and stopping blood coagulations in your blood . what thiorinne is used for : - to reduce the number of blood - clotes that build up in the blood and stop them from forming . if you have a problem with the way your blood looks like and contents of the pack , you should tell your doctor , pharmacist or nurse . it is used in adults and adolescents , adolescents and children whose blood has been removed from your blood after an operation . you have an acute illness ( unstable angina ) in your heart , or a heart attack . your doctor
do not take thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if any of these apply to you , tell your doctor straight away . you may experience an allergic reaction , such as rash , swallowing , breathing problems , swelling of your lips , face , throat or tongue . this is because you may be allergic to the active substance of heparin or other low molecular weight haparins : nadroparin , tinzaparin and dalteparin . there is a possibility that you have had a reaction to hparin that causes a severe drop in your clotting cells and platelets
thorinane belongs to a group of medicines called ' other similar medicines '. medicines that help to prevent blood clotting are medicines used to prevent bleeding . the bleeding should be stopped immediately . any bleeding event involving excessive bleeding , exceptional weakness , tiredness , paleness or dizziness ( headache ) or unexplained swelling . contact your doctor immediately if you notice any of the following : - a severe allergic reaction ( e . g . difficulty breathing , swelling of the lips , mouth , throat or eyes ) - blockage of a blood vessel , which can lead to the clot , or cramping pain . warnings and precautions talk to your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . thorinane pre - filled syringes should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 0 . 2 ml , equivalent to 2 , 000 micrograms . the other ingredients are chlorobutyl rubber stopper , a blue polypropylene plunger rod , and 2 - 5 mm . not all pack sizes may be marketed . if you have any questions on the safety of this product , ask your pharmacist .
senstend contains the active substances lidocaine and prilocaine . they are local anaesthetics used to treat lifelong premature ejaculation in the head and the penis . if you are not sure , talk to your doctor or pharmacist .
do not use senstend : if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if any of these apply to you , tell your doctor or pharmacist . allergy is a sign of sensitivity to local anaesthetics , especially amide - type local antiseptics . you have a genetic disease or other condition that affects your red blood cells , glucose , phosphate deficiency ( anaemia ( methaemoglobinaemia ), or medicine sensitivities ( sensitivity can lead to severe liver problems ). this medicine is not recommended for use on the face , accidental contact with ears , eyes , nose and mouth , or eyes .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of senstend is 3 mg once a day . your doctor will tell you how many doses to use . you will be given 3 doses per day , divided into 1 dose per head and penis . every 24 hours , you will receive 4 doses of the spray container with the pump mechanism and the valve . contact with eyes , nose , mouth and ears . if the pump is not working properly , the pump must be removed from the foreskin , head , penis or the valve is closed . for each dose , it is important that you do not have to use the pump . do not throw away any medicines via wastewater or household waste . ask your doctor , pharmacist or nurse how to throw away medicines you no longer use
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with senstend : very common ( may affect more than 1 in 10 people ): inability to develop or maintain an erection in the penis , feeling of burning or penis burning . this may affect up to 1 in 100 people . headache local irritation of the throat , irritation , the skin redness , failure to ejaculate during sexual intercourse , abnormal orgasm tingling , which may be accompanied by a feeling of discomfort , resulting in the pensitching . if you notice any of these , talk to your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the metal container in order to protect from light . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms ( e . g . the other ingredients are : - solution for solution for metering valve ). each spray container contains 1 , 5 , 6 . 5 mg / m3 solution for spraying . not all spray containers are made of the same material , but some contain more than one or two of the following ingredients : one spray container is made of an aluminium spray container in a metreing valve and is available in packs containing 1 or 5 spray containers , each containing one or more spray .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . it is used for complete resection in adults ( treatment with surgery ) and adjuvant therapy . advanced non - small cell lung cancer ( lung cancer ), adults advanced renal cell carcinoma , advanced kidney cancer , adults classic hodgkin lymphoma , previous therapies such as an autologous stem - cell transplant , or a transplant for advanced cancer of the head and neck ( adults advanced urothelial carcinoma ), bladder and urinary tract cancer ( nivolumab ), a monoclonal antibody .
do not take opdivo : - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . tell your doctor or nurse if : you have a change in the rhythm of the heartbeat . - you have an abnormal heart rhythm . this can cause breathing difficulties , cough , inflammation of the lungs ( pneumonitis , interstitial lung disease ) that affects your lung . you have diarrhoea , watery , loose or soft stools . your doctor will tell you whether you have any symptoms of inflammation of your intestines ( colitis ) or stomach pain . ask your doctor for advice .
what opdivo contains - the active substance is nivolumab . each ml contains 1 mg / kg of your body weight . the other ingredients are : capsules : 240 mg , 2 , 480 mg and 4 mg . if you are not sure , talk to your doctor , pharmacist or nurse before you start the treatment . how much to take the recommended dose is one tablet : one tablet contains one tablet called ipilimumab and one tablet of the treatment for adult patients with advanced kidney cancer . your doctor will tell you how many tablets you need to take . you will be given the tablet at the same time each day . it is recommended that you take one tablet at a time every day for at least 3 days .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the blister in order to protect from light . opdivo should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of waste material . these measures will help protect the environment .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg . - each vial contains 40 , 4 , 100 , 10 , 240 , 24 mg / m2 . the other ingredients are : sodium citrate dihydrate , sodium chloride ( see section 2 ). - other ingredients : mannitol ( e171 ), pentetic acid , polysorbate 80 - sodium hydroxide , hydrochloric acid . not all pack sizes may be marketed .
clopidogrel tad is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together to form blood clotting . by reducing the amount of platelet forming in your blood , you can reduce the risk of the clots forming , which can lead to thrombosis . if you are not sure what to do , talk to your doctor , pharmacist or nurse . what you need to know about the dangers of thrombi ( hardened blood vessels ( arteries ) in your body , and / or heart attack , or death , take your tablet as soon as you remember , as it may take longer to get to the end of the tablet , but it is important that you do not have to take it . this is because clo
always take clopidogrel tad exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have a medical condition that is currently causing bleeding , such as a stomach ulcer , bleeding within the brain , or severe liver disease . if this applies to you , tell your doctor as soon as possible . your doctor will tell you how to take it . this includes any possible risk of bleeding . it is important that you follow the advice given to you by a doctor or nurse . you should also tell the doctor if your child has a history of bleeding that is a result of a medicine condition that causes internal bleeding ( e .g . internal bleeding is bleeding inside any tissues , organs or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopidogrel tad : you have a condition called ' atrial fibrillation ' or an irregular heartbeat . your doctor will prescribe a dose of 75 mg once a day . if your doctor tells you to take more than the recommended dose , your doctor may increase the dose you need . you may have severe chest pain , unstable angina , or heart attack . the usual dose is 300 mg / kg / ml . it is recommended that you take the tablet at the same time every day for at least 75 days . during treatment , you will be given 75 mg per day until your next dose is reached . do not take clo
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following : fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or eyes , jaundice , bleeding under the skin , red point dots , confusion ( see section 2 ), swelling in the mouth , skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . if any of these occur , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what clopidogrel tad looks like and contents of the pack the film - coated tablets are white to off - white , with a colour of 75 . the other ingredients are : hydrochloride , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil ( 6000 ), polyvinyl alcohol , titanium dioxide , red iron oxide , yellow iron oxide ( e171 ), talc and macrogol 3000 tablets , which is a clear , colourless to slightly convex , box - containing 7 , 14 or 28 tablets . not all pack sizes may be marketed .
tacforius contains the active substance tacrolimus , which is an immunosuppressant . it is used to treat your organ transplant , i . e . liver , kidney and your body ' s immune system . your body will not be able to make the necessary changes to your organs , but it is important that you do not reject the transplanted parts of your liver or kidney or heart . any previous treatment before or after your transplantation is not recommended .
do not take tacforius : - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor or pharmacist straight away . children and adolescents : do not give this medicine to children under the age of 18 years of age , unless your doctor tells you otherwise . your doctor will check that you are not allergic to any macrolide , antibiotic , such as erythromycin , clarithromycin or josamycin . do not use tacrolimimus immediate release capsules ( e .g , tacni ) if your child is not sure , ask your doctor for advice . tacrolivimus extended - release capsules
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be used by transplant patients . the same taccrolimus medicine should be given to you by your doctor , nurse or nurse . your doctor will tell you how much tacforius to take and how often to take it . do not take more than the recommended dose . if your transplant is not successful , your doctor may prescribe a different tacforimus medicine . it is important that your doctor tells you to take the right medicine to prevent the rejection of your transplanted organ , depending on your body weight , on day 35 of transplantation . these same doses will depend on your general condition , immunosuppressive medication , and the duration of your treatment . you will need frequent blood tests and regular blood tests before and during treatment with tacfor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : infections . infections may occur when you are given tacforius . severe effects may include allergic and anaphylactic reactions , benign or malignant tumours . the most common side effects are : pure red cell aplasia . a very severe reduction in red blood cell counts ( agranulocytosis ), a severely lowered number of white blood cells . haemolytic anaemia ( decreased number of red blood cells ( abnormal breakdown ) or febrile neutropenia , a decrease in the number of black blood cells that help fight infection . this is caused by a reduction in white blood cell count , which helps the body to fight infection more effectively . it is not known whether
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in the original package in order to protect from light . all the prolonged - release hard capsules should be used within 1 week of opening the aluminium wrapping .
what tacforius contains - the active substance is tacrolimus . each capsule contains 0 . 5 mg / 1 ml of water . the other ingredients are : capsule core : 1 mg ( as monohydrate ). - each capsule is packed in a glass vial . - one vial contains 1 mg of tacolimus ( as homogeneous ). the other ingredient is : - capsule contents : 3 mg , 3 mg and 3 mg of syringe : tacollol ( ag ) - tablet contents hypromellose , 2910 , ethylcellulose , lactose and magnesium stearate . capsule shell tacofius is a clear , colourless to pale yellow capsule . it is available in capsule shell - tacfor
clopidogrel zentiva belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that prevent blood clotting . this clumping is caused by the use of anti platelet medical products , which help to reduce the amount of blood that clots form . thrombosis is a type of thrombus ( thrombi ) in hardened blood vessels ( arteries ). it is used to treat atherosclerosis and atherothrombotic events , such as stroke , heart attack or death .
do not take clopidogrel zentiva : - if you are allergic ( hypersensitive ) to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a medical condition that is currently causing bleeding , such as a stomach ulcer , bleeding within the brain , or severe liver disease . if any of these apply to you , tell your doctor or pharmacist . talk to a doctor or nurse . this includes any possible side effects not listed in this leaflet . it is important that you follow the advice given to you by your doctor as soon as possible , as this medicine may cause bleeding . your doctor will tell you how to protect yourself from the risk of bleeding if your doctor tells you to do so . you should also tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of clopidogrel zentiva is for patients with a condition called ' atrial fibrillation ' or an irregular heartbeat . your doctor will prescribe a dose of 75 mg / m2 . if your doctor decides that you should not be treated , your doctor may decide to increase your dose . warnings and precautions talk to your doctor , pharmacist , nurse or nurse before starting treatment . patients with severe chest pain , unstable angina , or heart attack , you will be given 300 mg each day . you will receive 300 mg every day for 4 weeks . this will be followed by a period of up to 75 days . it is important that your doctor tells you how long you are being treated .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following : fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or eyes , jaundice , bleeding under the skin , red point dots , confusion ( see section 2 ), swelling in the mouth , skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . if any of these occur , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . clopidogrel zentiva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel zentiva contains - the active substances are : 75 mg / ml : the other ingredients are hydrogen sulphate ( e171 ), mannitol , hydrogenated castor oil , microcrystalline cellulose , macrogol ( 6000 ) and low - substituted hydroxypropylcellulose . - lactose monohydrate ( milk sugar ) hypromellose (e ), triacetin , red iron oxide , titanium dioxide , carnauba wax . not all pack sizes may be marketed .
yttriga is a radioactive medicine that is mixed with another medicine . tiny radioation doses are used for the treatment . radiolabelled medicinal product must not be used after the expiry date which is stated on the carton .
do not use yttriga : if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using the product . if any of these apply to you , tell your doctor or pharmacist . pregnant women should tell their doctor if they are pregnant or are planning to become pregnant . pregnancy and breast - feeding pregnant women are advised to have a radioactive medicine . another medicinal product ( radiopharmaceuticals ) may contain radioactive material . radioactive medicinal products ( see section 2 ) are not recommended for use in children and adolescents under 16 years of age . other medicines and other medicines should not be used in combination with any other medicines , including medicines containing chloride , other medicines or clinical studies have been carried out on the use of y
keep this medicine out of the sight and reach of children . do not use yttriga after the expiry date which is stated on the carton and the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after the treatment , your doctor will determine the method of administration and radiolabelling of medicinal products to protect against specific diseases . if you are not sure , talk to your doctor , pharmacist or nurse . this medicine is not intended for use in children and adolescents . it is not recommended to be used in children under 18 years of age . you must not take more than one tablet at a time . however , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
like all medicines , yttriga can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor , pharmacist or nurse straight away if you notice any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . reporting of side effects you can help provide more information on the safety of this medicine .
keep out of the sight and reach of children . do not use yttriga after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . local regulations do not apply to radioactive substances . waste material should not be disposed of via wastewater or household waste .
what yttriga contains - the active substance is chloride . each ml sterile solution contains 1 mg of hydrochloric acid . - each vial contains 3 micrograms of solution with a v - shaped bottom and a colourless type i glass vial . it is available in packs of 10 vials containing a flat bottom , a silicone stopper and an aluminium seal . not all pack sizes may be marketed .
ciambra is a medicine used to treat cancer . it contains the active substance cisplatin , which is another anti - cancer medicine used in treatment of malignant pleural mesothelioma ( a type of cancer that affects the lining of the lung ). it is used in combination with prior chemotherapy , so that it can be used as the initial treatment in patients with lung cancer ( e . g . lung cancer whose disease has not responded to treatment with initial chemotherapy ) is not a cure for a treatment for lung cancer which is not responding to other initial chemotherapy is not working .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . do not breast - feed unless your doctor tells you otherwise . tell your doctor as soon as possible . if this applies to you , your doctor will tell you how many times a day you will be given the vaccine against yellow fever . your doctor may decide to give you the vaccine . it is important to tell you that you have problems with your kidneys . infusion , the blood of your kidney , liver function , and the number of enough blood cells , so that you can get the best results , you should not be given too low or too low with cisplatin . you should
always use ciambra exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 500 mg / m2 of your body ' s surface area , depending on your height and weight . this body surface area is important for treatment . your doctor will check your blood cell counts during treatment , and your doctor may adjust your dose based on your blood cells counts . mixed the mixture : 9 mg , 9 mg and 9 mg sodium chloride solution . infusion : the infusion will be given to you in your veins . after 10 minutes of infusion you will receive the product in the form of cisplatin . if your weight and height will be adjusted , the dose will be determined by your doctor , pharmacist or nurse . it is important that you do not have to wait at least 30 minutes after the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : 52 : fever , infection , a temperature , sweating , or signs of infection . white blood cells than normal can cause infection ( sepsis ), which can lead to death . chest pain with a fast heart rate , pain , redness , swelling , sores in your mouth . allergic reaction : skin rash , burning or prickling sensation , fever and skin reactions .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the infusion solution of pemetrexed should be used within 24 hours . if not used within 15 - 25 days , the reconstituted solution should be stored in the original package in order to protect from light . after re-use , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ciambra contains - the active substance is pemetrexed . each vial contains 100 micrograms ( i . e . 100 ml ) - one vial per 100 microlitre of water . the other ingredients are : - a powder for solution for infusion , white lyophilised powder , and a single vial of 500 microlitres . after reconstitution , the solution will be dissolved in 25 microliters of water for further dilution , mannitol ( e2 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide . for further adjustment , see section 2 for more information on the packaging and contents of the pack debossed with " a " on one side and " c " on the other side of the vial . what 
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam is used to treat certain infections in your blood . immunogam can be used to increase levels of human hepatitis b immunisations ( e . g , igg ) in the blood plasma of screened patients . the active substance is immunogam , which is used in the treatment of : haemodialysed patients who have not yet been vaccinated . in this case , vaccination is a type of vaccine that has been shown to produce an immune response . it can also be used in combination with continuous prevention of infected people who have already been in the past , such as those who have had a history of , or who have been , have been diagnosed as a result of the presence of a virus called ' he
immunogam may cause an allergic reaction to human immunoglobulins or other blood products . if you have an iga deficiency , it may be a sign of an allergy reaction to iga containing products ( see section 18 ). warnings and precautions talk to your doctor , pharmacist or nurse before using immunogam . allergic reactions may include chills , headache , fever , vomiting , allergic reactions such as nausea , arthralgia , joint pain , low blood pressure or moderate low back pain . immunogam can also be given to patients with antibodies to hepatitis b immunoglobuin regularly , or in combination with human hematopoizumab injections . children and adolescents immunogam is not recommended for use in children under 18 years of age . it is not known whether immunogam has been used in adults and adolescents .
immunogam is used to prevent the spread of hepatitis b virus . the first vaccine dose is a single - molecule , i . e . human immunoglobulin . administration prevention : if you have a high risk of developing a virus , your doctor may prescribe a dose of 500 mg / ml . in haemodialysed patients , the recommended dose is 500 mg once a day for 24 hours and 72 hours . your doctor will prescribe seroconversion following vaccination instructions . immunogam will be given to you at the same time each day . it will be administered to you by a doctor , nurse or nurse . you will also be given immunogam at a temperature of 20 to 25 degrees celsius , depending on the temperature of the vaccine .
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogam : very common ( may affect more than 1 in 10 people ): very rarely . very common : may affect up to 1 in 100 people , very common (1 in 10 or 1 in 1 , 000 people ), uncommon (1 in 1 10 or 10,000 people ); undesirable effects may occur during clinical trials . immunogam may cause muscle pain , nausea , fatigue , induration and swelling . not known ( frequency cannot be estimated from the available data ). if you notice any of the following symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety
keep out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the outer carton and the vial after exp . this medicine does not require any special storage conditions . immunogam should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / 5 mg solution contains human plasma protein 96 . the other ingredients are polysorbate 80 and water for injection in a glass vial . each vial contains 1 vial of clear , pale yellow liquid . not all pack sizes may be marketed .
remicade contains the active substance infliximab , which belongs to a group of medicines called ' tnf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis ( ankylosing spondylitis , bechterew 's disease ) and pruritus . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . it works by blocking its action , it helps to prevent tumour necrosis factor ( a type of protein ) from spreading to other parts of the body . this medicine is used in adults and adolescents aged 6 years of age and older . crohn' s disease or ulcerative colitis .
do not take remicade - if you are allergic to infliximab or any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given the medicine . if your child is allergic ( hypersensitive ) to tuberculosis , tb , another serious infection such as pneumonia , sepsis or heart failure . tell your doctor straight away if any of these apply to you . your doctor will tell you how long you need to take , how long it takes for you to take and how long your child will need to be given . you should not take more than 16 weeks after your first dose . it is important that you follow the instructions for your child ' s doctor as soon as possible . ask your doctor or pharmacist for advice before taking re
remicade is for use in adults with rheumatoid arthritis . the recommended dose is 3 mg / kg body weight . if you have psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) if your doctor tells you that you are not sure , talk to your doctor , pharmacist or nurse straight away . your doctor will tell you how much to give you . you will also be given the medicine once a day . it is given to you as an infusion ( drip ) over 2 hours in the veins of your arm . after the third treatment , you will receive the medicine over a period of over two hours . this will be given over two weeks .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are mild to moderate . serious side effects may occur during treatment . tell your doctor straight away if you notice any of the following side effects during your treatment with remicade : you may experience an allergic reaction , such as swelling of your face , lips , mouth or throat , difficulty in swallowing or breathing , skin rash , hives or swelling of the hands , feet or ankles . these reactions may be signs of an allergy reaction ( see section 2 for more information ). allergic side effects ( may affect more than 12 people ): pain in the muscles , fever , nausea , vomiting , diarrhoea , constipation , abdominal pain , muscle cramps , weakness or weakness . this includes any possible side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ) for up to 25 days . remicade should be used immediately after infusion . it should be stored in the original package in order to protect from light . infusion should not be stored above 3 , 2 , 8 or 28 days at room temperature . after additional 24 hours , the medicine should be removed from the refrigerator ( 24 - 25 days after removal ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what remicade contains - the active substance is infliximab . each vial contains 100 micrograms ( i . e . one vial containing 10 microgrammes / ml ). - other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate ( e172 ) and dibasic salt ( psp ) - not all pack sizes can be arranged in accordance with your doctor , pharmacist , nurse or nurse ' s instructions on how to prepare the powder for infusion . the powder is available in packs of 1 , 2 , 3 , 4 or 5 vials . not all packs may be marketed .
rasagiline mylan is used to treat parkinson ' s disease in adults . it belongs to a group of medicines called levodopa , which is a medicine that is used in adults for the treatment of the disease . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . you may need to take another medicine to help you manage your condition . your doctor will tell you how to manage your dose . this medicine works by blocking the release of dopamine in the brain . in the absence of cells in the body , it is not known how long it takes for the body to make it work properly .
do not take rasagiline mylan - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine , if : you have severe liver problems . - you are taking one of the following medicines : rasagaline mylan belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . medicinal products are natural products , such as john 's wort and pethidine , which is a strong pain killer . see section 14 for more information . rasagil mylan treatment is not recommended unless your doctor tells you to stop treatment with mao inhibitors or if your skin changes are suspected . you should not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of rasagiline mylan per day . once a day , take one tablet at a time . take the tablet with or without food . do not take more than 1 tablet by mouth . your doctor will tell you how much to take and how long to take . if your doctor tells you to take too many tablets , tell your doctor , pharmacist or nurse as soon as you remember . this will help you to remember to take the next dose . you will need to take your next dose at the same time each day as your usual . it is important that you do not miss a dose to make up for a forgotten tablet . don ' t take a double dose in order to protect yourself from the effects of this medicine 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan : very common ( may affect more than 1 in 10 people ): very rare : may affect up to 1 in 100 people , uncommon (1 in 1 , 000 people ), very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) feeling of being unwell neck pain , chest pain ( angina pectoris ). if you notice any of the following symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what rasagiline mylan contains - the active substance is rasagiline . it is a type of tablet derived from a plant - based diet . each tablet contains a single - use tablet containing 1 mg / ml . the other ingredients are : tablet core : microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( e172 ), talc , stearic acid and syringe . what rasa giliol mylan looks like and contents of the pack rasa mgiline tablets are white to off - white , round , biconvex tablets . they are available in blister packs of 7 , 10 , 28 , 30 , 100 or 112 tablets in perforated blister packs . not all pack sizes
do not take hulio : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine , if : you have a severe infection ( tuberculosis ). - you have symptoms of infections such as fever , wounds , feeling tired , dental problems , moderate or severe heart failure or a serious heart condition . - allergic reaction . allergic reactions : allergic reactions include symptoms such as chest tightness , wheezing , dizziness or swelling , and a rash . these reactions may be signs of infections , such as an infection or localised infection . tell your doctor or pharmacist if any of these reactions occur . this is because h
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . hulio is used to treat polyarticular juvenile idiopathic arthritis ( pjia ) in adults and adolescents aged 2 years and over . the recommended dose is 10 mg once a day for adults and children aged 17 years and older . your doctor may prescribe a dose of 30 mg once per day for children aged 10 years and above . how much to take the dose you will need to take , depending on your age , your doctor will prescribe the dose to your child . you will also need to keep the dose at the same time each day . it is recommended that you do not take more than 40 mg once every day for enthesitis and arthritis in children aged 6 months to 17 years of age . children aged 15 years to 30 years .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur with hulio : very common ( may affect up to 4 people ): allergic reaction heart failure severe rash , hives swollen face , hands or feet trouble breathing or swallowing pale complexion dizziness persistent fever bruising or bleeding signs and symptoms of infection such as fever or feeling sick . if you experience any of the following symptoms , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what hulio contains the active substance is adalimumab . each vial contains monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid for injections . the other ingredients are : - 40 mg / ml - a sterile solution for injection . - the other ingredient is water for injection in a pre - filled syringe . it is available in packs of 1 , 2 or 3 vials , each with a clear , slightly opalescent , and a rubber stopper . not all pack sizes may be marketed .
yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ). it is used to treat inflammation in adults , adolescents and children aged 12 years and older . the active substances are : - the active ingredient is yolx , which is used for the treatment of eye inflammation , and for cataract surgery .
do not take yellox : - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may have asthma , skin allergy or intense inflammation in your nose . other nsaids such as acetylsalicylic acid ( acid ), ibuprofen ( e417 ), ketoprofeen , diclofennac . this medicine contains topical steroids ( such as cortisone ), which can cause unwanted side effects . bleeding problems such as haemophilia have been reported in the past , or have been treated with other medicines to reduce bleeding time , such as warfarin . tell your doctor or pharmacist if any of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of yellox per eye ( s ) once a day . your doctor will tell you how many drops to use . do not use more than 2 drops . take the drops with you the next day after your cataract surgery . method of administration : wash your hands thoroughly before using the eyedrops . remove the bottle cap from the bottle . keep the bottle tightly closed . use the bottle with your thumb , fingers and your head , back , eyelid , finger , and the bottle tip should be inserted into the eye . if not used , contact your doctor , pharmacist or nurse as soon as possible . this will help to protect the eye from light . it is important that you do not drop the drops directly into
what yellox contains the active substance is bromfenac . the other ingredients are sodium sequihydrate , 33 mg / ml solution , and boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride ( e171 ), tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide ( see section 6 ), acidity levels and a clear yellow liquid ( solution ) is supplied in a glass vial with a screw cap . not all pack sizes may be marketed .
dzuveo contains the active substance sufentanil , which belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to severe pain .
do not take dzuveo : - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine , if : you have a serious lung or breathing problem . - you have any condition that affects your breathing , such as asthma , wheezing or shortness of breath . tell your doctor or pharmacist if this applies to you . your doctor may affect your breathing during treatment . you may experience a head injury , brain tumour , or your heart and circulation , slow heart rate , irregular heartbeat , low blood volume or low blood pressure , moderate to severe liver problems , severe kidney problems or your body breaks down . this may be a sign that your doctor has told you to stop taking d
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should be used to administer this medicine . do not take dzuveo with strong painkillers , such as sufentanil , 30 mg / ml . take the sublingual tablet with the disposable single dose applicator on the tongue . once the tablets dissolve , the tablets dissolve in the tongue for pain relief . swallow the tablet with a glass of water for at least 10 minutes . your maximum daily dose is 720 mg once a day . if your doctor tells you to stop your treatment , contact your doctor , pharmacist or nurse immediately . it is important that you do not stop the symptoms of overdose as soon as possible . don ' t stop the use of d
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects very common side effects ( may affect up to 1 in 10 people ): severe breathing problems , slow and shallow breathing . if you notice any of the following side effects you should contact your doctor immediately . very commonly side effects are : - nausea , feeling sick , vomiting , being sick or feeling hot . common side affects can be life - threatening . they may affect more than 1 in 100 people . inability or difficulty sleeping . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effect you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . light and oxygen should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each ml contains 30 mg sufentenil ( as citrate ), mannitol , dicalcium phosphate , hypromellose and croscarmellose sodium , indigo carmine ( e171 ) stearic acid , magnesium starate and round edges . - each tablet is supplied in a single - dose applicator ( labelled [ sublingual tablet ] ) and the application can be used in combination with one sucenil , 30 mg tablet , 5 or 10 tablets . not all pack sizes may be marketed .
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body after surgical treatments . if you have sensitive prostate cancer in your body , you may need surgical treatment to reduce the amount of testosterone in your blood . resistant prostate cancer can be treated by a combination of testosterone and androgens . the cancer is less likely to spread if your doctor tells you to stop taking erlada . this is because it does not work as well as it should if the cancer has spread beyond the body . your doctor will tell you how to stop the growth of prostate cancer cells .
do not take erleada : - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . tell your doctor or nurse if : you are pregnant , breast - feeding , or are planning to become pregnant . if this applies to you , you may need contraception section . this medicine is not intended for contraception . do not use this medicine to treat seizures or any medicines that can cause blood clots , such as warfarin or acenocoumarol . you have any heart or blood vessel conditions such as heart rhythm problems or arrhythmia , which can lead to falls . it is important that you take extra care in the event of a fall , broken bones , before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of erleada is 240 mg / 60 mg once a day . your doctor will tell you how much to take . do not take a double dose to make up for a missed dose . if your doctor tells you to take more than you should , talk to your doctor , pharmacist or nurse . take your next dose as soon as you remember . this medicine will be given to you by mouth . it is important that you take it at the same time each day , with or without food . you will need to take the next dose at the usual time . how long to take it , take it with food , drink , and water . always take the tablet with food or drink . don ' t take more
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following symptoms while taking erleada : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes , fever and flu -like symptoms may be signs of toxic epidermal necrolysis . serious side effects may include : fit and seizure . very common ( may affect more than 1 in 100 people ) if any of these effects happens , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 milligrams ( ml ). the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium ( e171 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystalline cellulose . the film coating : iron oxide black , iron oxide yellow , macrogol , polyvinyl alcohol and talc , and titanium dioxide ( see section 2 ). what erada looks like and contents of the pack the tablet is clear , colourless to slightly yellowish . it is available in cartons containing 8 . 7 x 60 tablet packs . not all pack sizes may be marketed
axumin is a radiopharmaceutical product that contains the active ingredient fluciclovine . it is used to perform a scan of a pet , which is previously under treatment for prostate cancer . other tests have shown that the prostate specific antigen ( psa ) is present in the tumour . if the cancer is present , the doctor will carry out an axemin pet scan to check that the cancer has been removed . the scan will be carried out by a doctor , nurse or nurse . this procedure is to make sure that it is safe to use , as it does not contain any radiation .
do not use axumin : - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . if this applies to you , tell your doctor straight away . children and adolescents under 18 years of age should not be given other medicines . other medicines may affect the results of the scan . pregnancy , breast - feeding , and a low sodium diet are not recommended . you should not have to take a xumumin more than once a day . your doctor will tell you how long you should wait . it is important that you do not have a high risk of kidney problems . this is because a lower dose is needed . the recommended dose is 4 mg / ml .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of radiopharmaceutical products is one ml of axumin per day . this medicine will be given to you by a doctor or nurse at the end of the procedure . your doctor will give you a dose of 370 mg of megabecquerel . how much to inject the medicine you will receive the dose you are given will be determined by your doctor . it is important that you do not inject more than once a day to make up for a missed dose . if your doctor tells you to do so , the procedure will be carried out in a vein with a flush of sodium chloride solution . after the procedure the procedure is complete , you will be injected at the same time each day , and the scan will
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported in clinical studies : very common ( may affect up to 1 in 100 people ) side effects of the medicine have not been reported . you may experience pain , rash , altered taste in the mouth or altered sense of smell . this radiopharmaceutical contains ionising radiation to treat cancer and hereditary abnormalities . talk to your doctor or pharmacist if you notice any of the side effects listed in this leaflet , you can also report side effects directly via the national reporting system listed in appendix v . reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . radiopharmaceuticals and radioactive materials should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of axumin . these measures will help protect the environment .
what axumin contains - the active substance is fluciclovine . each tablet contains a dose of 1600 mg / ml . the other ingredients are : multidose : 1 , 10 , 1600 , or 16000 mg . one tablet contains three doses : 3200 , 3200 and 32000 , sodium citrate , concentrated hydrochloric acid , and sodium hydroxide . see section 2 for more information on the contents of this leaflet . if you have any further questions on the use of this tablet , ask your doctor , pharmacist or nurse . you can also take one tablet at the same time each day . how much to take each tablet : 1600 mg is given as a multidose of 1 tablet or 10 tablets containing 1600 mg and 16000 . not all pack sizes may be marketed in your country .
what azopt contains - the active substance is brinzolamide . it belongs to a group of medicines called carbonic anhydrase inhibitors . they help to control pressure within the eye . - they are used to reduce the amount of pressure in the eye by reducing the need for eye drops to reduce high pressure . this can be a sign of an illness called glaucoma . the pressure in your eye can be too high , causing damage to your sight .
do not take azopt - if you have severe kidney problems or are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , tell your doctor or pharmacist straight away . you may be allergic to medicines called sulphonamides , medicines used to treat diabetes , infections , diuretics ( water tablets ). if your doctor tells you otherwise , you may have the same allergy to too much acidity in your blood , causing hyperchloraemic acidosis . your doctor will tell you how to take the next dose at the same time each day . kidney or liver problems , such as dry eyes , cornea problems or other sulphphonamide medicines to treat glaucoma
always use this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one glass of azopt a day . your doctor will tell you how many glasses to use . do not use more than 1 glass of water per eye . if your doctor tells you otherwise , your doctor may prescribe a different dose for you , or for your child ' s doctor or nurse . how much to use the bottle you will need to use it is important that you use it once a week . it is recommended that you keep the bottle tightly closed with the cap closed with a snap collar . open the bottle with your thumb or finger , either side of the head , back , eyelid or a clean finger . not all bottles are marketed .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) blurred vision , eye irritation and eye pain . eye discharge : itchy eye or dry eye , abnormal eye sensation in the eye and redness of the eye . other side effects include : bad taste , uncommon side effects (1 in 100 people ). - effects not known - may affect more than 1 in 1 , 000 people . - affects less than 1 per cent of the population . these side effects are mild to moderate . they may be mild , but may be serious , and may be life - threatening . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in app
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . azopt should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each 10 ml vial contains the other ingredients : benzalkonium chloride , carbomer 974p , edetate disodium ( e171 ), mannitol , purified water , sodium chloride and tyloxapol , hydrochloric acid and sodium hydroxide . acidity levels and ph levels are checked by a doctor or nurse before using the medicine . what ' s look like and contents of the pack azeopt is a milky liquid ( a suspension ) containing 5 mg , in a 10 mg plastic ( droptainer ) bottle containing 10 mg with a screw cap . not all pack sizes may be marketed .
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " medicines taken by mouth ". it is used to treat diabetes in adults , adolescents , and children aged 18 years and over . if you have diabetes , tell your doctor , pharmacist or nurse . type 1 diabetes is a condition in which your body does not produce enough insulin to control the level of sugar in your blood . this is due to the fact that you do not have any insulin in your body . you may be overweight or obese , or type 2 diabetes . your body produces more insulin than it should . the insulin helps to control diabetes by controlling your blood and your urine . when you are taking it , your doctor will tell you how long you need to take it .
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking : - feeling sick or sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness , tiredness , sweet smell to your breath , a sweet or metallic taste in your mouth , or odour to your urine , sweat , rapid weight loss . - the above symptoms may be signs of " diabetic ketoacidosis , diabetes , increased levels of " ketone bodies ' in your urine and blood . tell your doctor or pharmacist if this applies to you . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much forxiga to take take your doctor will tell you exactly how much to take . the recommended dose is one tablet once a day . for type 2 diabetes , your doctor may prescribe a dose of 10 mg to 5 mg , depending on the severity of a liver problem . if this applies to you , take the tablet with or without food . take your tablet with a glass of water . do not take too much for type 1 diabetes if your doctor tells you to . this medicine swallow the tablet whole . you can take it as soon as you remember . it is important that you take it at the same time each day to make up for a forgotten tablet . in case you take too many tablets , tell your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with forxiga : angioedema ( may affect up to 1 in 10 , 000 people ) if you have , or think you may , have a history of : - swelling of the face , tongue or throat , difficulties swallowing , hives or breathing problems . - diabetic ketoacidosis ( type 1 diabetes ) is a very common occurrence in patients with type 2 diabetes . rare , it is not known whether it affects more than 1 in 100 people . your doctor will tell you how to control your blood sugar . you will also have increased levels of " ketone bodies " in your urine . this may be a sign that your body is not responding to the medicine . tell your doctor immediately 
what forxiga contains - the active substance is dapagliflozin . one tablet contains 5 ml of film - coated tablet ( tablet ) containing a total of 0 . 7 milligrams dextranediol monohydrate equivalent to 5 milligrammes diaphragm . the other ingredients are : tablet core : microcrystalline cellulose , lactose ( see section 2 ' for more information '), crospovidone , silicon dioxide ( e171 ) and magnesium stearate . film coating : polyvinyl alcohol , titanium dioxide , macrogol 3350 , yellow iron oxide , and the colour of the tablet is white to off - white , round , oval - shaped tablets , each containing 5 tablets . not all pack sizes may be 
mepact contains the active substance mifamurtide , which belongs to a group of bacteria called ' eukaryotes '. it is used to treat certain types of cancer in adults , adolescents , and children aged 2 and 30 years of age . it can also be used for the treatment of osteosarcoma ( bone cancer ) after surgery to remove the tumour , chemotherapy to kill cancer cells and bring cancer to the back of the patient .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . medicines such as ciclosporin and other calciumineurin inhibitors ( nsaids ) may damage your heart or blood vessels , causing blood clots (thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vaculitis ). if any of these apply to you , you should tell your doctor or pharmacist . if this applies to you or your child ' s doctor tells you otherwise . you may experience long - lasting , worsening symptoms . your doctor may decide to discontinue mepacat treatment , especially if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepact is one tablet of 2 mg mifamurtide every 12 to 24 hours . your dose depends on your dose , your chemotherapy schedule , and the duration of your chemotherapy . you will be given a dose of 36 mg / m2 each day . if your doctor tells you to stop treatment , tell your doctor , pharmacist or nurse straight away . this will help to prevent an interruption of the freeze - dried powder , a liquid suspension , or the filter , is removed from the solution . it is important that you do not have to stop the treatment . do not stop treatment mepacat if an interruption occurs in the freezing - dry powder and / or if the liquid suspension has been removed .
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue are common ( may affect more than 1 in 10 people ) and are usually mild to moderate . if you are not sure , talk to your doctor , pharmacist or nurse straight away . some of the side effects may be life - threatening , including chills and fever . you may also experience fatigue . when you start treatment , mypact may be transient ( transient ) in combination with paracetamol , which may cause fever during treatment . it is important to tell your doctor immediately . stomach problems such as nausea , vomiting , loss of appetite , or chemotherapy should be stopped immediately , unless you experience continuing fever , chills or chills less than 8 hours after starting treatment : an infection such as rash or any problems breathing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in outer carton in order to protect from light . reconstituted suspension contains sodium chloride . the recommended dose is 9 mg / ml for up to 6 weeks . this medicine does not require any special storage conditions due to deterioration .
what mepact contains - the active substance is mifamurtide . each vial contains 4 ml of solution for infusion . after reconstitution , the suspension contains 0 . 08 micrograms . the other ingredients are : - 1 - palmitoyl - 2 - aldehyde - sn - glycocero - 3 . phosphocholine ( see section 2 ) - 2- dioleoyll - serine monosodium salt ( e172 ) in the vials , each containing 1 . 8 microgram of mfg / mcg , a clear , colourless , white homogeneous cake - infusion is supplied as a 50 mg vial with a grey butyl stopper , aluminium seal
mirvaso contains the active substance brimonidine , which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness associated with rosacea . if you have ever had redness on the face , you may be at risk of developing this condition . you may also have high levels of blood flow in the facial skin , resulting in enlargement ( dilatation ) of the small blood vessels of the skin . Mirvaso acts by reducing the number of blood vessels and reduces the excess blood flow . this reduces redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine , as this may cause side effects . the medicine should only be used under the skin . certain medicines used to treat depression ( parkinson ' s disease ) include monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( imipramine ), tetracyclic anidepressants , maprotiline ( mianserin ) and mirtazapin . if any of these medicines are used , tell your doctor or pharmacist .
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso is given under the skin and on the face . this medicine is given to you by a doctor or nurse who is experienced in the use of this medicine . it is used in combination with other medicines in the body and on body surfaces , such as your eyes , mouth , nose or vagina . the recommended dose is 1 gram ( a pea - sized amount ) per day . your doctor will prescribe the dose to you based on your symptoms . you will be given the maximum daily dose of 1gram ( 5 pea sizes ) every day on your face , hands and feet . do not use this medicine to treat your symptoms after treatment . if your doctor tells you otherwise , contact your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects include severe skin irritation , inflammation and skin rash , skin pain and discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects are worsening of rosacea . the treatment should be stopped if symptoms persist . see section 2 " contact allergy ". allergic reaction ( rash or rare angioedema ) is a serious allergic reaction . tell your doctor or pharmacist if you notice any of the following side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . tube and pump : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 micrograms ( i . e . 5 milligrams ) brimoniidine tartrate . the other ingredients are : carbomer , methylparahydroxybenzoate ( e171 ), phenoxyethanol ; glycerol , titanium dioxide ; propylene glycol ; sodium hydroxide ; purified water ( see section 2 ). if you are not sure , talk to your doctor , pharmacist or nurse straight away . it is available in a clear , opaque gel , available in packs of 2 , 10 or 30 tablets . gel is supplied in an airless pump system . not all pack sizes may be marketed .
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody . it belongs to a group of proteins called ' vegf ' and is produced by the immune system in the body to fight infection , cancer , and other types of cancer . mvai binds to human vascular endothelial growth factor , a protein found in the lymph vessels of the body . this protein is produced in the blood vessels , where it is produced , to make it easier for it to grow tumour growth . the nutrients in your blood vessels do not get enough of the nutrients that are needed to provide oxygen , making it a medicine used to treat advanced cancer in the large bowel or colon .
do not take mvasi : - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents 6 years of age and older who are allergic to chinese hamster ovary ( cho ) cell products . tell your doctor or pharmacist if : you are pregnant or breast - feeding . if any of these apply to you , ask your doctor for advice before you are given , or are planning to have a baby . your doctor will tell you what to do . you should also tell you how long you should wait for the next dose . the risk of developing holes in the gut wall and inflammation inside the abdomen ( diverticulitis , stomach ulcers , co
administration mvasi will be given to you by a doctor or nurse who is experienced in the administration of this medicine . your doctor will determine the dose you will receive based on your body weight and the type of cancer you have . the recommended dose is 5 mg , 7 . 5 mg or 10 mg once a day , or 15 mg once each day . if you are not sure , ask your doctor , nurse or nurse . how much to give your doctor should tell you how many doses to give you . doses may vary from one dose to the other . depending on your weight , your doctor may prescribe a dose that is right for you , depending on how long you have been given , and how often you are given . it is recommended that you do not need to be given a single dose . treatment with this medicine may take up to 2 or 3 weeks after infusion
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the side effects listed in section 6 . these side effects may be serious and may be life - threatening . mvasi is given to you by a doctor or nurse who is experienced in the treatment of patients who have recently been treated with chemotherapy . the following side effects have been reported : allergic reactions : an allergic reaction may include difficulty in breathing , chest pain , redness , flushing of the skin , a rash , chills or shivering , feeling sick , nausea , being sick ( vomiting ) other possible side effects include : severe side effects such as : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion solutions should be stored at room temperature for 24 hours at 2 to 8 oc . after dilution , the solution should be used immediately . if you notice any particulate matter or discolouration , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what mvasi contains - the active substance is bevacizumab . each ml contains 25 mg , 1 . 4 mg or 16 . 5 mg of solution . - each vial contains 4 , 100 mg / m2 of solution for infusion . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 , water for injections and a glass vial containing 20 mg or 20 mg syringe ( e171 ), water for solution for injection is a clear , colourless to slightly yellow liquid , with a rubber stopper . pack sizes of 100 vials , each containing 4 vial of 400 m3 . not all pack sizes may be marketed .
tecartus is a gene therapy medicine used for the treatment of mantle cell lymphoma . it belongs to a group of medicines called " refractory mastectomy ". it is used to treat your own white blood cells called " autologous anti - cd19 - transducer 3+ cells " ( b - lymphocytes ) in adults and children . in adult patients , it works by blocking the activity of the immune system , which is responsible for a type of cancer called a cancer that affects the body ' s ability to produce a certain number of a specific type of immune system ( e . g . by a particular type of b lymphocyte ) that causes a decrease in the number of these cells , causing them to grow in an uncontrolled way , where they grow in the lymph tissue ,
do not take tecartus - if you are allergic to this medicine or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . your doctor will check the number of white blood cells in your blood ( lymphodepleting chemotherapy ) every 3 months . this is because the medicine does not work as well as it should . tests and checks are performed on your lungs , heart , kidney , blood pressure , infection , inflammation , and your cancer may be more likely to develop graft - against - host disease ( a transplant ) in your body . you may experience symptoms such as rash , nausea , vomiting , indigestion , diarrhoea
tecartus will be given to you by a doctor who is experienced in the treatment of your own white blood cells . your cells will be injected into a catheter placed in a vein . a procedure called leukapheresis will take place in your blood . it will take approximately 3 to 6 weeks for your white blood to return to the vein , where it will be stored for at least 2 to 3 weeks . you will also be given medicines to help you get the most out of your treatment , such as lymphodepleting chemotherapy , to help your body , for 30 to 60 days . other medicines will be used to treat infusion reactions ( fever ) if you take any of these other medicines , tell your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the side effects listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse immediately . the following side effects have been reported after the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure , symptoms include dizziness , lightheadedness and fluid in the lungs . all symptoms may be signs of a condition called cytokine release syndrome ( loss of consciousness , decreased level of consciousness or confusion , memory loss ). if any of these occur , contact your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep infusion bag in order to protect from light . liquid nitrogen must be used within 150 ml . this medicine contains genetically modified human blood cells and human - derived material . tecartus does not require any special storage conditions .
what tecartus contains - the active substance is autologous anti - cd19 - stimulated CD3+ cells . each vial contains a specific single infusion bag containing a dispersion of anti . 68 car t cells per 2 ml of solution . the other ingredients are anti , sodium chloride , human albumin ( see section 2 ) and water for infusion in a single - use infusion vial . it is supplied as an infusion , in either a metal cassette , or vial of 68 individual infusion bags . cell dispersion . not all pack sizes may be available .
januvia contains the active substance sitagliptin . it belongs to a group of medicines called dpp - 4 inhibitors . dipeptidyl peptidase -4 inhibitors are used to lower blood sugar levels in patients with type 2 diabetes mellitus . this medicine lowers the levels of insulin in your blood . if you are taking this medicine , your doctor will check your blood sugar to see if it is right for you . your doctor may increase your dose of this medicine to lower the level of insulin that your doctor has prescribed . you can also take this medicine together with certain other medicines , such as insulin , metformin , sulphonylureas and glitazones , which help reduce blood sugar , and lower the risk of your diabetes .
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine , as this can cause inflammation of the pancreas . if this applies to you , tell your doctor straight away if : you have : pancreatitis ( see section 4 ) blistering of the skin ( bullous pemphigoid ). if any of these apply to you or your child , or you think you may be at risk of developing a disease of the liver . you may also have a condition called pancreatic disease . it can cause gallstones , alcohol dependence , and very high levels of triglycerides in your blood . these medical conditions can cause pancre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg coated tablet taken by mouth 63 times a day . for kidney problems , your doctor may prescribe a dose of 25 mg or 50 mg . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine may be used in combination with certain other medicines to lower blood sugar . blood sugar should be regulated by your doctor , pharmacist or nurse . januvia should not be taken with or without food . it is important that you do not stop taking this medicine unless your doctor tells you to . your doctor will tell you how long you should take the medicine . you should tell your doctor immediately if your blood sugar is too high , or if it is too low , stop taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects while taking januvia , contact your doctor immediately : - severe and persistent pain in the abdomen ( stomach area ) or back , nausea or vomiting , - an inflamed pancreas ( pancreatitis ), a serious allergic reaction ( frequency not known ). - rash or hives , blisters on the skin or peeling skin , swelling of the face , lips , tongue , and throat , difficulty in breathing or swallowing . tell your doctor , pharmacist or nurse immediately . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains a single - - action phosphate monohydrate , equivalent to 25 mg / ml . the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphat , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate on the tablet film : poly ( vinyl alcohol , macrogol 3350 ), talc , titanium dioxide ( e171 ), red iron oxide and yellow iron oxide . not all pack sizes may be available in pvc / plastic / glass vials .
xultophy is used to control blood glucose in adults with type 2 diabetes mellitus . diabetes is a condition in which your body does not make enough insulin . the insulin that your body produces is called insulin degludec , a long - acting basal insulin , which helps to control your blood sugar levels . liraglutide and glp -1 help to control the level of sugar in your blood during meals . you can also make more insulin during meals than you normally would if you are not sure , talk to your doctor , pharmacist or nurse . this is because it is used in combination with oral medicines used to treat diabetesxultphy is not a substitute for oral medicines for diabetic patients , such as metformin . it is also used in adults , adolescents , and children .
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 tell your doctor or pharmacist before taking a sulfonylurea such as glimepiride or glibenclamide . you should check with your doctor , pharmacist or nurse if they think you may be taking too much . if any of these apply to you , talk to your doctor about your blood sugar levels . read the leaflet for more information on how to take the tablet . see also section 1 . type 1 diabetes mellitus ( type 1 ) or ' ketoacidosis ', a condition in which you are not taking the tablet due to inflammatory bowel disease ( e 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . do not take xultophy if : you are blind or have poor eyesight . your doctor will check your blood sugar level . if this applies to you , your doctor may increase your dose to 41 mg / ml . it is recommended that you take the tablet with or without food . you should take it at least 8 hours before you take it . take it as soon as you remember . this is because it may take up to 8 hours after you take your tablet , the dose will be determined by your doctor , pharmacist or nurse . how many tablets you will need to take to make up for a forgotten tablet . use the tablet in a pre - filled dial - a 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are low blood sugar ( may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia ( brain damage ) can occur if you are taking xultophy . your doctor will tell you how much you need to eat . if this happens , your doctor may adjust your dose to meet your needs . it is important that you do not have enough sugar in your blood . this may be a sign of a high level of blood sugar . you may be at risk of being unconscious , which may be life - threatening . warnings and precautions talk to your doctor , pharmacist or nurse straight away . in this section , you may have serious allergic reaction ( anaphylactic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . xultophy should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what xultophy contains the active substance is insulin degludec . each vial contains liraglutide 100 mg / ml . the other ingredients are : glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( used for ph adjustment ) and water for injections ( see section 2 ), sodium in 1 , 3 or 5 vials . there is a multipack containing 10 tablets . not all pack sizes may be marketed .
giotrif is a medicine that contains the active substance afatinib , which belongs to a group of proteins called egfr [ epidermal growth factor receptor ] . these proteins are known as erbb1 , her2 [ herbb2 ] and ebb3 . they are important for the growth of cancer cells . this medicine works by preventing cancer cells from growing . it is used for the treatment of cancer of the lung ( non - small cell lung cancer ) and is used in combination with your first treatment . prior chemotherapy treatment for squamous type , before chemotherapy treatment , is not recommended .
do not take giotrif : - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents 6 years of age and older : low body weight 50 kg ; kidney problems ; side effects : lung inflammation ; interstitial lung disease ; liver problems ( see section liver tests ). this medicine can cause a severe liver disease . eye problems , severe dry eyes , inflammation of the transparent layer of the eye ( cornea ) and ulcers in the eye . if any of these apply to you , tell your doctor or pharmacist . this medicine is not recommended for use in children under the age of 18 years . you should not use this medicine for a long time . your doctor will check your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 40 mg once a day . do not take more giotrif than you should if your doctor tells you to . your doctor will tell you how much to take . this medicine will be given to you by a doctor who is experienced in the use of this medicine . it is important that you do not stop taking this medicine after the expiry date which is stated on the label on the carton . you should take the next dose as soon as you remember . take your next dose at the same time each day to make up for a forgotten dose . swallow the tablet whole with a glass of water , with or without food . if swallowing the tablet , swallow the capsule whole with water or other liquids , preferably at least 15 minutes .
like all medicines , giotrif can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects during treatment : diarrhoea ( may affect more than 1 in 10 people ): if your doctor tells you to stop treatment , you will be told to stop the treatment immediately . you may be given the following doses : - hepatitis a : 1 , 2 or 3 times a day . - severe diarrhea , fluid loss , may affect up to 1 in 100 people , low blood potassium , worsening kidney function , diarhoa if any of these apply to you , talk to your doctor or pharmacist . warnings and precautions talk with your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 micrograms . - each tablet contains lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica ( e171 ), crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide , polysorbate 80 and nitrif is supplied in packs containing 20 tablets . the tablets are available in packs of 1 , 2 or 4 tablets in blisters , each blister contains 7 tablets , which are coated with an aluminium porosity . not all pack sizes may be marketed .
lumacaftor is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and adolescents ( aged 6 years and older ) with f508del mutation , a protein that controls the activity of the cystic fibrillation transmembrane conductance regulator in the lungs . the mutation is caused by a change in the expression of an abnormal ccftr protein . orkambi does not work as well as it does not affect how well lucumactor works . it is not known if you have a problem with your breathing , your lung function and gain weight .
do not take orkambi - if you are allergic to lumacaftor or ivacafter or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor or pharmacist straight away . children and adolescents 6 years of age and older : if your doctor thinks you may be allergic , ask your doctor for advice . you may not be able to get the f508del mutation . your doctor may decide to change the dose , depending on the severity of your liver or kidney disease . the dose may be increased or decreased due to abnormal blood tests of the liver . it is important that you do not get these symptoms . liver problems may include pain , discomfort in the upper right stomach ( abdominal 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of orkambi every 6 to 12 hours . your doctor will tell you how much to take and when to take it . do not take more than one tablet at the same time each day . take the tablet with a glass of water . if not taken immediately , take it as soon as possible after the expiry date which is stated on the carton and the carton . it is recommended that you take your tablet at regular intervals : - take it at least once a day , with food , drink , or drink . children and adolescents the usual dose is 100 mg , 2 , 3 , 4 , 5 , 7 , 8 , 9 , 10 , 12 , 15 , 20 , 30 ,
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any of the side effects after taking orkambi or ivacaftor , tell your doctor , pharmacist or nurse straight away . serious side effects may occur when you are being treated for the following reasons : - raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease , or the worsening of liver function . the following side effects are common ( may affect up to 1 in 100 people ): the following symptoms may include pain , discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the eyes , loss of appetite , nausea , vomiting , diarrhoea , tingling of the skin and eyes . if any of these occur , talk
what orkambi contains - the active substance is lumacaftor . each ml contains 100 mg / 125 mg or 100 mg of lum - acetate . the other ingredients are : - oral solution ( e . g . oral solution ) - water for injections , a solution for injection , and a glass of wine . one bottle contains 200 mg , one vial containing 200 mg or a vial of 200 mg ( iu ) or ivacaffetor and the other ingredient is : oral solution in a cellulose , microcrystalline and croscarmellose sodium and hypromellose ascetate syringes . not all pack sizes may be marketed in your country .
lynparza contains the active substance olaparib , which is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it is used to prevent mutations ( changes ) in brca ( breast cancer gene ) that cause cancer to spread . parp inhibitors can cause death of cancer cells , causing them to produce an enzyme called repair dna . if you are not sure , talk to your doctor , pharmacist , or nurse before you are given this medicine , ask your doctor or nurse for advice on how to get the best treatment for ovarian cancer . brca is an inherited form of the cancer that has spread from previous treatment with standard pllatinol . this is because the cancer has spread to other parts of the body .
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents 6 years of age and older should not be given more than 2 doses . if any of these apply to you , tell your doctor or pharmacist . talk to a doctor or nurse immediately : - low blood cell counts - testing shows that you have low counts of red or white blood cells or low platelet counts . see section 4 for more information on side effects . 75 - the signs and symptoms of fever , infection , bruising and bleeding . more serious problems with the bone marrow ( ' myelodysplastic syndrome ') may occur . this may be a sign of
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg capsule once a day . your doctor will tell you how many capsules to take . each capsule contains 150 mg . depending on the dose , the dose will be based on the number of capsules . you can take the capsules as tablets , or as a capsule . if any of these apply to you , you may experience side effects . warnings and precautions talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . children and adolescents 8 years of age and older , your doctor may prescribe a dose that is right for you and your child ' s doctor will advise you on how to take it . take it by mouth or in the evening
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat , symptoms of a decrease in the number of red blood cells ( anaemia ). may affect up to 1 in 100 people . allergic reactions : hives , difficulty breathing , swallowing , dizziness , signs and symptoms of hypersensitivity reactions . other side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in the original package in order to protect from light . lynparza capsules should not be disposed of via wastewater or household waste . these measures will help protect the environment . keep the capsules in a refrigerator ( 2 - 8 ). do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . this medicine does not require any special storage conditions .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg / ml . the other ingredients are : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black , and a white , opaque , hard capsule containing the word ' l' on one side and " l ' on the other side . " is a clear , colourless to off - white capsule . it is available in packs containing 112 or 448 capsules . not all pack sizes may be marketed .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the active substance naloxone belongs to a group of medicines called " opioids ". this includes heroin , methadone , fentanyl and oxycodone , buprenorphine and morphine . nyxoid is given as a nasal spray for the emergency treatment of opioid overdose in adults . it is used in children and adolescents aged 14 years and over . overdose can lead to breathing problems , severe sleepiness , and it is not known whether a person has ever taken opioids . emergency medical care should be taken as soon as possible .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine , as this may affect your ability to use this medicine properly . if this applies to you , contact your doctor or nurse immediately . emergency medical care and emergency services may be required if an opioid overdose has occurred . the signs and symptoms of an opioidoverdose have been reported . this nasal spray should be used 2 to 3 times a day . it is recommended that you use a new nasal spray . tell your doctor immediately if your doctor tells you that you are physically dependent on opioids such as heroin , methadone , fentanyl or oxycodone , buprenorphine
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 ml once a day . symptoms may include : shoulders , ears , breastbone ( sternum ), ear , fingernail , clear the mouth and nose of any blockages . if breathing is the chest moving , the chest may hear breathing sounds or breath on the cheek . overdose may cause a response to touch or sounds , slow uneven breathing .
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following side effects while taking this medicine : nyxoid can cause acute withdrawal symptoms . opioid drugs can cause symptoms such as fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps or shivering trembling changes in behaviour such as violent behaviour , nervousness and anxiety . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains : 1 . 8 mg / ml ( as hydrochloride dihydrate ), trisodium citrate dihydrate ( e171 ), sodium chloride , water soluble ( i . e . chloric acid , sodium hydroxide ) and purified water . the other ingredients are : pre - filled nasal spray , a single dose container , and a carton containing 2 nasal sprays , in blisters containing one nasal spray each . not all pack sizes may be marketed .
ovaleap contains the active substance follitropin alfa , which is a gonadotropin , a type of hormone called fsh . it is used to stimulate the growth of the sacs ( follicules ) in the ovaries and to increase the production of sperm ( a mature egg cell ) during treatment with a medicine called " clomifene citrate " in assisted reproductive technology procedures and procedures . if you are pregnant , tell your doctor or pharmacist . this medicine is used in combination with " luteinising hormone " which is also used in the treatment of infertile women with low levels of certain hormones .
do not use ovaleap : if you are allergic to follitropin alfa or any of the other ingredients of this medicine ( listed in section 6 ) if : you have a tumour in your hypothalamus or pituitary gland , which is located in the brain , large ovaries , sacs of fluids in the ovary ( ovarian cysts ), unexplained vaginal bleeding , cancer in your ovaries , womb or breasts , or any condition that makes normal pregnancy impossible . if this applies to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , as this medicine is not recommended for use in children and adolescents under 6 years of age . you should also tell your doctors before you start using ovale
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much ovaleap to take this medicine will be given to you by injection into a tissue or under the skin ( subcutaneous injection ). irregular periods may occur during the first 7 days of the menstrual cycle . the medicine should be given at the same time each day . this medicine should not be given more than 75 mg or 150 mg once a day for 7 days , 14 days or 37 . 5 days a week . if this medicine is given , your doctor will tell you how long to give this medicine . it is important that you keep this medicine out of the sight and reach of children , adolescents and children aged 7 to 14 years of age . you should not inject this medicine to children under the age of 75 years . your doctor may prescribe a dose of 75
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor , pharmacist or nurse immediately if you notice any of the following serious side effects in women allergic reactions : skin rash , raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing , swelling of the face . 37 common ( may affect up to 1 in 10 , 000 people ) type of reaction . your doctor will tell you how to control your ovaleap injection . contact your doctor immediately . if any of these effects occur , stop using ovaleap . you should tell your doctor as soon as possible . the following side effects may occur in women lower stomach ache , nausea and vomiting . these may be signs of the symptoms of ovarian hyper - stimulation 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the pen cap after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine should be stored at room temperature ( up to 3 - 25 ). this medicine must be used within 3 days after first opening of the carton . the cartridge should be used immediately after opening . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ovaleap contains - the active substance is follitropin alfa . each cartridge contains 300 mg / 0 . 5 ml of solution . the other ingredients are : tablet core : 300 mg and 300 mg tablets : 22 mg and a corresponding amount . if you are not sure , talk to your doctor , pharmacist or nurse straight away . your doctor will prescribe a dose that is right for you . you will also be given a tablet with a solution containing a single dose of 0.5 mg of solution in a glass vial . one vial contains a total of 450 mg , corresponding to 0.75 mg . tablet : if your doctor or pharmacist has prescribed a higher dose , you will receive a different dose each day . this will be diluted to a maximum of 33 mg of 
the active substance voriconazole accord is an antifungal medicine used to treat the fungi that cause infections in children and adolescents aged 2 years and over . invasive aspergillosis is a fungal infection ( scedosporium sp and fusarium ). candidaemia is an infection caused by a non - neutropenic , abnormally low white blood cells count . candida spp . infections are caused by the same fungus as fluconazol , which is used in combination with another antibiotic medicine to treat serious fungal infections , e. g . in adults and children , the use of voricole accord has been shown to reduce the number of serious fungal infections . for example , in adults , it is not known if it has been used in adults or children .
do not take voriconazole accord - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine accord . this medicine does not replace any other medicines , including herbal medicines . tell your doctor or pharmacist how to take the medicines you are taking . 46 terfenadine is used to treat allergy to astemizole . allergy to cisapride for stomach problems , pimozide for mental illness , quinidine for irregular heart beat in the heart , rifampicin for tuberculosis or efavirenz .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much voriconazole accord you should take this medicine will depend on your weight and on the severity of your infection . the recommended dose is 40 mg once a day for 24 hours . your doctor will prescribe a dose of 400 mg once per day for 12 hours , 24 hours after the first dose . if the dose is not enough for you , your doctor may decide to increase the dose to 200 mg once every day . for 12 weeks after the second dose , you will be given 200 mg twice every 24 hours until the next dose is 100 mg once daily . you will receive treatment of 300 mg twice daily for mild to moderate cirrhosis ( see section 2 ). children and adolescents aged 12 years and older , 12 months and 14 years , 50 mg once each day 
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any side effects not listed in this leaflet . serious side effects have been reported with voriconazole accord : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). the following side effects are common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder such as halo vision or nightblindness or swinging vision . other possible side effects include : eye disorder , such as halosight , night blindness or swiping vision and / or glare . these may affect up to 1 in 100 people 
what voriconazole accord contains - the active substance is vorikonazole . each film - coated tablet contains 50 milligrams of vermiculite . the other ingredients are lactose monohydrate ( as pregelatinised starch ), croscarmellose sodium , povidone , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactisone monohydrate , triacetin ( see section 2 ) and a white to off - white - coloured tablet contains 200 millilitres ( 1 . 5 ml ). the film- coated tablets are coated in a glass vial . not all pack sizes may be marketed in your country . if you are not sure , ask your pharmacist .
mvabea is a vaccine to prevent ebola virus disease . it is given to you by your doctor , nurse or nurse in the future . the recommended dose is 1 dose / day / week . if you are not sure , talk to your doctor or nurse . you will be given a 2 dose course of vaccinations . your doctor will decide how much to give you . this vaccine is given in combination with the zabdeno vaccine , which is given 8 weeks later than usual . all vaccinations should be given at the same time each year . not all vaccines are not recommended .
always use mvabea exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the vaccine will be given to you at the end of the vaccination course . if there is a possibility of a severe allergic reaction ( see section 6 ). if this happens , talk to your doctor , pharmacist or nurse before you are given the vaccine . warnings and precautions contact your doctor immediately if : - you have a serious allergic reaction to an antibiotic ( ' gentamicin '). - your doctor may decide to change the dose of the vaccine as soon as possible . your doctor will tell you how long you should wait for the vaccine to be given . it is important that your doctor tells you to stop the injection immediately . you may fainted during the injection , bleeding or bruise easily . currently , you may have
mvabea is a vaccine that is given by injection into a muscle ( intramuscular injection ) into an arm , thigh , or blood vessel . vaccination with zabdeno vaccine is given 8 weeks later than the first dose . the second dose is given as a booster vaccine . primary vaccination first vaccination - the first and second doses are given in a red cap vial . if you are not sure , ask your doctor , pharmacist or nurse . your doctor will tell you how many doses you need . each dose will be given once a week . it is important that you follow the instructions for your child ' s doctor at the end of this leaflet . this is to ensure that your child is given the correct dose , which is given at the same time each day . secondary vaccination first vaccine first vaccination first vaccinated with 
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects have been reported with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling after the injection . very tired muscle ache joint pain uncommon : may affect up to 1 in 100 people : sick ( vomiting ) itching following the injection very common : affects 1 in 1 , 000 people redness or skin hardness , the injection may cause generalised itching . other side effects include : nausea , vomiting , diarrhoea if you get any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can
what mvabea contains - the active substance is zaire ebolavirus 29 . the other ingredients are : tai forest erbavir nucleoprotein marburg , 0 . 7 mg / 108 ml , chicken embryo fibroblast cells . this vaccine contains trace residues such as gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( used for ph adjustment ) and a suspension in a single - dose glass vial with a rubber stopper and yellow cap . each vial contains 20 vials . not all pack sizes may be marketed .
bondronat contains the active substance ibandronic acid , which belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer in adults to treat your bones , called ' bone ' metastases ' . your bones may break ( fractures ) or have other bone problems . surgery or radiotherapy bondronate can cause a raised calcium level in your blood . this may be a sign of a tumour that is lost from your bones and makes your bones weaker .
do not take bondronat - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . low levels of calcium in your blood may be a sign of this side effect . osteonecrosis of the jaw ( onj ) is a condition that can cause bone damage in the jaw . if this happens , tell your doctor straight away . you may have cancer or related conditions . your doctor will tell you to stop treatment if your onj becomes a painful condition , which can lead to developing osteonesorosis of your jaw , and you should take some precautions before starting treatment . tell your dentist if : you have poor dental health , gum disease , a planned tooth extraction or routine dental examination 
always use this medicine bondronat exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one infusion into a vein . your doctor will do regular blood tests to check the effectiveness of this medicine . this medicine will be given to you by a doctor who is experienced in the diagnosis and treatment of your illness . if your illness is a result of breast cancer that has spread to the bones ( see section 3 - 4 ). you will receive an infusion in your vein for at least 15 minutes . you will have a raised calcium level in your blood . it is recommended that you take the medicine at least 1 hour before and 2 hours after your illness has passed . do not take a repeat dose to make up for a missed dose . tell your doctor , nurse or nurse as soon as possible if it is too much , or
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with urgent medical treatment : very common ( may affect up to 1 in 1 , 000 people ) persistent eye pain . inflammation new pain , weakness , discomfort in your thigh , hip or groin , unusual fracture of the triceps . very common : may affect more than 1 in 10,000 people : pain or sore in your mouth or jaw . severe jaw problems : necrosis ( dead bone tissue ) in the jaw or bone . ear pain : discharge from the ear , an ear infection , bone damage in the ears . warnings and precautions talk to your doctor , pharmacist or nurse .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . dilution the infusion solution should be used within 24 hours . store in the original package in order to protect from light .
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 ml of solution for solution for infusion . the other ingredients are sodium monohydrate , sodium chloride , acetic acid ( e172 ), sodium acetate , water for injections and water for aqueous solution for injection . one vial containing 1 or 2 mg of solution contains a bromobutyl rubber stopper . not all pack sizes may be marketed .
zeposia belongs to a group of medicines called " white blood cells " and " lymphocytes ". it is used to treat patients with relapsing remitting multiple sclerosis ( rrms ) as an active disease . ms is a disease that affects the immune system , which controls the body ' s defenses . it works by reducing the number of the cells that make up the nerves in the brain , spinal cord and nerves , causing symptoms such as numbness and difficulty in walking .
do not take zeposia - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - you have a severely weakened immune system that may cause a heart attack ( angina ), stroke ( mini - stroke ), transient ischemic attack ( tia ), severe heart failure in the last 6 months , irregular or abnormal heartbeats ( arrhythmias ) in the heart . if treatment is not effective , you may have severe infection ( hepatitis ), tuberculosis , cancer , severe liver problems , and you may be pregnant or breast - feeding . tell your doctor or pharmacist if any of these apply to you .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose of zeposia will depend on your heart rate . you will receive a ' treatment initiation pack ' at the start of treatment . your doctor will give you a dose of 4 mg / ml of 0 . 23 mg of ozanimod once a day . each day , you will be given one dose of 1 mg or 4 mg of treatment at the beginning of treatment ( see section 3 ). the usual starting dose is 3 mg per kg of body weight ( kg ) per kg body weight . if your doctor tells you otherwise , your doctor may change your dose at any time of the year . it is important that you follow the instructions for the daily dose . this will help you to remember to take the next dose as soon
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects very common ( may affect more than 1 in 10 people ): slow heart rate , urinary tract infection , blood pressure , may affect up to 1 in 100 people . allergic reaction . the signs of allergic reaction are a rash . other side effects tell your doctor immediately if you notice any of the following . side effects that may occur are listed in section 6 : infections of the nose or nostrals , nasal cavity , mouth , throat ( pharynx ), voice box ( larynx) viruses , a type of white blood cell called lymphocytes common : may occur in children and adolescents . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg / ml of water . the other ingredients are hydrochloride , which is found in the capsule shell , in a solution of 0.23 mg . - each capsule is supplied in the following package : - capsule size : 1 . 46 mg : one capsule contains one capsule with one capsule containing one capsule of 0.46 mg , containing two capsules , each of which contains one tablet containing the other ingredient : water , and the other two ingredients are microcrystalline cellulose , silica , colloidal anhydrous ( e171 ), croscarmellose sodium and magnesium stearate . capsule shell contains a 0. 23 mg capsule , gelatin , titanium dioxide and yellow iron oxide ( 
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . the other ingredients are : - a group of medicines called corticosteroids and steroids , namely : mitochondria ( a type of medicine called bronchodilators ) and tetracycline ( tbsp ). - it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that causes breathing difficulties . - copd the muscles are not working properly . this is because copd can cause breathing problems .
do not take temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , ask your doctor or pharmacist for advice . tell your doctor as soon as possible : - asthma , heart problems , high blood pressure , liver problems - tuberculosis ( tb ) of the lung - any long standing or untreated infections - an eye problem such as narrow - angle glaucoma , an enlarged prostate , difficulty passing urine or a blocking in your bladder ( epilepsy ).
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every 24 hours . do not use temybric ellipta after the expiry date which is stated on the label and carton after exp . your doctor will tell you how much to inhale . if a sudden attack of breathlessness , wheezing or attack occurs , your doctor may prescribe a quick - acting reliever inhaler ( such as salbutamol ). if your doctor tells you to do so , you will be given the medicine at the same time each day . it is important that you do not stop taking the medicine without talking to your doctor , pharmacist or nurse . this will help to control your symptoms , such as your copd symptoms such as breathlessness or cough .
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties such as your breathing or wheezing are common side effects of this medicine . pneumonia is an infection of the lung ( copd ). this is a common side effect of temybric ellipta . symptoms of a lung infection include fever , chills , increased mucus production , change in mucums colour and increased cough . increased breathing difficulties uncommon side effects ( may affect more than 1 in 10 people ): sore , sore throat , tingling or numbness . if you notice any of the following , talk to your doctor or pharmacist . this includes any possible side effect not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each inhaler contains 92 mg / ml . the other ingredients are : - a dose for adults 65 years of age and older . - an inhalation for adults 55 years or older , if you are not sure , talk to your doctor , pharmacist or nurse before you inhale the contents of the pack the inhalers are white to off - white , light grey plastic body with a beige coloured mouthpiece cover and a dosing counter . it is supplied in a foil laminate tablet . not all pack sizes may be marketed .
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines known as ' cephalosporin antibiotics '. zefforo has been used to treat infections of the skin and the tissues under the skin . if you have an infection of the lungs ( ' pneumonia ') you should contact your doctor or pharmacist immediately . the main effect of zinfo is to kill certain bacteria , which can cause serious infections .
do not take zinforo : - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if your doctor thinks you may be allergic to other cephalosporin antibiotics , or previous severe allergic reactions to other antibiotics such as penicillin or carbapenem , tell your doctor or pharmacist if any of these apply to you . your doctor will tell you what to do , as soon as possible . you should also tell the doctor if : you have kidney problems , seizures or convulsions . it is important not to take any non - severe allergic reaction . this includes any allergic reactions not listed in this leaflet . see section 26 ' severe diarrhoea
always take zinforo exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 600 mg once a day . your doctor will give you a dose of 600 mg every 12 hours . you will be given a 600 mg tablet every 8 hours , depending on the severity of some infections . if your doctor tells you to take a drip into a vein , it may take up to 5 minutes , 60 minutes or 120 minutes . an increased dose may be given during treatment . 5 to 14 days . skin infections , 5 to 7 days , pneumonia , kidney problems and kidney problems , your doctor may tell you to stop your dose . it is important that you tell your doctor as soon as possible to make sure that your body is working properly and that your kidneys are working properly . do not stop taking
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of these symptoms , you may need urgent medical treatment . sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , or a serious allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus may occur during treatment with zinforo . medicines that slow bowel movement may occur in up to 1 in 10 people . a blood test ( a ' coombs test ') or antibiotic may be necessary . this test will be carried out at the same time each day . tell your doctor as soon as possible if any of the above applies to you . the following side effects may occur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg of ceftaroline fosamil . the other ingredients are arginine , ethidium , and ethylhexyl , which is a colourless , pale yellowish , light yellow powder for solution for infusion in a vial . each vial contains 10 ml of solution .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain , generalised anxiety disorder ( gad ) and peripheral and central neuropathy . it is used for the treatment of long lasting pain caused by damage to the nerves in patients with a variety of diseases . peripheral neuropathy can be caused by diabetes or shingles . pain sensations may include burning or throbbing , shooting , stabbing or sharp , cramping or aching or tingling or numbness . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
always take pregabalin pfizer exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor will tell you how much to take and when to take it . if any of the above applies to you , tell your doctor immediately . symptoms of an allergic reaction may include : swelling of the face , lips , tongue , and throat , diffuse skin rash . these reactions may be serious . the most common side effects are dizziness , somnolence , accidental injury , fall , or blurring , loss of vision , other changes in eyesight or any changes in your vision . diabetes , gain weight or lose weight , you may experience blurring or loss of sight . you may also experience other changes
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is used to treat peripheral and central neuropathic pain ( epilepsy ) and generalised anxiety disorder . the recommended dose is 150 mg once a day . your doctor will prescribe a dose of 600 mg once daily . you can take the tablet with or without food . take your tablet at the same time each day , either in the morning or in the evening , at the usual time 59 . if your tablet does not work , talk to your doctor , pharmacist or nurse as soon as you remember . it is recommended that you take it at least one hour before breakfast and one hour after breakfast . this will help to prevent problems with your kidneys , and you should use a different dosing schedule to ensure that your kidney
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : may affect up to 1 in 1 , 000 people : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest . irritability , disturbance in attention or clumsiness ( memory impairment , loss of memory ), tremor , difficulty with speaking or tingling feeling of pain . this may be a sign of memory loss . these may be signs of loss of sense of smell , taste , smell or taste . the most common side effects are : if you get any side effects not listed in this leaflet , talk to your doctor or pharmacist . you can also report side
what pregabalin pfizer contains - the active substances are : 25 , 50 , 75 , 100 , 150 , 200 , 225 , 300 mg / ml . the other ingredients are lactose monohydrate ( as maize starch ), talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac ( as black iron oxide ), propylene glycol ( as potassium hydroxide ) and 75 x 100 x 200 x 225 mg tablets . not all pack sizes may be marketed .
xadago is a medicine that contains the active substance safinamide and dopamine . these substances are produced in the brain . they are produced by the body ' s own cells . this helps the brain to work more efficiently . it is used to treat patients with parkinson 's disease . if you are not able to move or have difficulties moving , you should contact your doctor immediately . the medicine is used in combination with levodopa and other medicines used for treatment of this type , it is not known if any of these medicines work .
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . tell your doctor or pharmacist before taking the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline - moclobemide , phenelzine - isocarboxazid and tranylcypromine . - treatment for parkinson ' s disease and depression - pethidine is a strong pain killer . see section 7 for more information . do not stop treatment with mao inhibitors ( see section 2 ). if any of these apply to you , ask your doctor for advice before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg / 100 mg taken by mouth . your doctor will tell you how much to take . do not take more than once a day . if your doctor tells you that you have moderately reduced liver function , your doctor may prescribe a dose of 50 mg/ ml . take your dose as soon as you feel better . it is important that you tell your doctor , pharmacist , nurse or nurse . how long you should take the medicine , the usual dose is one tablet at a time . you can take the tablet at any time of the day , with or without food . this will help to reduce the risk of increased blood pressure , anxiety , confusion , forgetfulness , sleepiness 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis , very high blood pressure , collapse , neuroleptic malignant syndrome , confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion ( hypertension ), muscle stiffness , hallucinations , hypotension . other side effects of xadago include : parkinson ' s disease , safinamide and levodopa . if you get any of the side effects listed below , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by
what xadago contains - the active substance is safinamide . each tablet contains 50 mg / 100 mg methansulfonate . the other ingredients are : tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ) and iron oxide red . what if any of these apply to you , tell your doctor or pharmacist if you notice any of the following changes in the colour of the tablet : the tablet is white to off - white , biconcave film - coated tablets of 7 mm diameter with metallic gloss . it is available in packs containing 50 tablets and 100 tablets . not all pack sizes may be marketed 
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer in adults , adolescents , and children . this medicine works by reducing the amount of testosterone in your body . testosterone is also used to reduce the risk of prostate cancer . your doctor will tell you what to do if you need to stop hormone therapy . a treatment that lowers testosterone ( androgen deprivation therapy ) is used in combination with another medicine , prednisone , or prdnisolone . high blood pressure in the body can lead to fluid retention in your blood .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . tell your doctor or pharmacist if : you have severe liver damage or prostate cancer . if this applies to you , you should stop taking this medicine and contact your doctor immediately . this medicine can cause liver problems , high blood pressure or heart failure . low blood potassium can cause heart rhythm problems or other heart or blood vessel problems such as an irregular or rapid heart rate , shortness of breath , 65 years of age , gained weight , swelling in the feet , ankles , or leg . these may be signs of an increased risk of an increase in the risk of a sudden increase in blood pressure .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . this medicine should not be taken by mouth . swallow the tablet whole with a glass of water . take zytiga with or without food . do not take more than one tablet at a time . your doctor will tell you how much to take and how long to take . you should take the tablet as soon as you remember . it is important that your doctor tells you to take it with food , drink , or snack . if this happens to you , talk to your doctor , pharmacist , nurse or nurse . how to take prednisone - a medicine that contains the active substance is a tablet containing the active ingredient , namely : - the pred
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience any of the following side effects while taking zytiga , contact your doctor immediately : muscle weakness , muscle twitches , a pounding heart beat , palpitations . level of potassium in your blood is low . potassium is a mineral in your body . other side effects common ( may affect more than 1 in 10 people ): fluid in your legs or feet , legs , low blood potassium , liver function test , high blood pressure , urinary tract infection , diarrhoea .
what zytiga contains - the active substance is abiraterone acetate . each ml contains 250 mg amyraeterol . the other ingredients are : tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 ' other ingredients in this leaflet for more information ' in the product description and the contents of the pack - zytigea tablets are supplied in a plastic bottle with a child - resistant closure of 120 tablets . not all pack sizes may be marketed .
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases , including polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis ( paediatric plaque psoriasis ) , pediatric crohn ' s disease , and pni - acute , non - infectious uveitis ( e . g . in adults ), it is used in combination with a monoclonal antibody , which is also used in the prevention and treatment of children , adolescents and adolescents whose tumour necrosis factor has been shown to be a major inflammatory disease . this is because the inflammation in these diseases has been increased . the most common side effects are : a . polyarticulary juvenile 
do not take hefiya : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a severe infection such as tuberculosis , sepsis or blood poisoning . - you have other opportunistic infections . unusual infections may be caused by a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems , moderate or severe heart failure , or a serious heart condition . allergic reaction : allergic reactions may include symptoms such as chest tightness and wheezing , cough , itching , sore throat , swollen eyes , dry mouth 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 40 mg once a day . your doctor will tell you how much hefiya to take and how often to take it . do not take more than 20 mg once daily . if your doctor tells you otherwise , your dose may be increased by up to 40 mg twice a week . for polyarticular juvenile idiopathic arthritis your doctor may decide to increase your dose at any time of the year . this is because your body weight may vary from 2 to 30 kg to 40 kg . you can also take enthesitis ( arthritis age ) in children and adolescents aged 6 to 30 years of age , with a dose of 30 kg , or 40 kg in the 6 to 15 kg 30 kg tablets in the 20 kg tablets 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with hefiya : very common ( may affect up to 4 people ): allergic reaction ( heart failure ), severe rash ( hives ), swollen face , hands , feet , trouble breathing , swallowing , shortness of breath , swelling of the feet . signs and symptoms of infection include fever , feeling sick , wounds , dental problems . if you get any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine does not require any special storage conditions . hefiya should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of your medicines you no longer use . these measures will help protect the environment .
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg / 0 . 4 ml solution . the other ingredients are : adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide . - for injections , see section 6 ' recombinant ' for more information on the active ingredient list , please see section 2 ' the product contains water for injection in a glass vial containing 20 mg of solution for injection . it is supplied as a clear , colourless , slightly yellowish solution in clear type i glass , with a stainless steel needle and a needle guard with finger flange 
what ritemvia contains the active substance is rituximab . it is a " monoclonal antibody " that binds to a specific type of white blood cell , called " b - lymphocytes ". if you are not sure , talk to your doctor , pharmacist or nurse before you are given the medicine . a patient who is not sure is given the treatment , you should contact your doctor or nurse immediately . the treatment of non - hodgkin ' s lymphoma ( a disease of the lymph tissue ) that affects the immune system , which produces white blood cells called a type of lymphocyte called b lymphocyte . your doctor will decide whether or not to treat you . you will also be treated with other medicines , such as chemotherapy , before the treatment is started . when you are treated with 
do not take ritemvia - if you are allergic to rituximab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have a severe active infection with a weak immune system , severe heart failure , or severe uncontrolled heart disease , such as granulomatosis , polyangiitis ( microscopic polyangitis ) or pemphigus vulgaris . if any of these apply to you , tell your doctor or pharmacist . talk to a doctor straight away if your child has a history of a hepatitis infection . your doctor will tell you how to get rid of this infection and how to stop it . this infection can cause heart problems such as angina and pal
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much ritemvia to take the recommended dose is one tablet once a day . do not use this medicine after the expiry date which is stated on the carton and the carton after exp . your doctor will tell you how many tablets to take . if any side effects occur during treatment , your doctor may prescribe a drip ( intravenous infusion ) of medicines . this will be given to you by a doctor , nurse or nurse . the usual dose is two tablets , one tablet at a time . it is important that you do not take more tablets than your doctor tells you to . you may also need to take other medicines ( pre - medication ) to reduce the risk of side effects during your treatment for non - hodgkin ' 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are mild to moderate . after treatment , reactions have been fatal . infusion reactions may occur within the first 24 hours after the infusion . fever , chills , shivering , pain at the injection site , blisters or itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing or throat . if you get any of the following symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 milligrams ( mg ). - each vial contains 10 millilitres ( g ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 , water for injections and a clear , colourless solution for infusion in a glass vial . pack of 2 vials . not all pack sizes may be available .
capecitabine teva belongs to a group of medicines called cytostatic medicines . it works by inhibiting the growth of cancer cells , causing them to die . the active substance is cytocitabine which is an active anti - cancer medicine , and is used in adults to treat colon ,rectal , gastric , or breast cancers . if you are not sure , ask your doctor , pharmacist or nurse for advice . capsaicin is used for the treatment of colon cancer , complete removal of the tumour , surgery , with or without food , drink , tea , coffee , biscuits and tea .
do not take capecitabine teva : - if you are allergic to capsicum or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have an allergy to this medicine or have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines called fluorouracil ). - you are pregnant , have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), have severe liver or kidney problems . - your doctor may need to monitor you closely for the enzyme dihydropyrimeidine dehydrogenase ( dpd ) ( complete pd deficiency ) or brivudine ( herpes
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of capecitabine teva is one tablet of anticancer medicines . your doctor will prescribe a dose and treatment regimen based on your body surface area , height , weight and height . you will be given 1 . 125 mg / m2 , depending on your height and weight . it is recommended that you take the tablet at the same time each day . do not take more than one tablet at a time . each tablet will be absorbed by your doctor , nurse or nurse . how much you need to take will depend on how much to take , how long you need , and how often you should take it . what you should do if it is too high or too low , tell your doctor as soon as possible .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you notice any of the following symptoms : diarrhoea , an increase of 4 or more bowel movements during the first 4 days of your bowel movement . if this happens , talk to your doctor , pharmacist or nurse immediately : - vomiting , vomit , nausea , lose your appetite , stomatitis , pain , redness , swelling , sores in your mouth and / or throat , or hand . tell your doctor straight away if any of these symptoms occur . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you
what capecitabine teva contains - the active substance is capsaicin . each tablet contains 150 mg / ml of film - coated tablet . the other ingredients are : tablet - coating : 150 mg capsules , each tablet is a glass - topped tablet , containing 150 mg of ' recombinant ' in the tablet core . - capsule - coat : 500 mg capsule : film , coated tablets each film is coated with 500 mg ' capsule . lactose , microcrystalline cellulose ( e171 ), hypromellose , and croscarmellose sodium , magnesium stearate , macrogol 400 , capsules and tablets are a clear , colourless to off - white , yellow iron oxide and red iron oxide . not all pack sizes may
silodosin recordati belongs to a group of medicines called alpha1a - adrenoreceptor blockers , and is used to treat the prostate , bladder , urethra , smooth muscle and tissues . your symptoms will be controlled by your doctor , pharmacist or nurse . if you are not sure , talk to your doctor or nurse before you are given , or if your doctor tells you otherwise , your doctor will tell you how to treat your symptoms . the most common urinary symptoms are benign enlargement of the prostate ( prostatic hyperplasia ), difficulty in starting to pass water and feeling of not completely emptying the bladder .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before using silodosin recordati if any of the ingredients of this medicine are not listed in this leaflet . your doctor will tell you how to use it . if this applies to you , you should tell your doctor straight away . you should not be given this medicine if : - you have had eye surgery due to cloudiness of the lens ( cataract surgery ) in your eye ( see section 26 ). if your doctor tells you otherwise , your doctor may decide to change your dose , depending on the severity of the damage to the eye , or the size of your eye . 26 - your doctor should tell you that you may need to change the dose as soon as possible 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is 8 mg once a day . your doctor will tell you how many capsules to take . do not take more than your doctor tells you to . you may have kidney problems or moderate kidney problems . if this is not the case , your doctor may prescribe a higher dose . this medicine is for this purpose only . it is recommended that you take this dose at the same time every day for at least 4 hours every day , unless you feel dizzy or feel weak . when you take the tablet , take it as soon as you remember . take your tablet with food , drink or tea , or a glass of water . don ' t take a double dose to make up for
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect of silodosin recordati is dizziness . if you get dizzy or occasionally fainting , you may feel weak or dizzy . tell your doctor straight away if any of the symptoms are severe , or if your doctor tells you otherwise . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what silodosin recordati contains - the active substances are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ) and water . each tablet contains 8 milligrams ( mg / ml ) of silica . the other ingredients are : tablet core : mannatellite ( see section 8 ) tablet : siliconite . tablets containing silicanitidioxide , water , zinc oxide , yellow iron oxide . not all pack sizes may be marketed . sold in packs of 4 tablets , each containing 4 millilitres ( g / mg ) in a glass vial . if you are not sure , ask your pharmacist .
kinzalmono belongs to a group of medicines called angiotensin ii receptor antagonists . it works by causing the body ' s own natural ability to make enough of its own protein . this causes the blood vessels to narrow , causing your blood pressure to rise . kinzulmono blocks the activity of the hormone that makes your body more able to make more of it . as a result , the body relaxes and your blood vessels relax . the high blood pressure is a sign of essential hypertension ( a type of blood pressure ). it is important that you do not have enough blood vessels in several organs , which can lead to heart attack , heart or kidney failure , stroke , blindness .
do not take kinzalmono : - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents 3 years of age and over - the age of 3 months should not be taken . pregnancy section : severe liver problems such as cholestasis , biliary obstruction ( drainage of the bile from the liver and gall bladder ) or any other severe liver disease such as diabetes , impaired kidney function , or a blood pressure lowering medicine called aliskiren . tell your doctor or pharmacist if any of these apply to you . if this applies to you or your child ' s doctor or nurse is not sure , ask your doctor straight away . you should not use 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of kinzalmono is one tablet a day . take the tablets with a glass of water . your doctor will tell you how many tablets to take . do not take more than the recommended dose . if your doctor tells you to take too many tablets , your doctor may prescribe a different dose , depending on the type of treatment you are receiving . treatment for high blood pressure , the usual starting dose is 40 mg / kg / ml . you should take a lower dose of 20 mg once a week . it is recommended that you take the tablet with diuretics ( ' water tablets ') and hydrochlorothiazide , which have a lowering effect , should not be taken with 
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects include sepsis ( blood poisoning ) or a severe infection . whole - body inflammatory response ( rapid swelling of the skin or mucosa ( angioedema ). these side effects may affect up to 1 in 1 , 000 people . the following side effects have been reported with kinzalmono : common side effects ( may affect more than 1 in 10 people ): low blood pressure ( hypotension ) and cardiovascular events . uncommon side effects are : very common : uncommon : may affect 1 in 100 people urinary tract infections ( upper respiratory tract infections ), upper respiratory infections , high blood pressure , abdominal pain , nausea , vomiting , diarrhoea , tingling of the face , mouth , tongue 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . your doctor or pharmacist will take care of the storage of your medicine . store in a refrigerator ( 2 - 8 ). do not freeze . keep your kinzalmono tablet in the blister in order to protect from light .
what kinzalmono contains - the active substance is telmisartan . each ml contains 20 micrograms ( e . g . the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol and magnesium stearate . what the pack contains the product code ' s ' in the label ' on the back of the bottle . pack size : 20 mg blister packs : 14 , 28 , 56 and 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product . it is called lonoctocog alfa and is used to treat bleeding episodes in patients with haemophilia a ( inborn factor ixii deficiency ) who do not have enough of the active substance in their blood . this helps the body to clot and has an increased tendency to bleed . if you are not sure , talk to your doctor , pharmacist , nurse or nurse before you are given the product , see section 2 ' information on how to use it '.
do not take afstyla if you are allergic to hamster proteins or any of the other ingredients of the medicine ( listed in section 6 ). 46 warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine . the batch number will be given to you in your treatment diary . if any of these apply to you , tell your doctor or nurse immediately . allergic ( hypersensitivity ) reactions may occur . your doctor will check with you if your doctor tells you that you may have allergic reactions . symptoms of allergic reactions may include : hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis ). a serious allergic reaction , such as severe difficulty in breathing , nausea , vomiting , diarrhoea ,
keep this medicine out of the sight and reach of children . do not use afstyla after the expiry date which is stated on the carton and on the vial label after exp . your doctor will check the effect of this medicine on blood clotting disorders . if you are not sure , talk to your doctor , pharmacist or nurse before using this medicine . it is important that you use this medicine exactly as your doctor has told you to . check with your doctor or pharmacist if any of the following applies to you . treatment should not be interrupted if your disease the site of the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be diluted . aseptic conditions should be avoided if the solution is not clear , colourless or slightly opalescent . withdrawal of the solution should be made by a doctor or nurse .
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms may include allergic reactions . allergic reactions may include any of the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis and bleeding . factor viii medicines may contain inhibitor antibodies , which may be present in 2 , 1 or 10 days of previous treatment . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . this includes any possible side effects not listed in this leaflet .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . the reconstituted product should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what afstyla contains the active substance is 250 mg / ml . each vial contains 2 . 5 mg of solution for injections the solution contains 100 mg of lonoctocog alfa . after reconstitution , the solution is divided into 200 mg and 1000 mg vials . the other ingredients are : water for reconstitution ( see section 2 , 5 , 4 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 20 , 25 , 30 , 40 , 50 , 60 , 90 , 1 , 500 , 1500 , reconstitution (5 - 5 ) of the solution , 300 mg and 2000 , and reconstitution 5 . if the solution has been injected , it should be diluted , 400 m
praxbind contains the active substance idarucizumab , which is a reverse agent . dabigatran ( pradaxa ), a blood thinner medicine , reduces the risk of blood clot formation , and prevents it from being absorbed by the body ' s natural defence system . when a patient is taken , it is important that he or she immediately removes the drug from the bloodstream and immediately stops it from forming . if you have any further questions on the use of this product , ask your doctor , pharmacist , or nurse .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ) or to a genetic disease called hereditary fructose intolerance to the substance sorbitol . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . serious adverse reactions have been reported to patients who have taken this medicine before . this medicine contains dabigatran and other medicines that reduce the risk of blood clots in the body , which can lead to the build - up of the blood , or to medicines that help to reduce the chances of preventing the growth . if any of these apply to you , tell your doctor or pharmacist . your doctor will tell you about any possible side effects . you should not take this medicine with any other medicines .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of praxbind is 5 mg / 2 . 5 mg dabigatran . do not use this medicine after the expiry date which is stated on the label and carton after exp . your doctor will tell you how much to take . this medicine will be stored in a refrigerator ( 2 - 8 ). do not freeze . keep this medicine out of the sight and smell of food or drink . it is important that you do not throw away any medicines via wastewater or household waste . ask your doctor how to throw away medicines you no longer use . these measures will help protect the environment .
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor , pharmacist or nurse before taking praxbind . if you notice any of the following side effects while taking this medicine , tell your doctor straight away : - side effects not listed in this leaflet . reporting of side effects you can help provide more information on the possible side effects by reporting side effects directly via the national reporting system listed in appendix v .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate and acetic acid , sorbitol ( e171 ) and polysorbate 20 . each vial contains 20 micrograms of water for injections . how much to store the vials the ' s ' label on the back of the bottle is a clear to slightly opalescent , slightly yellow solution . it is supplied in a butyl rubber stopper with an aluminium cap .
temomedac is a medicine that contains the active substance temozolomide . this medicine is an antitumour agent . it is used to treat patients with brain tumours , such as newly - diagnosed glioblastoma multiforme ( e . g ., a type of brain tumour ) in adults , adolescents and children aged 3 years of age and older who have not had radiotherapy ( concomitant phase of treatment ) or monotherapy phase of therapy ( see section 3 ) if you have a child ' s doctor tells you to stop radiotherapy . your doctor will tell you how long your child will be treated . you will be able to have standard treatment , but it is not known how long it will take for you to be given .
do not take temomedac : - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). you have an allergic reaction to dacarbazine , an anticancer medicine called dtic . allergic reaction may include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . blood cells may be severely reduced ( myelosuppression ) in your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting in your blood . if these cells are not working properly , your doctor may decide to stop treatment .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of temomedac is based on your height , weight and recurrent tumour . you may need chemotherapy treatment in the past . your doctor may prescribe other medicines , such as anti - emetics , to help you get the best results . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of the above apply to you , your doctor will tell you how long you will be given the medicine , as this may affect your ability to control nausea and vomiting , or newly - diagnosed glioblastoma multiforme . it is important to tell your doctor as soon as possible if your doctor tells you otherwise . treatment may be interrupted by radiotherapy ( con
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction such as hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills or severe headache , temomedac treatment may cause a reduction in certain kinds of blood cells , increased bruising and bleeding ( anaemia ), increased red blood cells ( fever ) and reduced resistance to infections . the reduction in blood cell counts may be a sign of anemia ( aplastic angiotensive disorder ), which may increase the risk of infection . this may be due to the reduction of blood cell count , which may lead to an increase in the number of cells in the blood , such as an apoptosis ). this may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . this medicine does not require any special storage conditions . if you notice any change in the appearance of the capsules , contact your pharmacist . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . each ml contains 5 mg / m2 . the other ingredients are : - capsules : 1 , 5 , 10 , 25 , 20 , 200 , 300 , 400 , 500 , 600 , 700 , 800 , 900 , 1000 , 2000 , and 2000 . - tablets : one vial : each vial contains 20 mg , 2 , 000 , 1 . 5 mm , 100 mm ( 0 . 100 micrograms ). - temozalomide in the capsule : the other side of the vials are 140 mm in diameter , with 140 mb , in the middle of the pack , 140 microgram ( m ) in the centre of the
cialis is a treatment used to treat erectile dysfunction in adults . if you cannot get a sex , you may not have a clear , asymmetric , or unsuitable , penis suitable for sexual activity . your doctor will tell you what to do . what you should do if your doctor tells you that you are not sure , ask your doctor , pharmacist or nurse . it is used to help you get back to your normal self - esteem . the active substance tadalafil is part of a group of medicines called phosphodiesterase type 5 inhibitors ( pda ) in your blood vessels and the penis . this helps your penis to return to normal , which helps you to get back on track , and help you to re-establish a healthy , happy ,
do not take cialis : - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents 6 months of age and older : organic nitrate . - for nitric oxide donors , amyl notitrite is a form of medicines ( " nits ") used to treat angina pectoris ( " chest pain "). if this applies to you , tell your doctor or pharmacist . this medicine is not recommended for use in children under the age of 18 years of age . these medicines are not suitable for children , adolescents and adolescents . you should not take these medicines at the same time each day . it is not known whether you have serious heart disease . tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of cialis tablets is one tablet a day . swallow the tablets whole with a glass of water . do not take more than the recommended dose of 5 mg or 2 . 5 mg . take the tablets with or without food . your doctor will tell you how many tablets you should take . how much to take : take one tablet at a time . if your doctor tells you otherwise , take the next tablet at the same time each day , the tablets should be swallowed whole . you can take a tablet at any time of the day to make up for a forgotten tablet . it is important that you take the tablet as soon as you remember . this will help you to get erection at least 24 hours after you start taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following side effects while taking the medicine : allergic reactions : rashes , frequency of chest pain , nitrates ( frequency of priapsim ), a prolonged and possibly painful erection after taking cialis . if this happens , contact your doctor immediately . sudden loss of vision ( frequency not known ). other side effects ( may affect more than 1 in 10 people ) or 100 people : headache , back pain . common : may affect up to 1 in 1 , 000 people , headache and back pain not known ( frequency cannot be estimated from the available data ). this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the
what cialis contains - the active substance is tadalafil . each vial contains 2 . 5 milligrams ( ml ). - each tablet contains two tablets : - lactose monohydrate ( see section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ( e172 ), sodium laurilsulfate and magnesium stearate . film - coated tablets are coated in a white to off - white , colourless to opalescent . the other ingredients are : lauryllose , triacetin , titanium dioxide , iron oxide yellow and iron oxide red . talc is not included in the pack . not all pack sizes may be marketed . you can also buy the pack in packs containing 2 , 5 and 2 tablets
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it works by reducing the amount of insulin your pancreas makes . this helps to control your blood sugar and glucose . type 2 diabetes is a disease in which the body does not make enough insulin to control the sugar in the blood . the sugar is released into the body by the body . if you are not sure , talk to your doctor , pharmacist , or nurse before you start treatment . treatment with exercise and weight reduction will help to lower the level of sugar in your blood , so that your doctor will tell you how much you should eat and how long you should take . you may need to take metformin , which is used to treat diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . type 1 diabetes is a condition where the acid level in your blood is too high . diabetic ketoacidosis ( a severe liver disease ) is caused by gemfibrozil , a medicine used to lower increased fat levels , liver problems , or moderate liver 28 disease . see section 2 for more information . read section 2 of this leaflet . if any of these apply to you , ask your doctor or pharmacist for advice before you start taking the medicine , as this may affect your ability to control diabetic control . you should also tell your doctor as soon as possible if : you have a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of enyglid is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . take the tablet with or without food . your doctor will tell you how much to take . do not take more than you should if your doctor tells you to . this medicine is for oral use . it is recommended that you take it at least 30 minutes before you start taking it . you should take it as soon as you remember . if it is more than 30 minutes after you have taken it , your doctor may decide to increase the dose to a maximum of 4 capsules of 30 capsules per day for up to 16 capsules . in case your blood sugar is too high , take a double dose to make
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of enyglid ( may affect up to 1 in 10 people ) and is usually mild / moderate , but can sometimes be severe . if you notice any of the following symptoms , talk to your doctor , pharmacist or nurse straight away , as this may be a sign that you may not be able to take the medicine , or that you are not sure , ask your doctor or pharmacist . this includes any possible side effect not listed in this leaflet . you can also report side effect directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enyglid contains the active substance is repaglinide . each ml of solution contains 0 . 5 mg of solution . one vial contains 1 or 2 vials . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine and poloxamer , yellow iron oxide 1 , red iron oxide ( e171 ) ( see section 2 ), 0. 5 mg , white , round and biconvex with bevelled edges , 1 mm in diameter , pale brown , or yellow . not all pack sizes may be marketed .
azacitidine mylan is an anti - cancer agent . it is used to treat cancer cells by blocking a substance called a ribonucleic acid ( rna ) that is produced by the bone marrow , which is responsible for normal blood cell production . this medicine works by blocking the activity of cancer cells that have not been able to make enough of the active substance , namely : - adipose ( e . g ., mds ) - chronic myelomonocytic leukaemia ( cmml ) ( aml ), which is a type of cancer that has not been detected in the bones and / or blood clot . your doctor will tell you if you need to have a stem cell transplantation . you may have higher - risk mye
always take azacitidine mylan exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of the ingredients of this medicine are not listed in this leaflet , you may be at risk of advanced liver cancer . your doctor will tell you if : you have decreased counts of platelets ( red or white blood cells ). you have kidney disease or liver disease . you have a heart condition ( such as heart attack or lung disease ). your doctor may ask you to do blood test and blood tests before and during treatment . it is important that your doctor tells you what to do . blood tests should be performed before and after the start of treatment , your doctor should tell you how long you will be treated . the duration of treatment is a ' cycle
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of azacitidine mylan is one tablet of another medicine used to treat nausea and vomiting . do not take more than 75 mg of this medicine . your doctor will determine your dose based on your height and weight . it is recommended that you take the tablet at least 3 times a day . this " treatment cycle ' will be repeated every 4 to 6 weeks . you will be given this medicine under your skin , under the skin of your thigh , tummy , or under your arm . if any of the above applies to you , talk to your doctor , pharmacist , nurse or nurse . how long you should take your tablet , as this medicine may take longer than the usual time . take it as soon as you remember .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . symptoms include liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite , confusion , restlessness and fatigue . if you notice any of the following symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use any unused azacitidine mylan after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the suspension in the original package in order to protect from light . the suspension should not be disposed of via wastewater or household waste . if you have any further questions on the use of this medicine , ask your pharmacist . these measures will help protect the environment .
what azacitidine mylan contains - the active substance in the powder consists of 100 milligrams / ml . - after reconstitution , 4 millilitres of water are used for injections . the reconstituted suspension contains 25 milligrammes d . each vial contains a single - oxidized form , similar to that of mannitol , which is added to the powder in a glass vial with a clear , colourless to pale yellow , white to off - white powder . pack sizes of 1 vial or 7 vials are available . not all pack sizes may be marketed .
what duotrav eye drop solution contains - the active substances are travoprost and timolol . both of these substances are known as prostaglandin analogues . they are used in the treatment of glaucoma in adults and children . - they are also used as beta blockers to reduce the amount of fluid in the eye and to reduce pressure within the eye . the active substance is a beta blocker , which helps to prevent fluid from leaking out of the eye or causing an illness , such as cataracts , in adults , children and adolescents .
do not take duotrav : - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . respiratory problems such as asthma , severe chronic obstructive bronchitis ( severe lung disease ), wheeziness , difficulty in breathing , long - standing cough , or breathing problems , such as severe hay fever or a slow heartbeat ( heart failure ), a disorder of heart rhythm ( irregular heartbeat ). if your eye is cloudy , tell your doctor or pharmacist . if this happens , your doctor will tell you what to do .
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop of duotrav per eye . your doctor will tell you how many drops to use . do not use more than once a day . eye drops should be used 1 , 2 , 3 or 4 times a week . you should use a bottle ( 1 ml ) with your hands . use the bottle with your thumb , fingers or your head , back , eyelid with a clean finger or a "pocket " on your eyelid . if not used , contact your doctor or pharmacist as soon as possible . keep the bottle in a refrigerator ( 2 - 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use
like all medicines , this medicine can cause side effects , although not everybody gets them . check with your doctor or pharmacist if you notice any of the following side effects while taking duotrav : very common side effects ( may affect more than 1 in 10 people ): the eye eye redness . uncommon side effects may affect up to 1 in 1 , 000 people . eye eye surface inflammation and surface damage : eye pain , blurred vision or abnormal vision , dry eye or itchy eye , eye discomfort , signs and symptoms include eye irritation , burning or stinging . rare side effects are eye irritation and burning , tingling . unusual side effects include skin rash , redness and redness in the eyes . these may be signs of eye irritation or burning . if any of these occur , talk to your doctor . this includes any possible side effects not listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep in the original package in order to protect from light . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains the active substance is travoprost . each vial contains 40 mg of timolol . the other ingredients are : tablet core : 5 mg / ml : - the other ingredient is tibiol maleate , polyquaternium - 1 , mannitol , propylene glycol and polyoxyethylene hydrogenated castor oil . 40 mg : boric acid , sodium chloride and sodium hydroxide , hydrochloric acid . purified water containing sodium hydrogenoxide and water with a colourless , acidity levels and ph levels are normal .
what nplate contains - the active ingredient is romiplostim , a protein used to treat low platelet counts in patients with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are produced in your blood , which can cause blood clots . if you are not sure , talk to your doctor , pharmacist or nurse before you are given n plate . it is important that you tell your doctor as soon as possible . this is because platelets do not make enough of your blood and can cause bruising and serious bleeding . 1 in 100 people have had their spleen removed . chronic itp occurs when you have previously been treated with corticosteroids or immunoglobulins ,
do not take nplate : - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking n plate if : you have a low blood platelet count ( e . coli ) or thrombocytopenia . your doctor will check your platelet counts to make sure that your blood clots do not form . check with your doctor or pharmacist if any of these apply to you . you should also tell your doctor as soon as possible if your blood count is too low or if there is a high risk of blood coagulation . it is important that your doctor tells you to check that your body is working properly . this is especially important for patients with liver problems . 65 years of age or older if
always use nplate exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 mg per kg of body weight . your doctor will tell you how much to inject . n plate is given as an injection under the skin ( subcutaneous ). you will be given 1 mg / kg of blood platelet counts . you will receive regular blood samples to check your platelets and your platelet count . this will help your doctor determine how much you need . it is important that you do not have enough platelets in your blood , as this will affect how much your body weight will be affected . do not inject more than 1 ml of water once a day . however , your doctor may decide to increase the dose to 1 mg of water per kilogram ( kg ) per kg / m2 . how much n
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ) headache allergic reaction ( upper respiratory tract infection ) respiratory tract : uncommon (1 in 10 ) bone marrow disorder ( increased bone mmarrow fibres ) trouble sleeping ( insomnia ) dizziness , tingling , or numbness of the hands or feet , paraesthesia ( migraine ). nplate has been reported in children and adolescents . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . each ml of solution for injection contains 125 micrograms . the other ingredients are : - water for injection , 230 microlitres , and a 125 - millilitre syringe . if you are not sure , talk to your doctor , pharmacist or nurse before you start the preparation . you will receive a clear , colourless , clear and colourless solution . your doctor will provide you with a deliverable amount of 0 . 25 microlitre solution , which will be poured into a glass vial , is a white to off - white , round , oval , blue , yellow , orange , red , green , pink , black , brown , white or blue . how n
this medicine contains an active substance called glycopyrronium bromide . it belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in patients with a lung disease called chronic obstructive pulmonary disease ( copd ). copd is a condition in which the muscles in the lungs are tightened . breathing difficult , this medicine can cause tightening of the muscles that attach to your lungs . if you are given this medicine , your doctor will tell you how to use it .
do not use tovanor breezhaler : - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . tell your doctor immediately if : you have kidney problems , have an eye problem ( narrow - angle glaucoma ) or have difficulty passing urine during treatment . if this applies to you , ask your doctor or pharmacist for advice before you have to use it . your doctor will tell you how to use this medicine you will be given to you by a doctor or nurse . contact your doctor straight away , as soon as you notice tightness of the chest , coughing , wheezing or breathlessness . immediately , if your doctor tells you to stop using
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to inhale : store in a refrigerator ( 2 8 ). do not freeze . keep this medicine out of the sight and reach of children . store in the original package in order to protect from light . this medicine does not require any special storage conditions . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( g . 63 ml ). - each capsule contains 50 microgram s . the other ingredients of the inhalation powder are lactose monohydrate , magnesium stearate , and water for inhaling . how to use the pack the following pack sizes are available : pack size 44 hard capsules containing a white powder , a device or an inhaler . capsules are supplied in blisters , each blister strip containing 6 or 10 capsules each pack size . not all pack sizes may be marketed .
adasuve contains the active substance loxapine . it belongs to a group of medicines called antipsychotics . dopamine , also known as serotonin , has calming effects and relieving aggressive behaviour . acute symptoms include mild - to - moderate agitation . schizophrenia is a form of bipolar disorder ( diseases characterised by symptoms , such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious , tense or depressed ( depressed or guilty ), anxious or tensed , and adversave is not intended for use in adults .
do not take adasuve : - if you are allergic to loxapine or amoxapene or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . symptoms of wheezing and shortness of breath may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or shortness or 25 signs of neuroleptic malignant syndrome ( nms ). symptoms of antipsychotic medicines may be associated with these symptoms such as high fever and rigid muscles .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg / 2 ml / 4 . 5 mg once a day . your doctor will adjust your dose based on your condition . use the device with your hand or mouth . do not touch the device unless you notice the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements . if your doctor tells you to stop using this medicine , talk to your doctor , pharmacist or nurse . this is because adasuve is not suitable for use in children and adolescents . it is important that you tell your doctor as soon as possible . take the tablet with you when you first take it .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness or irritating to your airways ( asthma , copd ), light - headedness or fainting . your blood pressure may increase . worsening agitation , confusion , fever , muscle stiffness ( a severe condition called neuroleptic malignant syndrome ). the following side effects may occur with adasuve : very common : may affect more than 1 in 10 people . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
always use adasuve exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . an open or damaged pouch may cause physical damage . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 micrograms / ml . the other ingredients are : - it delivers a maximum dose of 4.5 mg / kg . - if you are not sure , talk to your doctor or pharmacist . how much to inhale each inhalation is a white to off - white , disposable white plastic inhaling device containing the active ingredient in the inhalers , which are supplied in a sealed foil pouch . pack sizes are available in packs containing 1 or 5 inhalations .
azacitidine betapharm is an anti - cancer agent . it belongs to a group of medicines called ' medicines for the treatment of cancer ' ( e . g . medicines used to treat cancer ) and is given to you by a doctor who has been trained in the use of this medicine . your doctor will prescribe the right dose for you , depending on the type of cancer you are trying to treat . you will also be given a stem cell transplantation to treat higher - risk myelodysplastic syndromes ( mds ) in adults , adolescents , and children . this is a type of myeloidomonocytic leukaemia ( cmml ) if you have chronic myelatomyeloid leukemia ( aml ). these are diseases that affect the bone marrow and normal blood cell
always take azacitidine betapharm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if your doctor thinks you may have advanced liver cancer , ask your doctor for advice . your doctor will tell you how much to take . you may also be more likely to have decreased counts of platelets ( red or white blood cells ) in patients with kidney disease , liver disease or a heart condition , such as heart attack or lung disease . blood test and blood tests will be carried out before and during treatment . it is important to tell your doctor as soon as possible if blood tests are carried out . patients with lung disease will be asked to take blood tests before and after treatment , so that you know what to do , and how long you should take 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of azacitidine betapharm is one tablet of another medicine used to treat nausea and vomiting . do not take more than 75 mg of this medicine , depending on your height and weight . your doctor will tell you how much to take and how long to take . this " treatment cycle " will last 3 weeks . you will be given this medicine under the skin , on the skin of your thigh , tummy , or under your arm . if your doctor tells you to take it immediately , talk to your doctor , pharmacist or nurse . it is important that you keep taking this medicine at the same time each day . these measures will help to protect the environment . children and adolescents this medicine should not be given to children under 4 years of age
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . symptoms include liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite , confusion , restlessness and fatigue . if you notice any of the following symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use any unused azacitidine betapharm after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the suspension in the original package in order to protect from light . if you are not sure , ask your pharmacist how to use the suspension . the recommended storage time for the suspension is 45 minutes . it is important that you do not throw away any medicines via wastewater or household waste . ask your doctor how to throw away medicines you no longer use . these measures will help protect the environment .
what azacitidine betapharm contains - each vial contains 100 milligrams ( ml ). - the other ingredients are : water for injections . after reconstitution , the reconstituted suspension is stored at room temperature for 4 hours in a refrigerator ( 2 - 8 ). the remaining contents of the vial are white to off - white . - mannitol is not included in the suspension . how much to store and how long to use the suspension should be stored in the refrigerator ( 1 - 6 hours ) and is a clear , colourless to off white , white powder and a glass vial containing 100 vials containing the active substance . not all pack sizes may be marketed .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 , an inherited condition in which the body does not produce enough glucosylceramide . the body ' s spleen , liver and bones are not affected . if you are not sure , talk to your doctor , pharmacist or nurse before you start treatment . your doctor will check your affected organs for signs of damage . this medicine will be given to you at a slow speed , poor metabolisers . you can also test for gaucher disorder type 1 with a simple laboratory test to see if it is safe to use , but it is not recommended that you take it at the same time each day .
do not take cerdelga : - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine is not intended for use in children under 31 years of age . moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine , 31 ) - modecip3a inhibitors such as erythromycin and itraconazole . these medicines affect your body ' s ability to work properly . you should not take these medicines unless your doctor tells you to . tell your doctor or pharmacist if any of these apply to you . it is important that you follow the instructions given in this leaflet . do not use
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of metaboliser is one tablet a day . swallow the tablet whole with a glass of water . your doctor will tell you how much to take . take the tablet with or without food . do not take more than the recommended daily dose , which is 84 mg / ml . you can take a double dose to make up for a forgotten dose . if your doctor tells you to take more cerdelga than you should , talk to your doctor , pharmacist or nurse . it is important that you read the label on the blister / wallet . open the sleeve with your thumb or finger . when opening the blister or wallet , open the sleeves and open the bottle . tell your doctor immediately if
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsia) , feeling sick ( nausea ), diarrhoea constipation , abdominal pain , stomach ache ( upper abdomen pain ), acid reflux disease ( gastrooesophageal reflux disease ), bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 , difficulty swallowing ( diarrhea ), difficulty breathing ( vomiting ), stomach pain ( indigestion ). common : uncommon : may affect up to 1 in 100 people . not known : if you get any side effects while taking cerdelga
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the sleeve after exp . this medicine does not require any special storage conditions . store in the original package in order to protect from light .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 micrograms ( i . e . 1 ml ). - other ingredients are : - capsule core : microcrystalline cellulose , lactose monohydrate ( see section 2 ' other ingredients '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide , yellow iron oxide , indigotine , shellac , black iron oxide ( e171 ) and propylene glycol and ammonia solution . what are the colour of the capsules are white to off - white , round , oval - shaped capsules . they are available in packs containing a pearl blue or green opalescent capsule
what zoledronic acid hospira contains - the active substance in the tablet - contains the active substances , called bisphosphonates , which are substances that are present in bone . they are used to treat bone change , bone complications , e . g . fractures , or bone metastases , in patients with cancer at the primary site of the bone , to increase the amount of calcium in a tumour . tumours in the bone can cause more calcium to be produced . this is called tumour - induced hypercalcaemia ( tbh ).
always take zoledronic acid hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will do blood tests before and during treatment to make sure that you are getting the right dose . if your doctor tells you to stop treatment , tell your doctor straight away . warnings and precautions talk to your doctor , pharmacist or nurse before you start treatment . you should not be treated if : you are allergic ( hypersensitive ) to the active substance , or if it is , you are taking , have recently taken or might take another bisphosphonate . it is important that you do not take any of the ingredients listed in this leaflet . this will help to ensure that your doctor is aware of the substances listed in section 6 . children and adolescents , adolescents and adults , are not allowed to use zol
always use zoledronic acid hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet containing bisphosphonates intravenously into a vein . ' iv ' administration is recommended for patients with dehydration . your doctor may decide to increase the dose to 4 mg once a day . you have a kidney problem . tell your doctor if your kidney problem is worsening . it is important that your doctor tells you to stop the dose . this will help to prevent bone complications and bone metastases . infusion , your doctor will tell you what to do . how to get the best results , the doctor will decide how long to give you the dose you need . when to give the medicine , he or she may need to give it as soon as possible
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): severe kidney impairment . blood tests show low level of calcium in the blood . very common : may affect up to 1 in 100 people : pain in the mouth , teeth and / or jaw , swelling , non - healing sores inside the mouth ( jaw discharge ), numbness , feeling of heaviness or loosening of a tooth , bone damage in the jaw ( osteonecrosis ). such symptoms may occur when zol . if you notice any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via
keep out of the sight and reach of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture .
what zoledronic acid hospira contains the active substances are : - the active substance ( e . g . one ml of concentrate for solution for solution ) contains : one vial containing 4 mg dextrose , monohydrate , mannitol , and sodium citrate . the other ingredients are water for injections , water for infusion and a liquid concentrate for ' infusion '. the concentrate is a ' sterile concentrate ' and contains 4 mg of dexterous solution . each pack contains a concentrate . not all pack sizes may be marketed .
varuby contains the active substance rolapitant . it is used to treat cancer feeling sick ( nausea ) and being sick ( vomiting ) after cancer treatment chemotherapy . chemotherapy destroys nerve cells in the brain . vomiting is a sign of being sick . if you are sick , your doctor will tell you to stop taking va ruby . this helps to stop these nerve cells from working properly . the effect of rolapant is to reduce the number of nerve cells that make you sick and reduces the risk of nausea and vomiting .
do not take varuby - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine is an herbal medicine that contains st john ' s wort ( hypericum performatum ) and is used to treat depression and difficulty sleeping ( see section 2 ). this medicine should not be used after the expiry date which is stated on the carton . 27 - severe liver or kidney problems . - certain medicines such as rifampicin to treat tuberculosis and other infections , carbamazepine to treat epilepsy and nerve pain , and phenobarbital to reduce the need to take enzalutamide to reduce your risk of prostate cancer ( phenytoin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg / 90 mg once a day . swallow the tablet whole with a glass of water . do not take varuby more than 2 hours after your chemotherapy cycle . chemotherapy can cause sickness or sickness . this medicine can be taken with or without food . your doctor may decide to change the dose of this medicine , depending on how you respond to chemotherapy . you may need to take another chemotherapy cycle to make up for feeling sick . if your doctor tells you that you are sick after receiving chemotherapy , talk to your doctor , pharmacist or nurse . it is important to keep this medicine out of the sight and reach of children , adolescents and children under the age of 18 years of age . tell your doctor as soon as possible if this medicine is used 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with varuby : very common ( may affect up to 1 in 1 , 000 people ): - symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever or faster heartbeats . contact your doctor immediately if you notice any of the following . other possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what varuby contains - the active substance is rolapitant . each ml contains 90 milligrams ( mg / m3 ). - each film - coated tablet contains : lactose monohydrate ( see section 2 ' oleic acid '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide ( e171 ) and magnesium stearate . the other ingredients are : polyvinyl alcohol , titanium dioxide , macrogol , polysorbate 80 . - blue , 100 mg film twinned blister . not all pack sizes may be marketed .
what enerzair breezhaler contains the active substance is indacaterol . the other ingredients are glycopyrronium - mometasone furoate . a group of medicines called bronchodilators work by stimulating the muscles in the lungs , thereby reducing the amount of oxygen in the airways , which in turn reduces the flow of oxygen to other parts of the body , such as the heart , kidney , liver , and the intestines . it is used to relieve the swelling of the small airways in the lung . corticosteroids ( also known as steroids ) are used to treat the swelling and irritation ( inflammation ) in the small lungs which can lead to breathing problems . these are also used to prevent attacks of asthma that have been reported in patients who have been treated with a high dose of cortic
do not take enerzair breezhaler : - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , tell your doctor or pharmacist straight away if : you have heart problems such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , severe kidney problems or severe liver problems or low level of potassium in your blood . you have an eye problem called angle - closure glaucoma , difficulty passing urine , tuberculosis ( tb ) of the lung , or any long standing history of diabetes . tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the original package in order to protect from light . enerzair breezhaler will be used to treat your asthma and to relieve your symptoms . after a full day of use , you will be given an inhaler and capsules . the medicine will be inhale the capsules in the bottle . it is important that you use the medicine at the same time each day . you will need to take the medicine as soon as possible after you have taken the medicine . this will be stored in the refrigerator ( at room temperature ). if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects have been reported with enerzair breezhaler . very common ( may affect more than 1 in 10 people ): difficulty breathing , swallowing , swelling of the tongue , lips or face , skin rash , itching , or hives . allergic reaction other side effects common side effects may affect up to 1 in 100 people : sore throat , runny nose , sudden difficulty breathing or feeling of tightness . not known ( frequency cannot be estimated from the available data ). if you notice any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special temperature storage conditions . the capsules should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ) , glycopyrronium ( as bromide ) and mometasone furoate . each inhaler 150 mg / ml inhales 63 mg of , e . g . one inhalation contains , in a single syringe , the other inhalers 50 mg and 160 mg of the other ingredients , both in the mouthpiece of the inhaling 114 mg . the other ingredient is in d . aldosteric acid ( e171 ), 58 mg and / or edgy - sulfate , and 46 mg ' s ' and 136 mg or mt ' in the sulphur
the active ingredient clopidogrel acino pharma gmbh belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures that form in the blood clotting process . this clumping is called ' ' after the name is given to you by your doctor , pharmacist or nurse . these products are used to reduce the number of clots ( called thrombi ) in hardened blood vessels ( arteries ) and reduce the risk of atherothrombosis , which is a type of thrombotic events , such as stroke , heart attack or death , is not recommended .
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , nurse or nurse before taking , or have recently taken , a medical condition that is currently causing bleeding ( such as a stomach ulcer or bleeding within the brain ) or severe liver disease . if any of these apply to you , tell your doctor or pharmacist before taking or have had a blood test . your doctor will monitor you closely for signs of bleeding . it is important that you do not have a medicine that causes internal bleeding and / or stomach ulcer . this is because there is no known blood disorder that can cause internal bleeding or bleeding inside any area of your body . you should also tell your
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 75 mg once a day . your doctor will tell you how much to take . if your doctor tells you to take more than you should , talk to your doctor , pharmacist or nurse . do not take a double dose to make up for a missed dose . take your next dose as soon as you remember . it is important that you take the next dose at the same time every day for the next 12 hours . don ' t take it more than 12 hours at the usual time . this is to make sure that you are taking the correct dose , as it may take longer than usual . however , if it is too high or too low , contact your doctor immediately 
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( may affect more than 1 in 10 people ) yellowing of the skin and / or eyes , jaundice . if you notice any of the following side effects you should contact your doctor immediately : fever , infection , extreme tiredness , rare decrease of some blood cells , liver problems . redness of the face , lips , tongue , mouth , nose , throat , eyes and mouth . common : may affect up to 1 in 1 , 000 people , not known : uncommon : rare : not known ( frequency cannot be estimated from the available data ): unusual taste , smell , taste or smell of urine , nausea , vomiting 
keep out of the sight and reach of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . store in the original package in order to protect from light . film - coated tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substances are : - 75 mg / ml . - the other ingredients are macrogol 6000 cellulose , microcrystalline ( e462 ), crospovidone , a castor oil , hydrogenated film - coating , macrogol 6 kb ethylcellulose ( 462 ) titanium dioxide (e171 ) and 6000 mg ( 171 mg ) the active substance is a monoclonal , biconvex , 14 x 28 x 30 mm , 50 x 84 x 90 mm and 100 mm film . not all pack sizes may be marketed .
delstrigo is used to treat hiv ( ' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines ' . doravirine is a non - nucleoside reverse transcriptase inhibitor . nnrti is also known as lamivudine , a nuclearly active substance , and is also used in combination with tenofovir disoproxil , which is an aminoside analogue reverse transcriptional inhibitor , for example , to prevent hiv infection in children and adolescents aged 18 years and over . hiv is an inherited form of the virus that causes aids ( acquired immune deficit syndrome '). it is not known if the virus is being treated .
do not take delstrigo - if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : carbamazepine ( oxcarbazepine ), phenobarbital ( phenytoin ( medicines used to treat seizure ) rifampicin ( rafapentine ) medicines used for tuberculosis ( john ' s wort ) hypericum perforatum ( a herbal remedy used for depression ) and anxiety . products containing mitothelioma ( antidepressant ) are not recommended for use in children and adolescents
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe a complete regimen for you to take a single tablet to treat hiv infection . the recommended dose is 1 tablet once a day . do not take certain medicines , such as doravirine or medicines . take this medicine swallow the tablet whole with a glass of water . this medicine may be taken with or without food . it is important that you take it as soon as you remember . you should not take it more than 12 hours after your treatment . if your doctor tells you otherwise , tell your doctor , pharmacist , nurse or nurse . how much deltrigo you should take : your doctor may decide to change your dose , depending on how long your treatment lasts . before you start treatment you should stop taking de
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ): abnormal dreams , difficulty in sleeping ( insomnia ), headache , dizziness , sleepiness , cough , nasal symptoms , such as feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( such as pain or stiffness ) and feeling tired . if you notice any of the above , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the bottle in order to protect from light . delstrigo does not require any special storage conditions .
what delstrigo contains the active substances are doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( see section 6 ), microcrystalline cellulose e , silica , colloidal anhydrous ( e171 ), sodium stearyl fragrancerate and a coating material , carnauba wax e903 , the active substance of deltrigo 100 mg film - coated tablets are : iron oxide yellow , lactose monohydrate , titanium dioxide e 171 , triacetin , film , 776 . not all pack sizes may be marketed .
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine is used to treat your depression . the symptoms of depression are : feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . another antidepressant may be prescribed if you are not sure . talk to your doctor , pharmacist or nurse before taking this medicine .
do not take spravato : - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have an aneurysm ( a weak spot in a blood vessel wall ) that bulges out and causes bleeding in the brain . - you have recently had a heart attack within 6 weeks . you may have a temporary increase in blood pressure . serious complications in these conditions may occur . your doctor will tell you how long you should take the medicine . tell your doctor as soon as possible if your heart problem is due to poor blood flow to your blood vessels . it is important that you take this medicine exactly as your doctor tells you . this will help to protect the environment 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray you should use the nasal spray device . the recommended dose is 1 , 2 or 3 nasal spray devices . one nasal spray unit should be used at least 4 times a day . your doctor will tell you how many doses to use . do not use more than 4 doses . if your doctor tells you to , your doctor may decide to change the dose as soon as possible . this medicine can cause nausea and vomiting . it is recommended that you use it at least 2 hours before and 2 hours after your first dose . you should take this medicine at least 30 minutes before you start treatment with this medicine . nasal sprays should not be used in combination with steroid or decongestant medicines . use a nasal
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with spravato : very common ( may affect more than 1 in 10 people ): feeling disconnected , feelings and things around you feeling dizzy , headache , change in sense of taste feeling , sleepy , decreased feeling or sensitivity in the mouth area , spinning sensation , vertigo , vomiting nausea . very common : may affect up to 1 in 100 people , feeling extremely happy , euphoria or feeling agitated . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what spravato contains - the active substance is esketamine . each nasal spray device contains e . s . hydrochloride . one ml of solution contains 28 mg e se . the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ), water for injections and spvato is a nasal spray solution . this medicine is supplied as a clear , colourless solution for injection . it is available in packs of 1 , 2 , 3 or 6 nasal spray devices in a sealed blister . not all pack sizes may be marketed .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat patients with melanoma , which is a type of cancer that has spread to other parts of the body after surgery . if you have had cancer , you may have a change ( mutation ) in your body , or if your cancer has spread , and you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . this medicine works by targeting proteins that help fight your cancer .
do not take zelboraf : - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . symptoms of allergic reactions include : swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation . if any of these applies to you , tell your doctor straight away . allergic reactions are rare , but not all patients are not likely to experience allergic reactions . contact your doctor immediately if : you experience any symptoms of an allergic reaction , such as swollen skin or rash , fainting sense , severe skin redness , redness or redness of the eyes , nose , throat , eyes or ears . your doctor will tell you how to use 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zelboraf is one 4 mg tablet once a day . your doctor will tell you how much to take and how often to take it . do not take more than the recommended daily dose of 8 mg . take the tablet with a glass of water . if your doctor tells you to take a double dose to make up for a missed dose , talk to your doctor , pharmacist or nurse . you may experience side effects during your treatment . this includes any possible side effects not listed in this leaflet . it is important that you tell your doctor as soon as you remember . swallow the tablet whole with water , with or without food . when swallowing the tablet , the tablet should be swallowed whole , and swallow it whole .
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions , such as swelling of the face , lips or tongue , difficulty breathing rash fainting sensation , may be signs of radiation treatment . warnings and precautions talk to your doctor , pharmacist or nurse immediately if you notice any of the following symptoms : skin rash , blistering , peeling or discoloration , the skin shortness of breath , or a ccc . if any of these occur , tell your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the vial after exp . store in a refrigerator ( 2 8 ). do not freeze . these measures will help to protect the product from light .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 micrograms / ml ( 0 . 5 mg / mg ). - this is a co - precipitate of v . a mixture of hypromellose acetate succinate , colloidal anhydrous silica ( e171 ), croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film , iron oxide , macrogol 3350 , polyvinyl alcohol , and talc and titanium dioxide ( see section 2 ). what is the colour of the tablet is white to off - white , pinkish white to orange white in an aluminium perforated unit dose blister . not all pack sizes may be marketed .
duoplavin contains the active substance clopidogrel , acetylsalicylic acid ( asa ), which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which can cause blood clotting . this clumping can occur in blood vessels , and can be a sign of a decrease in the amount of blood - clots that form in the form of atherothrombosis . the active ingredient in the tablet contains a substance called " e . g . " on one side and " c " on the other side . in this case , the product contains an active substance called ' c '. in a similar way , it is used to treat blood coagulation in hardened arteries . it is also used to prevent at
do not take duoplavin : - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , tell your doctor or pharmacist straight away . children and adolescents 6 years of age and older : you may be allergic to other products or non- steroidal anti - inflammatory products . you may have painful and / or inflammatory conditions of muscles or joints , or a medical condition such as asthma , nasal discharge , runny nose , polyps or type of growth in the nose . this may be a sign of a medicine condition that is currently bleeding or has a stomach ulcer or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of duoplavin is one tablet once a day . your doctor will tell you how much to take . do not take more than your doctor tells you to . take your medicine as soon as possible after the expiry date which is stated on the label and carton after exp . you may have a heart attack . if necessary , you should contact an emergency department immediately , if bleeding occurs . don ' t take any further questions on the use of this medicine , ask your doctor , pharmacist , or nurse . it is important that you follow the instructions for use in this leaflet . children and adolescents - the recommended dose is 12 mg / kg / ml . this is a double dose of 14 , 28 or
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following : fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or eyes , jaundice , bleeding under the skin , red point dots , confusion ( see section 2 ), swelling in the mouth , skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . this is a serious side effect of duoplavin . the following side effects have been reported in patients treated with this medicine , tell your doctor , pharmacist or nurse immediately , as these may be serious . these may include : - swelling of the mouth and - skin disorders , e . g . skin disorders
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 to 25 ). do not freeze . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what duoplavin contains - the active substances are clopidogrel , acetylsalicylic acid ( asa ) and 75 mg / ml film - coated tablets . each tablet contains 46 active substances ( e . g . the other ingredients are : tablet core ( pbs ) ( cs ). tablet core : 75 mg ( asa ). - tablets : - tablet shell - coating ( db ) - syringe ( bsp ), acetate , hydrogen sulphate , sodium , potassium , calcium , magnesium , manganese , zinc , copper , iron , silicon dioxide ( iodide ). tablets containing : microcrystalline cellulose , low substituted hydroxypropylcellulose
what simbrinza contains the active substance is brinzolamide . the other ingredients are brimonidine tartrate , which belongs to a group of medicines called carbonic anhydrase inhibitors ( cnih ) and brimoniidine tartratrate . they are used in combination with other medicines called alpha -2 adrenergic receptor agonists to reduce pressure within the eye . simbr inza is used in adults , adolescents and children aged 18 years and older with eye conditions such as glaucoma , ocular hypertension and high pressure in the eyes .
do not take simbrinza : - if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , tell your doctor or pharmacist . children and adolescents 6 years of age and older : you may be allergic to sulphonamides , medicines used to treat diabetes , infections , diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors . medicines used for depression , parkinson ' s disease , certain antidepressants . you should not take any antiidepressant medicines . severe kidney problems , too much acidity in your blood can lead to hyperchloraemic acid
always use this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of simbrinza per day . your doctor will tell you how many drops to use . do not use more than once a day , unless your doctor tells you otherwise . take the drop into your eyelid with a clean finger . there is a ' pocket ' between the eyelid and the eye . if the drop does not work , contact your doctor immediately . it is important that you do not touch the cap or snap collar . use the medicine with your fingers . you can use the bottle with your thumb , fingers , head , back , eyelid , or with your clean finger to remove the drop . this is to protect your eyes from light . keep the bottle closed
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following side effects while taking this medicine : - a reaction to the medicine ( frequency not known ). - an allergic reaction . - severe skin reactions ( rash , redness , itching ) on your body , eyes trouble breathing , chest pain , irregular heart beat . contact your doctor immediately : extreme tiredness and dizziness . other side effects of simbrinza may occur with other medicines such as brine brine . these include : mild to moderate to severe fatigue , diarrhoea , nausea , vomiting , tingling , chills , sore throat , muscle spasms and shivering . tell your doctor if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the bottle in the original package in order to protect from light . if you notice any signs of infection , a new bottle should be used . this medicine does not require any special storage conditions .
what simbrinza contains - the active substances are brinzolamide , brimonidine tartrate and water for suspension . each vial contains 10 mg / ml / 1 . 3 octane . the other ingredients are : - acetate ( e171 ) ( i . e172 ). - anhydrous , hydrochloric acid , sodium hydroxide , purified water . not all of the ingredients are hydrogen peroxide , hydrogen percarbonate , and acetylene glycol , carbomer 974p , boric acid and mannitol ; - sodium chloride and tyloxapol ; water for aqueous solution . water for purified solution : water for the suspension : 10 micrograms ( g .
filgrastim ratiopharm is a medicine that contains the active substance filgra stim , which belongs to a group of proteins called escherichia coli , a natural protein , called granulocyte , that is produced by the bone marrow to produce new blood cells . more blood cells are produced , and more white cells are formed . white cells help your body fight infection by reducing the number of white blood cells that your body needs to produce . if you are not sure , talk to your doctor , pharmacist or nurse , or nurse before you are given this medicine , ask your doctor or nurse for advice on how to get the right kind of medicine that works best for you . filgrartim ratioopharm works by preventing the formation of a white blood cell called a type of medicine called ' nasopharm '.
do not take filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the product . - you may experience a cough , fever or difficulty breathing ( a pulmonary disorder ). - side effects of sickle cell disease ( see section 57 ) - left upper abdominal pain , pain in the shoulder , or spleen disorder . other possible side effects tell your doctor or pharmacist if any of these apply to you . your doctor will conduct regular blood tests to check how well your immune system works . you will also be tested for the presence of neutrophils and white blood cells in your blood before and during treatment . this will help to monitor the levels of these cells .
filgrastim ratiopharm will be given to you by a doctor or nurse who is experienced in the treatment of a specific type of disease . your doctor will decide how much to give you and how long you will need to receive it . if you are not sure , talk to your doctor , pharmacist or nurse before you are told to give it to you . the recommended dose is 60 mg / kg / m2 of your bone marrow transplantation . this is based on your body ' s response to chemotherapy , which is equivalent to 0 . 5 mg/ kg of your body weight , or 30 mg of your treatment , depending on your disease types , your treatment may take up to 14 days . some disease types may need to be stopped , but your doctor may decide to discontinue your treatment immediately . you should tell your doctor as soon as possible . fil
filgrastim ratiopharm is used to treat sickle cell disease in adults 57 with left upper abdominal pain or pain in the shoulder . if you have a spleen disorder , see section 4 . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor will do regular blood tests to check for any possible side effects , including : neutrophils , or white blood cells , in your blood during treatment . other medicines tell your doctor or pharmacist if any of the above apply to you . this includes any other medicines , such as medicines used in pregnancy or breast - feeding . you should not take any medicine , except if your doctor tells you that you are pregnant or are planning to become pregnant . it is important that you inform your doctor as soon as possible , as this medicine is not intended for use in pregnant women .
keep out of the sight and reach of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . if the product is cloudy , tell your pharmacist . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is a single - molecule solution for solution for infusion . each vial contains 60 micrograms ( 1 ml ) dna . the other ingredients are : infusion 30 mg , 0 . 5 mg / m2 , and 30 mg filgrartim . - infusion 48 mg - 1 . 8 mg per m3 of solution for injection 48 % of solution : - sodium hydroxide , glacial acetic acid ( e171 ), sorbitol , polysorbate 80 , water for injections , the infusion is supplied in a glass vial . not all pack sizes may be marketed .
riluzole zentiva contains a substance called glutamate ( a chemical messenger ) in the nervous system . it is used to treat adults with amyotrophic lateral sclerosis ( e . g . motor neuron disease in which the nerve cells in the muscles are damaged , causing weakness , muscle waste and paralysis . the destruction of nerve cells is a sign of motor neurodeath , which can lead to motor neuropathy , because there is too much glutamates ( an important part of the brain and spinal cord ), which can cause the nervous cells to become weak , and causing muscle damage , paralysis and / or paralysis in the body . this is because it is important to take care of your nerve cells .
do not take riluzole zentiva : - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , if : you have any liver disease , increased blood levels of some enzymes of the liver ( transaminases ). - you are pregnant or breast - feeding . tell your doctor or pharmacist if any of these apply to you . - any liver problems , such as yellowing of your skin or your eyes , jaundice , itching , feeling sick or sick , especially if your kidneys are not working properly . you may experience fever or a low number of white blood cells , which may be a sign of infection . children and adolescents under 18 years of age should not be given 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the tablets should be taken by mouth every 12 hours . do not take riluzole zentiva after the expiry date which is stated on the carton and the blister after exp . your doctor will tell you how many tablets to take . take the tablets with a glass of water . you should take the tablet with or without food . if your doctor tells you to take more than one tablet than you should , talk to your doctor , pharmacist or nurse . it is important that you take a double dose to make up for a forgotten tablet . don ' t take more tablets than your usual time .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience fever ( increase in temperature ) while taking riluzole zentiva . you may notice a decrease in the number of white blood cells in a blood sample . your doctor will take a test to check that your white blood cell count is correct . infections may be caused by the following symptoms : yellowing of your skin and / or eyes , jaundice , itching , feeling sick or sick , or being sick due to liver disease ( hepatitis ) and regular blood tests should be carried out regularly . if any of the above applies to you , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . these may include : - cough , difficulties in breathing ,
what riluzole zentiva looks like and contents of the pack the tablets are white to off - white , with anhydrous dibasic calcium phosphate . the other ingredients are : - microcrystalline cellulose ( e171 ) - ahydrous colloidal silica , magnesium stearate , croscarmellose sodium / hypromellose , macrogol 6000 , titanium dioxide ( iodine ). what reconstituted in the package the tablets have a clear , colourless tablet . they are available in packs of 50 tablets . each tablet contains 202 tablets , each containing 28 tablets ( 56 tablets ), 98 tablets or 112 tablets ( 168 tablets ). not all pack sizes may be marketed .
emgality contains the active substance galcanezumab , which belongs to a group of medicines called calcitonin genes . it is used to treat migraine in adults with increased levels of cgrp . this is a type of migraine that affects more than 4 per cent of adults . if you suffer from migraines , you may be more likely to have a migraine headache . your doctor may decide to reduce the frequency of migraine headache and improve your quality of life .
do not take emgality : - if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a serious cardiovascular disease or serious cardiovascular diseases . if any of these apply to you , tell your doctor or pharmacist . allergic reactions emmgality is used to treat serious allergic reactions in adults . these reactions may affect up to 40 people . this is because if this is the case , you may be at risk of serious allergic reaction . such signs may be signs of side effects . see section 4 for more information . children and adolescents this medicine is not recommended for use in infants and adolescents under 18 years of age . other medicines - this includes any other medicines used in pregnancy ,
always take emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg tablet once a day . your doctor will tell you how much to take . do not take a double dose to make up for a missed dose . if your doctor tells you to take more than you should , talk to your doctor , pharmacist or nurse . take the tablet with a glass of water . it is important that you do not use this medicine without first checking your skin ( subcutaneous injection ). your doctor may decide to increase the dose you need . you will need proper training before you start . this is to make sure that you have proper training . don ' t use more than 240 mcg / kg of body weight . however , a single dose may be necessary .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions have been reported with emgality : rash or itching serious allergic reactions ( may affect up to 1 in 1 , 000 people ): difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps . other side effects very common side effects may affect more than 1 in 10 people at the injection site . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 - 7 ). do not freeze . emgality should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of this medicine . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 micrograms ( i . e . 1 ml ) of l - histidine ( e171 ) - hexidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections the other ingredients are water for the solution for injection in a clear glass syringe , which is slightly yellow on the inside . the pen is supplied as a single - dose pen containing 1 , 2 or 3 injections . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease , which affects the blood vessels in the liver and causes blood clots . this medicine is used in combination with medicines that have been given prior to a stem cell transplantation . the medicine works by reducing the number of blood vessels that are damaged , allowing the blood to flow freely . if you have any further questions on the use of this medicine , ask your doctor .
do not take defitelio : - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . other medicines may cause blood clots , including tissue plasminogen activator warnings . this medicine is used to prevent bleeding and heavy bleeding after a blood transfusion . after surgery , you may have problems with blood circulation and a constant blood pressure ( see section 1 ). other medicines : medicines that reduce the risk of clotting such as acetylsalicylic acid ( heparins ), warfarin , dabigatran , rivaroxaban and apixaban . tell your doctor or pharmacist if any of these apply to you . warning
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the treatment with defitelio is a type of stem cell transplantation . it is given into veins by an ' intravenous infusion ' or drip . this treatment is for 21 days , depending on your symptoms . children and adolescents under 18 years of age should not be taken without the advice of a doctor or nurse . a double dose is recommended . do not use this medicine after the expiry date which is stated on the carton . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
like all medicines , defitelio can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious or serious side effects while you are taking the medicine : very common ( may affect more than 1 in 10 people ): low blood pressure ( can affect up to 1 in 1 , 000 people ). bleeding in general bleeding : the nose bleeding , the brain bleeding or the gut vomiting , blood bleeding in the lungs bleeding and blood in the urine . the mouth bleeding and the skin coagulopathy ( disturbance of blood clotting ). if any of these side effects happens , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of
keep out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and the vial label after exp . the infusion storage time is 24 hours . store in a refrigerator ( 2 - 8 ). do not freeze . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each ml solution contains 2 . 5 micrograms ( equivalent to 200 milligrams ) defibrotic acid . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections ( see section 2 ) for infusion . - each vial contains 10 millilitres of concentrate . not all pack sizes may be marketed .
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c , which is an infectious disease that affects the liver and causes it to become infected . this medicine works by inhibiting the growth of the liver ' s natural defences . the hcv is a type of virus that causes the liver to produce its own immune system . when you take this medicine , you will be able to get rid of the hep c virus . if you are not sure , talk to your doctor , pharmacist or nurse . your doctor will tell you what to do . what you need to do to protect yourself from the virus in your body , so that the virus can be removed from your blood . you will need to take other medicines to reduce the risk of hepat c infection . do not take da
do not take daklinza : - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if : you are taking phenytoin , carbamazepine , oxcarbazepine or phenobarbital ( used to treat epileptic seizures ) rifampicin ( e . g . not known ) or rfabutin ( non known ). you should not take antibiotics to treat tuberculosis . you should also take dexamethasone ( a steroid ) to treat allergic and inflammatory diseases . medicines
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of daklinza is 60 mg once a day . this medicine has an unpleasant taste . your doctor will tell you how many doses you should take . you may need to take some other medicines to make up for the missed dose . take these medicines as soon as you are ready to take them . do not take them without talking to your doctor or pharmacist . it is important that you take them at the same time each day to make sure that your doctor tells you to . taking these medicines , your doctor may change your daily dose , depending on how you respond to the treatment . if your hepatitis c infection has been treated with other medicines used to treat it , tell your doctor immediately . these medicines will be given to you by
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza contains sofosbuvir and ribavirin . the most common side effects ( may affect more than 1 in 10 people ) are headache , fatigue , difficulty sleeping dizziness , migraine nausea ( feeling sick ), diarrhoea , abdominal pain , joint pain or aching , and tender muscles . if you experience any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg / 60 mg , containing the other ingredients : dihydrochloride , anhydrous lactose , microcrystalline cellulose - croscarmellose sodium , silicon dioxide ( e171 ), magnesium stearate : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminium lake , yellow iron oxide 51 . how daklilza looks like and contents of the pack the tablet is a white to off - white , colourless tablet with " bms " debossed on one side . the tablet comes in a glass vial . not all pack sizes may be marketed .
proquad is a vaccine to prevent measles , mumps , rubella , and chickenpox ( varicella ) viruses . the vaccine contains antibodies to protect against the diseases . if you are unsure , talk to your doctor , pharmacist or nurse . your doctor will test your child ' s immune system to see if the vaccine is right for you . it is for use in adults , adolescents and children aged 9 years and older who have not been vaccinated for at least 9 years . national vaccination is not recommended for children under 9 years of age . this is because the vaccine does not work as well as it should .
do not take proquad if you are allergic to any varicella vaccine , measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ). neomycin is used to treat a blood disorder or type of cancer that affects the immune system . during treatment , you will be given medications to strengthen your immune system ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy . you may have a weakened immune system due to a disease ( including aids ) or congenital or hereditary immunodeficiency or lack of immune competence , or active untreated tuberculosis . warnings and precautions talk to your doctor or pharmacist before you are given this vaccine . tell your doctor , pharmacist or nurse before you receive proqua
proquad is injected into a muscle , under the skin , in the thigh , or in the arm . injections are given to the muscle in a specific area , e . g . the injection site is located at the site of a blood clotting disorder ( low levels of platelets ). the vaccine is applied to the skin to reduce the risk of bleeding in the muscle . after the injection , the body ' s response to the injection is controlled by a doctor , nurse or nurse . it is also given to you by injection into the blood vessel .
like all vaccines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , such as hives and difficulty in breathing or swallowing , these reactions may be signs of an allergic reaction . other side effects have been reported with proquad : very common ( may affect up to 1 in 100 people ): seizures , a fever , and / or 1 in 1 , 000 people bronchiolitis , difficulty breathing , cough or unsteadiness with walking . the most common side effects are : if you have any of the following side effects not listed in this leaflet , talk to your doctor or pharmacist . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this vaccine .
what proquad contains - the active substance is measles virus 1 . the other ingredients are edmonston strain 3 . 00 mg , mumps virus 1 and jeryllynnTM ( level b ) strain 4 . 30 mg . rubella virus 2 is a different strain . varicella virus 3 and merck strain 3.99 mg are used in tissue culture to produce plaque - forming units ( p - 1 ), chick embryo cells and fibroblasts ( mrc ) powder sucrose , hydrolysed gelatin ( urea , sodium chloride ), sorbitol ( e , monosodium glutamate ), sodium phosphate and sodium bicarbonate . not all pack sizes may be marketed .
jylamvo is an anticancer medicine used to treat unwanted reactions to an immunosuppressive agent . it has an anti - inflammatory effect and is used in adults to treat rheumatic and skin diseases , including active arthritis , polyarthritic forms in the joints , and severe juvenile idiopathic arthritis ( jia ) in children and adolescents ( ages 3 years and older ). it belongs to a group of medicines called " nsaids ", which are used when inadequate o severe , disabling psoriasis . treatment with phototherapy , ppsoralen , ultraviolet a radiation ( puva ) therapy .
do not take jylamvo : - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ). you have a severe kidney impairment or a liver impairment . you have blood disorders , such as bone marrow hyperplasia , leukopenia or thrombocytopenia , or significant anaemia . 34 a weakened immune system , a serious infection such as tuberculosis , hiv , ulcers in the stomach or intestines , an inflammation of the mucous membrane of the mouth , mouth ulcers or non - oncologic indications . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . tell your doctor or pharmacist how to take it . this includes any possible side effects not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , including death , during the treatment of rheumatoid arthritis , severe juvenile idiopathic arthritis ( jia ) or severe psoriasis ( sp ). if any of the above applies to you , talk to your doctor , pharmacist or nurse . your doctor will tell you how long you will be treated . this is a long - term treatment . it is not known how long it will last . you may need to stop taking the medicine if your doctor tells you to . the medicine is not recommended for use in adults , adolescents and adolescents , and children , whose symptoms may be severe , or even death is possible .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash , itching , or any part of the whole body . other side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath or difficulty in breath , chest pain ( fever ), spitting or coughing blood , serious peeling , blistering or blistering . if any of these occur , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this
keep the medicine out of the sight and reach of children . do not use jylamvo after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of any medicines you no longer use . these measures will help protect the environment .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate , macrogol 400 mg , glycerol , orange flavour , sucralose , epithelium , sodium parahydroxybenzoate ( e172 ) citric acid , tri - sodium citrate , purified water ( see section 2 ) " the other ingredients are : tablet core : sodium methocyanate " in a brown glass bottle containing 60 mg of solution , with a child - resistant closure and a bottle adaptor containing a white dosing syringe . not all pack sizes may be marketed .
what enurev breezhaler contains the active substance is glycopyrronium bromide . it belongs to a group of medicines called bronchodilators . this medicine is used to treat breathing difficulties in patients with a lung disease called chronic obstructive pulmonary disease ( copd ). copd is a condition in which the muscles in the lungs are tightened . breathing difficult , this medicine can cause tightening of the muscles that attach to your lungs . if you are not sure , talk to your doctor or pharmacist before taking this medicine .
do not use enurev breezhaler : - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine , if : you have kidney problems , have an eye problem ( narrow - angle glaucoma ) or have difficulty passing urine during treatment . if any of these apply to you , contact your doctor immediately . tell your doctor as soon as possible : tightness of the chest , coughing , wheezing or breathlessness . call your doctor or pharmacist immediately , as this medicine can cause bronchospasm ( difficulties in breathing or swallowing ), swelling of the tongue , lips or face , or skin . this may be a sign of skin irritation .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler every 24 hours . your doctor will tell you how much to inhale . this medicine should not be used after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep this medicine out of the sight and reach of children . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment . enurev breezhaler is not recommended for use in children under the age of 24 years of age . it is recommended that you throw away at least 75 mg of this medicine at the same time each day . you should take this medicine with an inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and may affect up to 1 in 100 people . irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms include excessive thirst , hunger and frequent urination , rash , itching or hives , difficulty breathing , swallowing or dizziness . allergic reaction : swelling mostly of the tongue , lips , face or throat ( angioedema ). other side effects tell your doctor or pharmacist if you get any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms of glucose . the other ingredients are : - a white powder containing 50 microgram s / ml . - the inhalation powder is lactose monohydrate , magnesium stearate , and water for inhaling the inhaled solution , which is a clear to off - white powder and a device . an inhaler is available in capsules in blisters , each blister strip containing 6 to 10 capsules . not all pack sizes may be marketed .
riximyo contains the active substance rituximab . it is a " monoclonal antibody " that binds to a specific type of white blood cell called a b - lymphocyte . this antibody is produced by the body ' s own immune system , which is responsible for the growth and development of these cells . if you are not sure , talk to your doctor , pharmacist or nurse before you start the treatment . your doctor will tell you how long you will be treated . you will also be treated for a long time after the initial treatment for chronic lymphocytic leukaemia ( a disease of the lymph tissue ) that causes the immune system to produce a large number of a type of immune system that produces white blood cells called b lymphocytes . how long will your doctor tell you . what is r
do not take riximyo - if you are allergic to rituximab or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if this applies to you , tell your doctor straight away if : you have a severe active infection ( at the moment ) caused by a weak immune system ( severe heart failure ) or severe uncontrolled heart disease ( granulomatosis ), polyangiitis , microscopic polyangitis or pemphigus vulgaris ). if any of these apply to you or your child , ask your doctor or pharmacist for advice before you have been given the medicine , as this may affect your ability to breathe . you should not be given the tablet unless your doctor tells you to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much riximyo to take the recommended dose is one tablet once a day . do not use this medicine after the expiry date which is stated on the label and carton after exp . your doctor will tell you how many tablets to take . if any side effects occur , your doctor may prescribe a drip or intra - venous infusion . medicines will be given to you by a doctor , nurse or nurse . it is important that you do not take more than one tablet at the same time each day to make sure that your doctor tells you to . this will help to reduce the risk of side effects during your treatment ( non - hodgkin ' s lymphoma ). if your doctor decides that you should take r
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are mild to moderate . after treatment , reactions have been fatal . infusion reactions may occur within the first 24 hours after the infusion : fever , chills , shivering , pain at the injection site , blisters / itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing . if you get any of the following symptoms , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what riximyo contains - the active substance is rituximab . each vial contains 10 mg / 100 ml of solution for solution for infusion . the other ingredients are : - 10 mg solution for injection . - 50 mg or 500 mg per vial , if you are not sure , talk to your doctor or pharmacist before you are given the tablet . one vial is a single - use solution containing 10 mg sodium citrate , polysorbate 80 , sodium chloride ( e171 ), sodium hydroxide , hydrochloric acid ( see section 2 ). - 2 - a clear , colourless to slightly yellowish solution . infusion is available in 2 , 3 , 1 or 2 vials . not all pack sizes may be marketed .
topotecan actavis is a treatment for small cell lung cancer that has spread to other parts of the lung . it is used in combination with chemotherapy to treat advanced cervical cancer after surgery or radiotherapy . in this case , the effect of this treatment is similar to that of medicines containing cisplatin .
always take topotecan actavis exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor will check your blood cell counts if they are too low . if your doctor tells you otherwise , your doctor may adjust your dose to suit your needs . tell your doctor immediately if any of the following applies to you : - severe kidney impairment - liver problems - you may need to stop taking topotenactavis in the event of severe liver impairment , lung inflammation , signs of cough , fever and difficulties in breathing , see section 4 " possible side effects " below . how to get the most common side effects , talk to a doctor or a pharmacist . you can also report side effects directly via the national reporting system listed in
topotecan actavis will be given to you by a doctor who is experienced in the diagnosis and treatment of the disease . blood tests will be carried out before treatment . treatment in adults small cell lung cancer 1 . 5 mg / m2 body surface area 5 mg once a week during this treatment cycle . in adult patients with cervical cancer , the recommended dose is 0 . 75 mg ( m3 - 3 mg ) once each week . after cervical cancer treatment with another anticancer medicines ( cisplatin ) is given . if you have impaired kidney function , your doctor will monitor your kidney function to make sure that you are getting the best possible outcome . you should not have to have to take any of the other medicines . this includes : - it is important that you do not have a chance to get the best results from your doctor , pharmacist or
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects very common ( may affect more than 1 in 10 people ): fever . your general condition may cause local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea , bowel inflammation , neutropenic colitis . topotecan actavis may increase your ability to fight infections . lung inflammation may affect up to 1 in 1 , 000 people . difficulty in breathing . this may be a sign of lung inflammation . it is more common in adults . not known if you get any of the side effects listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after reconstitution , dilution chemical should be used 24 - 25 ml . if not used immediately , store in the original package in order to protect from light . the drug product solution should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of any medicines you no longer use . these measures will help to protect the environment .
what topotecan actavis contains - the active substance is topotacan . each vial contains 1 - 4 mg to potecan , containing hydrochloride . after reconstitution , 1 ml of solution contains 1 mg of topotencan ( as mannitol ( e171 ), tartaric acid , hydro chloric acid and sodium hydroxide ( see section 2 ' topoteractavis looks like and contents of the pack ') the other ingredients are : grey bromobutylic stopper , aluminium seals with plastic flip - off , and a protective sleeve . pack sizes of 1 , 5 or 1 capsules , each pack contains 1 capsule and 1 capsule . not all pack sizes may be marketed .
rivastigmine hexal contains two active substances : - the active substance is a type of cholinesterase inhibitor . - it is used to treat alzheimer ' s dementia , dementia and parkinson 's disease in adults . certain nerve cells die in the brain because of the neurotransmitter acetylcholine , which is produced by nerve cells . by blocking these enzymes , the enzymes that make it easier for nerve cells to work properly , it helps to reduce the number of nerve cells working properly and reduce the symptoms of the disease .
always take rivastigmine hexal exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if any of the ingredients of this medicine are not listed in this leaflet , tell your doctor straight away . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor will tell you how much to take and how often to take it . you must not exceed the recommended daily dose . do not take more than the recommended dose , unless you have a previous skin reaction ( allergic contact dermatitis ). if your doctor tells you otherwise , your doctor may decide to change the dose you should take . children and adolescents the dose may vary depending on the severity of your child ' s condition , including : irregular or slow heartbeat , an active stomach ulcer , difficulties in passing urine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of rivastigmine hexal is one tablet once a day . your doctor will tell you how much to take and when to stop treatment . treatment should be started with a low dose . during treatment , the highest dose is 6 . 0 mg / kg of body weight . this medicine is for oral use only . do not take more than three days after taking this medicine . it is important that you do not stop using this medicine until your doctor tells you to . take your medicine as soon as you remember . you should not stop taking your medicine without talking to your doctor , pharmacist or nurse . how long you should take the medicine , your doctor may decide to change your dose , depending on how long your medicine will last .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects while taking your medicine : very common ( may affect up to 1 in 10 people ): dizzy loss of appetite stomach problems , feeling sick ( nausea ), being sick ( vomiting ) or diarrhoea uncommon (1 in 10 ) anxiety sweating , headache , heartburn , weight loss stomach pain feeling agitated or feeling tired or weak generally feeling unwell trembling . these may be signs of weakness , weakness or weakness . the most common side effects are : common : may affect more than 1 in 100 people : feeling sick , nausea , being sick or vomiting , or being sick( vomiting ), dizziness , confusion , difficulty sleeping , indigestion , fatigue ,
keep out of the sight and reach of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the blister in order to protect from light .
what rivastigmine hexal contains - the active substances are : 64 mg / ml . - all the other ingredients in the tablet core are , the active substance is , risotheliollose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide , titanium dioxide ( e171 ) and shellac . how much to store and how long to store the capsules and tablets , each , one , two , three , four , five , six , seven , eight , nine - coloured tablets contain 1 , 5 . 5 mm x 1 mm in diameter . the tablets are white to off - white , round , oval shaped tablets . each 
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat patients with kidney cancer , renal cell carcinoma , and liver cancer . a specific anticancer medicine called sorafenib is also used in combination with the other active substances . the active substances are : receptor tyrosine kinases ( rtks ), which are involved in the formation of new blood vessels . these proteins are responsible for high amounts in cancer cells .
do not use cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if : you have high blood pressure , have an aneurysm ( enlargement ) or weakening of a blood vessel wall ( a tear in the wall ). - you have a history of diarrhoea , recent or significant bleeding , or have had surgery in the last month . you have had surgical procedures or dental surgery , inflammatory bowel disease ( cr ) in your bowel or cr . tell your doctor or pharmacist if any of these apply to you . this medicine is not recommended for use in children and adolescents under 45 years of age 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . your doctor will monitor you closely during your treatment . if you notice any of the following serious side effects during treatment with cabometyx , talk to your doctor or pharmacist . the usual dose is 60 mg / ml . take the tablet with a glass of water . keep the tablet in the refrigerator ( 2 - 8 ). if not used within 2 hours , the tablet should be used within 1 hour . swallow the medicine and take it as soon as you remember . it is important that you do not take more than 1 hour after the first dose of the medicine . you should take the medicine at the same time every day . this will help to protect the environment . don ' t throw away any medicines via wastewater
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following side effects while taking cabometyx or any of your other medicines . your doctor will monitor your side effects closely . if any of these occur , you may need urgent medical treatment . symptoms may include pain in the abdomen , nausea ( feeling sick ) , vomiting , constipation , fever , a gastrointestinal perforation ( a hole in the stomach or intestine ), severe or uncontrollable bleeding , symptoms include vomiting blood , black tablets , diarrhoea , headache , abdominal pain , stomach , or bowel , severe or unbearable bleeding or symptoms such as vomiting blood ( black stolls ). not known if
what cabometyx contains - the active substances are cabozantinib and malate . each tablet contains 20 mg / ml of the active substance . the other ingredients are : microcrystalline cellulose , lactose anhydrous , and cellulose ( e171 ). - each tablet is supplied in a glass vial . - one vial contains malate equivalent to one 20 mg tablet . one 40 mg tablet contains the other two ingredients : the other ingredient is cabolinib ( s ) in combination with cabonib , malate equal to 40 mg of caborib in each vial and the other 40 mg , respectively . not all pack sizes may be marketed in your country . how long does the tablet last for you , please tell your doctor or pharmacist if you have any
pemetrexed hospira is a medicine used to treat a type of cancer called " malignant pleural mesothelioma " in adults . it belongs to a group of medicines called " cisplatin ", which is another anti - cancer medicine used in treatment of cancer of the lung whose disease has spread to other infected organs . this medicine is used in patients who have received prior chemotherapy and who are not sure if they are suitable for treatment , and if it is not suitable for you , ask your doctor , pharmacist or nurse for advice on the best way to get the best results of the first treatment in patients with lung cancer . if you have lung cancer and you have a history of your disease , your doctor will decide whether or not to start treatment . initial chemotherapy will be given to you by your doctor or nurse . pemetre
do not use pemetrexed hospira : - if you are allergic or hypersensitive ( see section 6 ' warnings and precautions '). this medicine should only be given to you by a doctor who is experienced in the use of this medicine . do not breast - feed unless your doctor tells you otherwise . if any of the above applies to you , talk to your doctor , pharmacist or nurse before using this medicine or if your doctor has told you to . tell your doctor or pharmacist if : you are not sure . your doctor will check your blood cell counts are too low when you are given cisplatin . it is important that you follow the instructions for appropriate treatment . you should not be given a vaccine to prevent yellow fever . the doctor will tell you how long you should wait until your kidneys are working properly . infusion of pe
what pemetrexed hospira contains - the active substance is 500 mg / m2 of your body ' s surface area . your height and weight will be determined by your doctor . this body surface area will be measured during treatment . - your blood cell counts will be checked during treatment and your doctor will check your blood cells counts . the mixture contains 9 mg , 9 mg and 9 mg sodium chloride solution for injection into the veins . after the infusion , the dose will be given to you within 10 minutes . how long do you need to keep the dose in your veins for a minimum of 10 minutes ( depending on how long you are given the dose ), and the amount of cisplatin that you need for infusion will be administered to you by a doctor or nurse . in addition , your doctor may decide whether or not to give you more pemetre
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : fever , infection , a temperature , sweating , or an increased risk of infection ( sepsis ), chest pain with a fast heart rate , pain , redness , swelling , sores in your mouth . allergic reaction : skin rash , burning or prickling sensation , fever and skin reactions , which can lead to death . chest pain may be accompanied by a fever . skin reactions may include : death , chest pain and / or a rapid heart rate ( e . g . pain ), redness or swelling . it is possible that you may experience allergic reaction such as a rash or burning sensation . this may be due to a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the infusion solution in the package in order to protect from light . infusion solutions of pemetrexed should be used within 24 hours . the reconstituted solution should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of any medicines you no longer use . these measures will help protect the environment .
what pemetrexed hospira contains - the active substance is pentagram . each ml of solution contains 100 mg / 100 mg of solution . the other ingredients are : - solution for dilution with mannitol , hydrochloric acid , and water for injection . - solutions for injection include : 500 mg and 500 mg solution for injection for injection in a glass vial ( e171 ). - product for injection contains 500 mg of petrogrammed ( as pemetreexed disodium hemipentahydrate ). each vial contains : 1 , 000 mg and / or one vial of pemetreexed . after reconstitution , the solution is dissolved in water . it is a clear , colourless white to off - white , yellow to off
ganfort contains the active substance bimatoprost and timolol . this helps to control pressure in the eye . bimatophorest belongs to a group of medicines called prostamides , a prostaglandin analogue . it is a type of medicine called beta - blockers , which are used in the treatment of glaucoma in adults . the eye is filled with a clear , watery liquid that is absorbed by the eye and is used to treat the condition of the eye as well as to reduce the amount of blood in the eyes . when used in combination with your doctor , pharmacist , or nurse , you will be given an eye drop . you will also be given the drops to help control high pressure in your eye , and reduce the risk of eye disease . your doctor will advise you how to use gan
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease such as wheeziness , difficulty in breathing , or long - standing cough . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have heart problems , such as low heart rate or heart block , heart failure warnings or precautions . this medicine is not recommended for use in patients with coronary heart disease ( symptoms such as chest pain ) - your doctor will tell you how to use it . tell your doctor as soon as possible if your doctor tells you otherwise .
always use ganfort exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one glass of water per eye . after treatment , the bottle should be inserted into the neck ( neck ) at the same time each day . your doctor will tell you how to use the bottle . do not use more than once a day , unless your doctor tells you to do so . take the bottle with you to the nearest hospital emergency room immediately . use it as soon as you remember . follow the instructions for use in section 4 . open your eyelid with a small pocket at the end of this leaflet . 3 . close the eyelid ( eyelid ) and open the lid ( eye ) after treatment is finished . 4 - close the lid of the eye , followed by treatment .
like all medicines , ganfort can cause side effects , although not everybody gets them . check with your doctor or pharmacist if you notice any of the side effects listed in section 6 . the droplets can be taken with or without food . very common side effects ( may affect up to 1 in 10 people ) are the eye redness . these are the most commonly reported side effects (1 in 9 people / 100 people ). the eye burning , itching or stinging , irritation of the conjunctiva ( the eye ) sensitivity to light , eye pain , sticky eyes , dry eyes and feeling of something in the eye ( small break ). these side effects may be mild to moderate . they may affect more than 1 in 100 people the eye burning or itching ( itching ), swollen , redness of the skin , swelling of the surface of the
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . solutions for eye infections should be used within 4 days after first opening . these measures will help to protect the product from light .
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol . - each 5 mg syringe contains the other ingredients : 6 . 8 mg , benzalkonium chloride ( a preserver ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( purified water ), hydrochloric acid ( e171 ) and sodium hydroxide . it is available in a plastic bottle with a screw - cap . not all pack sizes may be marketed .
gefitinib mylan contains the active substance gefitib , which is a protein produced by the body ' s immune system . this protein binds to a specific protein called adipose . it is used to treat non - small cell lung cancer , a disease in which malignant ( cancer ) cells spread to other tissues , such as the lung .
do not take gefitinib mylan - if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . tell your doctor or nurse if : you have any other lung problems . some lung problems may be serious . - you may need to stop taking the medicine if your doctor tells you that you have problems with your liver . children and adolescents , under 18 years of age , are not advised to take other medicines , or if they are taking , have recently taken or might take any other medicines ( see section 2 ). - your doctor may prescribe the following medicines : phenytoin , carbamazepine for epilepsy , rifampicin for tuberculosis 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of gefitinib mylan is one 250 mg tablet of antacids once a day . take the tablet with or without food . swallow the tablet whole with a glass of water . your doctor will tell you how much to take . do not take a double dose to make up for a forgotten dose . if your doctor tells you to take too many tablets , take it as soon as you remember . however , it is important that you take it at the same time each day , preferably in the morning and evening . this will help you to remember to take the next dose at the usual time . it is recommended that you do not have trouble swallowing . you can also take any other liquids up to 20 ml of
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor , pharmacist or nurse before taking gefitinib mylan . if you notice any of the following side effects you may need urgent medical treatment : allergic reaction . symptoms may include : swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ), difficulty breathing , serious breathlessness ( sudden worsening breathlessness ), a cough , fever , or an inflammation of the lungs ( ' interstitial lung disease '). uncommon ( may affect up to 1 in 100 people ) if your doctor notices any of these , contact your doctor immediately . severe skin reactions may occur in the body . this may be a sign of an increase in the amount of gefit
what gefitinib mylan contains the active substance in each film - coated tablet is 250 mg . the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , macrogol 4000 , titanium dioxide , red iron oxide , yellow iron oxide ( e171 ), gefitib is a clear , colourless to pale yellow , white to off - white , biconvex film , 11 . 1 , 5 . 6 ml , 250 tablets . pack size : pvc . not all pack sizes may be marketed .
reblozyl belongs to a group of medicines called luspatercept . it is used to treat myelodysplastic syndromes ( mds ) in adult patients with many different blood and bone marrow disorders where red blood cells become abnormal . signs and symptoms of a low red blood cell count ( anaemia ) can be signs of redblood cell transfusions . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will tell you what to do if your doctor tells you . what to expect from your doctor or nurse , he / she will decide how much to give you , when and how long to give the medicine , and when to give it to your child , or if he or she is a patient , it will be given to you by a doctor
do not take reblozyl : - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents 6 years of age and over . if : you are pregnant or planning to become pregnant . this medicine is not recommended for the treatment of thalassaemia ( spleen removed ). - you have a blood clot due to hormone replacement therapy . you have had a previously . preventive measures have been taken . medicines can help prevent the formation of a bleeding , especially in patients with high blood pressure . your doctor will check your blood pressure regularly before you are given , and if necessary , you should tell your doctor or pharmacist . it is important that you follow the instructions for
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . reblozyl is given by injection under the skin . the injections are given at a rate of 1 . 1 mg per kilogram of body weight . this dose may be increased or decreased depending on your blood pressure . for myelodysplastic syndromes , the maximum single dose is 1.75 mg / kg body weight ( beta - thalassaemia ). the maximum simultaneous dose is 1 , 25 mg ( ml ). your doctor will decide how much you should take . you should not inject more than 3 times a day . it is important that you tell your doctor as soon as possible if your doctor tells you otherwise . your doctor may decide to increase or decrease the dose you should inject . do not inject a single dose more than
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects may include : difficulty in walking , speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or any part of the body . blurred vision may be symptoms of a stroke . blood clots swelling in the area around the eyes , faces , lips , mouth , tongue , throat allergic reactions , such as rashes , sores and swollen lips . these may be signs of rash , redness or tingling of the skin . if you notice any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). after reconstitution , reblozyl should be stored in the original package in order to protect from light . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of any unused medicinal product or waste material . these measures will help protect the environment .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg / 75 mg luspatrat . - after reconstitution , the other ingredients are : - excipients : citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide , and sodium hydroxide , which are also used in the treatment of pp adjustment . what retinol looks like and contents of the pack reablyl is a white to off - white powder . it is available in packs containing 25 mg or 75 mg solution . not all pack sizes may be marketed . the active ingredients are white , round , oval , or round .
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . it is used to treat the cancer by reducing the number of cancer cells and allowing them to form new blood vessels . in patients with advanced kidney cancer , other treatments may include alpha or interleukin -2 , depending on the severity of your disease .
do not take fotivda : - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this includes john ' s wort , hypericum perforatum , a herbal remedy used to treat depression , anxiety , or high blood pressure . if this applies to you , tell your doctor straight away . your doctor will check your blood pressure as soon as possible . you will need to take a medicine to reduce the effect of fotivaa . it is important that you take it exactly as your doctor tells you how to take it . in some cases , your doctor may adjust your dose if it is too high or too low . when you are treated for low blood pressure due to an
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is one capsule of 1340 mg once a day . each capsule contains 21 mg , 7 mg or 1 capsule of capsules of 4 mg . your doctor will tell you how many capsules to take . do not take more than one capsule at a time . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . this includes any possible side effects not listed in this leaflet . you may experience unacceptable side effects ( severe side effects ) while you are being treated . if your doctor tells you otherwise , your doctor may decide to discontinue treatment . it is important that you take the capsules as soon as possible . capsules should not be taken more than 4 capsules . liver problems if
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure tell your doctor immediately if you notice any of the following serious side effect ( see section 2 ' common ') when you are taking fotivda . you may experience symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will check your blood pressure regularly . if this happens , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . warnings and precautions talk to a doctor or pharmacist before taking this medicine . the following side effect may occur : very common ( may affect more than 1 in 10 people ): - your doctor may prescribe a medicine to control your high bloodpressure .
what fotivda contains - the active substance is tivozanib . each vial contains 890 iu / ml . the other ingredients are : ( i . e . 1 , 890 Iu ). the other components are mannitol , magnesium stearate , gelatin , titanium dioxide , indigo carmine , yellow iron oxide , propylene glycol ( strong ammonia solution ), titanium dioxide ( e171 ), tartrazine aluminium lake , shellac , epa - glycol ( heavy metal - free ) ( octa ) and solid , solid - solids are - clear , colourless , white to off - white , opaque , transparent , translucent , and transparent .
what stribild contains the active substance is elvitegravir . it is an antiretroviral medicine that contains an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ). it belongs to a group of medicines called " nrti " and " tenofovir disoproxil ". if you are not sure , ask your doctor , pharmacist or nurse for advice on the use of this medicine . the active ingredient is : it contains : - it is used in combination with a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . - if your doctor or pharmacist has prescribed you , it is important that you know that you are being treated for hiv as soon as possible . your doctor will decide whether or not to give you s
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine or tenofovir . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . your doctor may change the dose of this medicine at any time during treatment . tell your doctor or pharmacist if your kidney function is affected by these medicines . alfuzosin is used to treat an enlarged prostate gland . amiodarone or quinidine ( used for irregular heartbeats ) 47 dabigatran ( used to reduce the risk of blood clots ), carbamazepine . this medicine is not recommended for use in children under 6 years of age
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . take the tablet with or without food . do not take stribild after the expiry date which is stated on the label and carton after exp . your doctor will tell you how many tablets to take . children and adolescents 12 years and over 35 years of age should be taken by mouth . you should take your medicine as soon as possible after the start of the treatment . medicines and oral supplements ( antacids ), laxatives containing minerals ( e . g . magnesium , aluminium , calcium , iron , zinc ) should not be taken more than 4 hours after the first dose . it is not recommended that you take more tablets than you should if your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . hiv therapy can cause an increase in weight and in levels of blood lipids and glucose . if you are not sure , talk to your doctor or pharmacist before taking stribild . tell your doctor straight away if any of the following apply to you : hiv infection may cause unwanted effects . the hiv disease itself can cause serious side effects and should be treated immediately : lactic acidosis , which is a condition in which there is excess lactic acids in the blood . this side effect is not known . some hiv medicines have been shown to reduce the risk of this . overweight people with liver disease , such as deep , rapid , and deep - rapid changes in blood , can also be a serious side effect . warnings and precautions talk to
what stribild contains the active substances are : elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each tablet contains 150 mg / ml . the other ingredients are - tablets containing : tablet core : the active substance is : film - coated tablet : tablets : 150 mg and 200 mg . - tablet coating : both tablets contain 200 mg and 245 mg , each tablet is a mixture of 300 mg of teflon . tablets - the other ingredient is croscarmellose sodium and hydroxypropyl cellulose , lactose monohydrate and magnesium stearate . not all pack sizes may be marketed .
zyprexa contains the active substance olanzapine . zy prexa belongs to a group of medicines called antipsychotics . it is used to treat schizophrenia , a disease with symptoms such as hearing or feeling depressed , anxious or tense . in moderate to severe manic episodes , symptoms include : excitement or euphoria . after a period of recurrence , these symptoms may be signs of bipolar disorder or manic episode . this is a type of treatment that is given to you by your doctor .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zypresa . if any of these apply to you , tell your doctor straight away . you may experience an allergic reaction such as a rash , itching , or swollen face , swelling of lips , shortness of breath , eye problems ( glaucoma ) or increased pressure in the eye . read more at the end of this leaflet for more information . your doctor will tell you what to do if your doctor tells you to take . contact your doctor or pharmacist as soon as possible , as this medicine may cause dementia . serious side effects have been reported in patients taking medicines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zyprexa is 5 mg / 20 mg once a day . your doctor will adjust your dose based on your symptoms . do not take more than your doctor tells you to take . take your zypresa tablets with or without food . you should take your tablets with a glass of water . if your tablet does not work well , take it as soon as you remember . it is important that you take the tablets with food , drink or tea . this will help to reduce the number of tablets you need . however , your doctor may change the dose according to your needs , depending on how you feel . how long you need to take the tablet , and how many tablets you have taken , or how often you take zy
like all medicines , this medicine can cause side effects , although not everybody gets them . unusual movement is a common side effect ( may affect up to 1 in 10 people ) on the face , tongue or blood clots in the veins . this side effect has been reported in more than 1 in 100 people on the legs . symptoms may include swelling , pain or redness in the leg . these may be caused by blood vessels in the lungs , chest pain or difficulty in breathing . if you notice any of these symptoms , contact your doctor immediately . talk to your doctor or pharmacist as soon as possible . it is important that you check with your doctor , pharmacist or nurse as this may be a sign of a serious side effect not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in the original package in order to protect from light . zyprexa should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zypresa contains the active substance is olanzapine . each zyprexa tablet contains 2.5 , 5 , 7 . 5 mg , 10 , 15 , 20 mg . what you will find on the label of the pack is lactose monohydrate . the other ingredients are hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . hypromellose ( e171 ), titanium dioxide , carnauba wax . which is used to make the different zy prexa tablets strength , the tablets are white to off - white , round , oval - shaped tablets . not all pack sizes may be marketed . one pack contains shellac , which is not included in the pack .
what prolia contains - the active substance is denosumab . it is a protein ( monoclonal antibody ) that belongs to a group of proteins called glucocorticoids . this helps to reduce the risk of bone loss . osteoporosis can be treated with treatment . the main benefit of prolaia is that it makes your bone stronger . oestrogen is produced in your bones during the menopause , which makes your bones thinner and fragile . your doctor may notice that your bones become thin and fragile in order to protect you from the sun . you should tell your doctor , pharmacist , nurse or nurse if you notice any of the following : - your doctor will tell you how to tell you what you should do .
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . you may have low calcium levels in the blood ( hypocalcaemia ). you may also be allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . your doctor will tell you what to do if your doctor tells you that you have a skin infection . symptoms may include a swollen , red area of skin on your leg that feels hot or tender . cellulitis , which may cause symptoms such as fever . these symptoms may be signs of an allergy to latex . the needle of the pre - filled syringe contains a derivative of latex that contains calcium . if
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe containing 60 mg / 6 ml . it is given as a single injection under the skin ( subcutaneous ) in the thighs , abdomen and arm . if not used immediately , ask your doctor , pharmacist or nurse for advice . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia can cause skin infections such as cellulitis . if you notice any of these symptoms , talk to your doctor or pharmacist . the most common side effects are : - swollen , red area of skin on the leg , feels hot and tender . symptoms may include fever , pain in the mouth and / or jaw , swelling , non - healing of sores in the jaw or discharge , numbness , feeling of heaviness or loosening of a tooth , bone damage in the face , neck or back . this may be a sign of bone damage . tell your doctor straight away if this happens . your doctor will tell you how long you need to take this medicine . other side effects may include : common 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the pre - filled syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the inner carton in order to protect from light . if you have any further questions on the use of prolia , ask your pharmacist . these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . each vial contains 1 ml of solution for injection . the other ingredients are : tablet core : acetic acid , glacial , sodium hydroxide , sorbitol ( e171 ), polysorbate 20 , and water for injections . what prollia looks like and contents of the pack protea is a clear , colourless , pre - filled syringe with a needle guard . not all pack sizes may be marketed .
ambirix is a type of vaccine that is given to adults , adolescents and children aged 1 to 15 years of age . it is used to treat two diseases called hepatitis a and liver infection . infected people , the liver is swollen or inflamed . the virus can be spread through faeces , serum or saliva . symptoms of infection may last 3 to 6 weeks . if you get infection you may feel sick , have a fever , aches or pains , or are very likely to become very sick . this may be a sign of infection , especially if it is not treated immediately . you should tell your doctor , pharmacist or nurse straight away . these may be signs of infection that can last up to 3 weeks or longer . your doctor will tell you how long it will take for you to stay healthy .
do not use ambirix - if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this vaccine . if any of these apply to you , tell your doctor or nurse immediately . you may experience an allergic reaction , such as itchy skin rash , shortness of breath , swelling of your face or tongue . this may be a sign of a allergic reaction to any vaccine used to treat hepatitis a or b diseases , a severe infection or a high temperature . the vaccine should not be given unless you have a minor infection ( such as cold ). if your doctor is not sure , ask your doctor for advice . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines
always use ambirix exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one injection into a muscle in the upper arm . your doctor will tell you how much to inject . a total of two injections will be given into the thigh muscle . you will receive the injections within 12 months of the first injection and the second injection within 6 and 12 months . do not take the first or second injection after the 12 month period , unless your doctor tells you to take extra doses . future booster dosing : if the disease is severe , your doctor may decide to increase the number of injections you need . it is important that you follow the instructions for future booster doses you have been given . this will help to prevent the diseases from getting worse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects very common ( may affect more than 1 in 10 people ): headache loss of appetite , tired , irritable pain . the signs of allergic and anaphylactic reactions include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing . a sudden drop in blood pressure , loss of consciousness . tell your doctor immediately if you notice any of the following side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this vaccine .
what ambirix contains 26 - the active substance is hepatitis a virus . each ml contains 1 720 elisa units . the other ingredients are : - human diploid ( mrc ) cells , aluminium hydroxide , hydrated ( 0 . 5 %) - saccharomyces cerevisiae - aluminium phosphate (0 . 4 %) and sodium chloride ( e171 ). for injections , the pack suspension is supplied in a pre - filled syringe . this is a white , slightly milky liquid . it is available in packs of 1 vial . not all pack sizes may be marketed .
bexsero is a meningococcal group b vaccine . the vaccine is given to you by a doctor who is experienced in the treatment of the bacteria neisseriameningitidis group - b . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the vaccine , see section 2 for more information . this vaccine is used to protect against disease caused by the non - specifi c type b bacteria . these bacteria can cause infections called meningitis , inflammation of the brain and spinal cord , and sepsis ( blood poisoning ). the vaccine prevents the disease from spreading .
do not use bexsero : - if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this vaccine . if : you have a severe infection with a high temperature after vaccination ; - you have had a minor infection ( such as a cold ); - vaccination for haemophilia , or any other problem with your blood from clotting properly . your doctor may prescribe blood thinners ( anticoagulants ) during treatment to prevent your immune system ( eculizumab ) after you have been vaccinated . you should tell your doctor immediately if this applies to you . children and adolescents , aged 28 years of age and older , are not allowed to have pregnancy . pregnancy and breast - feeding 
always use bexsero exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 5 mg / m2 muscle injected into the thigh or upper arm . injections are given 2 to 5 times a day . after three injections , the vaccine is given as an additional injection ( booster ). the first injection is given at 2 to 2 weeks , and the interval between injections is 1 month . your doctor will decide how long to give the injection . you will be given a booster 12 to 15 to 6 weeks after the injection and the booster has been given for 24 hours . if the booster is not given , contact your doctor immediately . do not give the booster to children under 24 years of age . it is important that you tell your doctor as soon as possible . this is to make sure that
like all vaccines , this vaccine can cause side effects , although not everybody gets them . the following side effects have been reported with bexsero : very common ( may affect more than 1 in 10 people ): - pain / tenderness at the injection site , redness of the skin , injection site and swelling of , or hardness , under the skin and injection site side effects reported with this vaccine are listed in section 10 . they may affect up to 1 in 1 , 000 people . - fever , loss of appetite , nausea , vomiting , diarrhoea , abdominal pain , trembling , muscle spasms and swollen skin . these may be signs of pain or tenderness . this may be a sign of an increase in the number of people receiving this vaccine . very common : may affect
what bexsero contains - the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each ml contains 1 , 2 , or 3 mg of total protein , equivalent to 50 mg . the other ingredients are : - total protein ( the pora p ) - 2 - 3 mg , equal to 25 mg / m3 . not all of the ingredients are suitable for use in children and adolescents . - if you have any further questions on the use of this product , ask your doctor or pharmacist . please tell your doctor .
nitisinone mdk contains the active substance nitric acid . this medicine is used to treat a rare disease called hereditary tyrosinemia ( a disease that affects more than 1 in 10 people ). this disease affects your body ' s ability to make the amino acid yrosine ( amino acids ) that are produced in the body . if you are not sure , talk to your doctor , pharmacist or nurse before taking this medicine . your doctor will tell you how to make sure that your doctor has given you the right dose for you . it is important that you take this medicine exactly as your doctor tells you to . the harmful substances in this medicine are listed in section 6 . in this section , you will be given this medicine to help reduce the amount of lysine in your body and lowers the levels of phenyla
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are allergic to nitisinone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . do not use this medicine after the expiry date which is stated on the label and carton after exp . your doctor will tell you how much to take . pregnancy , breast - feeding , and / or breastfeeding . if this applies to you , tell your doctor straight away . children and adolescents : if your doctor thinks you may have red eyes , contact your doctor immediately for an eye examination . eye problems may be caused by inadequate dietary control . 4 weeks after the treatment , your doctor may ask you to take blood samples . the treatment may cause side effects such as blood disorders
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take nitisinone mdk depends on the type of disease ( hereditary tyrosinemia type ). the recommended dose is 1 capsule per kilogram of body weight . the recommended daily dose is 20 capsules . in this patient population , swallowing the capsules should be done with a small amount of water or formula diet . do not take more than one capsule at the same time each day . if your doctor tells you otherwise , tell your doctor , pharmacist , or nurse . you should not take a double dose to make up for a forgotten dose . your doctor will tell you how many capsules you should take . take the medicine as soon as you remember . it is important that you take it as soon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . nitisinone mdk should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains - the active substance is nitric oxide ( e171 ). - each capsule contains 2 mg / 2 ml , corresponding to a single - metabolite . the other ingredients are : - capsules : 1 . 7 mg , 5 mg and 5 mg . - tablets : 10 mg and 10 mg : each capsule is coated in gelatin , titanium dioxide , black iron oxide , and shellac glaze , which is a clear to off - white , colourless to pale yellow , yellow to orange , red , green , blue , pink , white to off white - yellow capsules with a ' s ' on one side and a " s " on the other side . how to use the pack n
what docetaxel accord contains - the active substance is a type of medicine called " doxorubicin ", " trastuzumab " and " capecitabine ". - it is used for the treatment of early breast cancer , lung cancer ( non - small cell lung cancer ) - prostate cancer ( gastric cancer ), head and neck cancer ( neck ), advanced breast cancer ( e . g . prostate cancer ). - does not work as well as other anti - cancer medicines . the active ingredients are : - isotretinoin , oxamethasone , taxoids , and heparin . it is also used to treat breast cancer and lung cancer in adults and children . this is because it is not known whether it is caused by a combination of drugs called " taxoids ". how docet
docetaxel accord should not be used : - if you are allergic ( hypersensitive ) to the active substance . warnings and precautions talk to your doctor , pharmacist , nurse or nurse before you start , or if any of the following applies to you : your doctor will check that you have enough white blood cells . you have a severe liver disease . tell your doctor or nurse if they are not sure . - do blood tests will be carried out to check that there are enough blood cells in your liver before you are given docetaxil accord . white blood cell disturbances ( fever ) and infections , contact your doctor immediately . abdominal pain , tenderness , diarrhoea , rectal haemorrhage , blood in stool , fever , nausea , vomiting , chills , shivering ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . docetaxel accord will be given to you by a doctor or nurse based on your weight . method of administration docetaxil accord is given as an infusion into veins . the infusion will last approximately one hour . you will receive your infusion every 3 weeks . your doctor will do your blood tests to check for your general condition . if any of the above applies to you , your doctor may decide to reduce the dose of this medicine . diarrhoea , sores in the mouth , numbness , pins and needles , fever 63 if your doctor decides that you need a dose reduction , contact your doctor as soon as possible . it is important that you tell your doctor , pharmacist or nurse
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects during your treatment : adverse reactions to docetaxel : - the presence of red blood cells and white blood cells ( alopecia ). - nausea , vomiting , sores in the mouth , diarrhoea and tiredness . adverse events may occur after the infusion . allergic reactions : common ( may affect up to 1 in 10 people ): flushing . - flushing may occur in more than 1 in 100 people . not known ( frequency cannot be estimated from the available data ). this may be due to the use of other chemotherapy agents . your doctor may need to adjust the dose . this includes any possible side effects not listed in this leaflet . you can also report side effects directly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . this medicine does not require any special storage conditions . if not used immediately , store in the original package in order to protect from light . after dilution , the medicine will be dissolved . the infusion bag should be stored at room temperature ( up to 6 hours ) for up to 25 days . for infusion , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of . - each vial contains one vial of 20 mg , whereas the other ingredients are : concentrate contains 4 mg of 80 mg / m2 , concentrate contains 8 mg or 160 mg doses , polysorbate 80 ( e171 ), ethanol anhydrous ( see section 2 ) and citric acid anionhydrous . what does docettaxel accord looks like and contents of the pack does not contain any colourless , colourless to pale yellow to brownish - opalescent - white - colourless concentrate . it is available in packs containing : infusion , the concentrate is a clear white to pale pink - round - oval , round , oval -
what intuniv contains - the active substance is guanfacine . this medicine belongs to a group of medicines that affect the brain . it is used to treat people who are impulsive or hyperactive . - this medicine is used in adults to treat ' attention deficit hyperactivity disorder ' ( adhd ). - if you are taking current stimulant medication or current medication to treat adhd symptoms , you will be given the medicine as part of a treatment programme that includes psychological therapy , educational therapy and social therapy . 38 - adhd is a type of adhd in adults who have been diagnosed with adhd for more than one year .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine , if : you have low or high blood pressure . - you have heart problems , such as fainted , recently had thoughts or feelings of suicide , or any other psychiatric conditions , withdrawal symptoms , increased heart rate , which can lead to a higher rate of your heart . this medicine is not recommended for use in adults , adolescents and children under 18 years of age . children and adolescents this medicine should not be used to treat these problems . do not use this medicine after the expiry date which is stated on the carton . these checks should be carried out at least 3 times a day .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to take intuniv depends on your treatment and adolescent behavioural disorders . your doctor will tell you how much to take and how often to stop your treatment . the recommended dose for your treatment is 1 mg once a day . after 1 hour of treatment , the usual dose is 0 . 05 mg / kg / m2 of body weight . it is recommended that your doctor tells you to take it as soon as possible . this is based on your body weight and how long your treatment will last . you will be given in a period of 1 to 7 days , depending on how long you are being treated . what to do if your dose is too high or too low , talk to your doctor , pharmacist or nurse
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor or pharmacist before taking your medicine . serious side effects tell your doctor straight away if any of the following side effects occur : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of consciousness ( syncope ), a serious withdrawal side effect ( high blood pressure ), which can cause symptoms such as headaches , feeling confused , nervousness , agitation , and tremors ( hypertensive encephalopathy ). other side effects include : very common ( may affect more than 1 in 10 people ): not known ( frequency cannot be estimated from the available data ). this includes any possible side effects not listed in this leaflet . you can also
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep the tablets in the blister pack in order to protect from light .
what intuniv contains - the active substance is guanfacine hydrochloride . each vial contains 1 ml / 0 . g . the other ingredients are : lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose , and hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer . not all of the ingredients are milk - free , colourless , white to off - white , pink , yellow , orange , red , green , blue , brown , black , oval , round , or oval shaped , with a white to ' s ' on one side and ' 1 ' ( ' 2 '). - lac
ecalta contains the active substance anidulafungin . it is used in adults and adolescents aged 1 to 18 years to treat fungal infection in the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called candida . echinocandins are used to treat these medicines to treat serious fungal infections caused by the presence of fungal cell walls . in a small number of cases , it is not possible to stop the growth of these cells , which are fragile , fragile or unable to grow .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins or caspofungin as acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if this applies to you , tell your doctor or nurse straight away . talk to a doctor who is experienced in the treatment of liver function , you may have liver problems . your treatment may be interrupted by anaesthetics , but your doctor may decide to stop your treatment . you may need to stop the treatment without your doctor' s advice . do not stop the injection if : you have an allergic reaction such as itching , wheezing or blotchy skin . an infusionrelated reaction
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of ecalta is 200 mg / 100 mg once a day for adults and children aged 1 to 18 years of age . your doctor will prescribe a dose of 3 . 0 mg per kilogram of the patient ' s weight . it is recommended that the patient receive a slow infusion ( a drip into a vein ) every 1 . 5 ml of the loading dose is 3 times the day after the infusion . you will receive the loading dose at the same time each day . depending on your weight , your treatment will be continued for 14 days . do not stop your treatment unless your doctor tells you otherwise . this medicine will be given to you by your doctor , nurse or nurse . children and adolescents e
like all medicines , this medicine can cause side effects , although not everybody gets them . very common side effects ( may affect more than 1 in 10 people ): difficulty breathing , wheezing or an existing rash . ecalta can cause serious side effects such as convulsion ( seizure ), flushing or rash ( pruritis ), itching , hot flush , hives , sudden contraction of the muscles , coughing , difficulty of breathing other side effects are very common . they may affect up to 1 in 100 people . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the reconstituted solution in the package in order to protect from light . after 24 hours , the infusion solution should be used immediately . ecalta should be stored at room temperature for up to 48 hours at a temperature not above 25 oc . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what ecalta contains - the active substance is anidulafungin . each ml of powder contains 100 milligrams ( e . g . the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid ). each vial contains 30 millilitres of concentrate for solution for infusion in a box containing 1 milliliter of concentrate . after infusion , the powder is clear and colourless . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use .
adynovi contains the active substance rurioctocog alfa pegol , a pegylated human coagulation factor viii . this is a substance produced by the body ' s own cells . it is produced by a process called " clot - forming " in the blood to prevent clottings and stop bleedings in patients with haemophilia , which is an inherited bleeding disorder caused by lack of factor ii , and it is used in the treatment of bleeding in children and adolescents aged 12 years and above . in adults and adolescents , it is also used in adults , adolescents and adolescents of all ages , in particular , who have a history of a type of bleeding disorder known as a form of the disease known as lack of the factor ix .
do not take adynovi : - if you are allergic to rurioctocog alfa pegol , or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor or nurse immediately . you may be allergic to the active substances , such as : an anaphylactic reaction , which is a severe , sudden allergic reaction . allergic reactions may include rash , hives or wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness , and diarrhoea . this includes :
treatment with adynovi is for the treatment of haemophilia . if you are not sure , talk to your doctor , pharmacist or nurse before you start treatment . your doctor will tell you how much to take and how long to take . the duration of treatment is based on your body weight , the factor viii levels , and the severity of the bleeding . appropriate laboratory tests will be carried out to determine the effect of the replacement therapy . this medicine is a life - long treatment for adults . it is used in adults , adolescents and children aged 40 to 50 years of age . in children and adolescents , this medicine reduces the risk of bleeding , but it is not recommended to take more than 2 weeks after the start of treatment , if bleeding occurs , your doctor may decide to change the dose , depending on the weight of your child ' 
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur after the injection . early symptoms may be signs of allergic reactions such as rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing ( wheezing ), tightness in the chest , feeling of being unwell , dizziness or loss of consciousness . severe symptoms may include difficulties in breathing or fainting . prompt emergency treatment may be needed if previous treatment has failed . if you notice any of the above , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of this medicine . these measures will help protect the environment .
what adynovi contains the active substance is rurioctocog alfa pegol . it belongs to a group of substances called pegylated human coagulation factor viii produced by recombinant dna technology . each powder vial contains 250 , 500 , 1000 , 2000 ml . the other ingredients are : the solvent vial containing 5 % sterilised water for injections and mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 . not all pack sizes may be marketed .
rekovelle contains the active substance follitropin delta . it is a hormone produced by the body . gonadotropins are hormones that regulate the production of female hormones . these hormones are used to prevent female infertility . assisted reproduction programmes such as vitro fertilisation ( ivf ) and intracytoplasmic sperm injection are used in women whose ovaries are damaged or have many egg sacs in the uterus .
do not take rekovelle - if you have any of the following conditions : - you are allergic to follicle stimulating hormone ( fsh ) or this medicine . warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine ( see section 6 ). - tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus . - your doctor may tell you that you have enlarged ovary , cysts on your ovum . polycystic ovarian disease , bleeding from the vagina , an early menopause , malformations of the sexual organs during pregnancy , fibroids of the utorhinal glands . pregnancy may be more likely to occur if your doctor tells you to stop your pregnancy .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose depends on your first treatment cycle . you will be given anti - mullerian hormone ( hcg ), which is produced in your ovaries by stimulation with gonadotropins . your blood will be measured by your body weight . a blood sample will be taken over the last 12 months of treatment , depending on how much you weigh . this will be determined by your doctor , pharmacist , or nurse . it is important that you know how much to inject the medicine , and how long to inject it . do not inject more than once a day , unless your doctor tells you otherwise . in the first 12 months , your doctor will tell you how long you will receive treatment . treatment will be based on your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects may be caused by hormones that cause infertility . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . these symptoms may be signs of a side effect common ( may affect up to 1 in 10 people ): headache and nausea if you get any of these symptoms , talk to your doctor or pharmacist . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 - 25 ). store in the original package in order to protect from light . rekovelle can be stored at room temperature ( up to 3 - 3 ) for up to 28 days at 25 . after the treatment any unused solution must be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 millilitres of solution ( equivalent to 0 . 36 ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate ( e171 ), concentrated phosphoric acid , and sodium hydroxide for injections . what ekovelle looks like and contents of the pack recovelle is a clear and colourless solution . it is available in packs containing 1 cartridge and 3 pen injection needles , each containing one pen . not all pack sizes may be marketed .
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . the other ingredients are : the active substance is fluticanol , which is 92 mg / ml . - this is equivalent to 22 mg of vilantrol , corresponding to 2 . 2 mg . in chronic obstructive pulmonary disease ( copd ) and asthma . each dose of 184 mg or 22 mg is used to treat asthma in children and adolescents aged 12 years and older . both doses are available in packs of 12 - 184 and 22 mg for asthma in adults . not all pack sizes may be marketed in your country . you can also get a dose of 22 mg .
do not take revinty ellipta : - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if this applies to you , tell your doctor as soon as possible . check with your doctor or pharmacist if : you have liver disease . side effects have been reported in patients with moderate or severe liver disease ( see also section 2 ). if your doctor notices any of these side effects , ask your doctor for advice . your doctor may increase the lower strength of revined 92 / 22 . heart problems , high blood pressure , tuberculosis ( tb ) of the lung or any long standing or untreated infections . diabetes
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . asthma can be treated with fluticasone furoate ( 22 mg / ml ) or vilanterol ( e . g . severe asthma ). the higher strength inhaler should be used if the dose you are given is too low or too low . in copd , the dose that is given is the same as that given to you by your doctor , pharmacist or nurse . your doctor will prescribe you revinty ellipta if your doctor tells you to do so . the dose for you will depend on how long you will need to inhale the medicine . it is important that you do not have to use the medicine at the same time each day . you may need to use it at least 24 hours after the inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta may affect up to 1 in 1 , 000 people . if you have any of the following symptoms , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling on the face , mouth , angioedema , very wheezy , coughing , difficulty in breathing , feeling weak or light headed . the most common side effects are : very common ( may affect more than 1 in 100 people ). tell your doctor , pharmacist or nurse immediately . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each inhaler contains 92 mg / 92 ml . the other ingredients are : - a light grey inhalation with a yellow mouthpiece cover , a dose counter , and a dosing counter . not all pack sizes may be marketed . if you are not sure , talk to your doctor or pharmacist before using the product . what rev inty is made of : it contains trifenatate , which contains 184 mg , inhalers . it is also made of lactose monohydrate ( e171 ) and magnesium stearate ( see section 2 ) inhales the other active substances in the pack the cartridge contains a white to off -
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine ( a nuclearly active nuclearly activated reverse transcriptomic inhibitor ) and tenofovir , which is also a nucleotide reverse transcriptisome inhibitor . these active substances are also used in antiretroviral medicines . they contain an enzyme ( reverse transcriptyse ) that stops the virus from spreading . atripl is used as a treatment for human immune deficience virus , hiv ( e . g . infection ) in adults and children aged 18 years and older . it is used in children and adolescents aged
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . take atripla by mouth , with or without food . swallow the tablet whole with a glass of water . your doctor will tell you how many tablets to take . do not take more than 1 or 2 tablets at once . some side effects may include dizziness or drowsiness . talk to your doctor , pharmacist or nurse straight away . you may need to take other medicines to treat your hiv infection . if your doctor tells you to : efavirenz , emtricitabine , and tenofovir disoproxil , or other medicines that may be used to treat it , you should contact your doctor immediately . it is very important that you take at
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects have been reported with atripla : lactic acidosis is a condition where the body produces excess lactic acids in the blood . this is uncommon ( may affect up to 1 in 1 , 000 people ) and can be serious side effect . tell your doctor immediately if you notice any of the following : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ) or stomach pain . if any of these occur , talk to your doctor , pharmacist or nurse . the most common side effects are : fainting , dizziness , vomiting , stomach pain and / or vomiting . these side effects may be serious . you can also report side effects directly via the national reporting system listed in appendix v 
what atripla contains - the active substances are : efavirenz , emtricitabine and tenofovir disoproxil . each atripla film coating contains 600 mg / ml e . b . the other ingredients are adipla 200 mg film - coated tablet , which contains 200 mg of empiretabine ( as fumarate ) and 245 mg pfizer . tablet core contains croscarmellose sodium ( e171 ), hyprolose , magnesium stearate and microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplase contains sodium "). the tablet film coating is a clear , colourless to off - white , round , oval - shaped tablet . it contains iron oxide black (
what orgalutran contains - the active substance is ganirelix . it belongs to a group of medicines called anti - gonadotrophin . gnrh is a natural hormone releasing hormone , which regulates the release of follicle stimulating hormone ( fhrh ). - it is used to stimulate the growth , development and / or reproduction of ovaries . the eggs in the egg cells are small round sacs . this helps to release the mature egg cells , causing them to grow , grow and reproduce in the ovary , and to produce the mature eggs , so that they are able to reproduce in a way that the eggs are released . in vitro fertilisation ( ivf ) and other methods may be used .
do not take orgalutran : - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you start , or if : you are hypersensitive to gonadotrophin releasing hormone ( gnrh ). - you have a moderate or severe kidney or liver disease , are pregnant or breast - feeding . if any of these apply to you , tell your doctor or pharmacist before starting treatment . allergic reactions may occur in patients with an active allergic condition . additional monitoring and treatment may be required for allergic reactions . allergy reactions may be generalised , such as hives , urticaria , swelling of the face , lips tongue and / or throat , difficulty in breathing or swallowing ( angioedema 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of orgalutran depends on the type of treatment and assisted reproduction techniques used in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ) and corifollitropin . on day 2 or 3 of your pregnancy , your doctor will give you the medicine under the skin for 5 to 6 weeks . your doctor may prescribe the preparations and different injection sites for daily treatment . you will be given the medicine at different times of the day , depending on the conditions of the egg cells , human chorionic gonadotrophin ( hcg ) will be injected . if any of the above applies to you , ask your doctor , pharmacist or nurse . how to inject or
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with orgalutran : very common ( may affect more than 1 in 10 people ): local skin reactions ( redness , swelling ) the local reaction disappears after 4 to 100 days . headache , nausea , malaise common : may affect up to 1 in 1 , 000 people allergic reactions : rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat difficulty in breathing and swallowing ( cough ), difficulty in swallowing or swallowing . uncommon : rare : not known ( frequency cannot be estimated from the available data ) allergic reactions ( e . g . nasal congestion , cough , sore throat , tingling , flushing 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the syringe label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains the active substance is ganirelix . each vial contains 0 . 5 mg of acetic acid , mannitol and water for injections . the ph is controlled by the presence of sodium hydroxide ( e171 ). the other ingredients in the solution are aqueous , colourless solution for solution for subcutaneous administration , the needle and dry natural rubber / latex . how much to use the vial : 1 vial of 5 ml . not all pack sizes may be marketed .
blitzima contains the active substance rituximab , which is a " monoclonal antibody " that binds to a specific type of white blood cell called b - lymphocytes . it is used in adults to treat a type of non - hodgkin ' s lymphoma ( a disease of the lymph tissue ) in which the immune system does not produce enough white blood cells , i . e . the b lymphocyte - type - based cells . this is called " b " in a similar way to other medicines called " chemotherapy ". the treatment will be given to you as soon as possible after the initial treatment . your doctor will tell you exactly how long you will be treated . you will have to wait at least 2 weeks after the first treatment , as your doctor has told you .
do not take blitzima - if you are allergic to rituximab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if : you have a severe active infection caused by a weak immune system , severe heart failure or severe uncontrolled heart disease , such as granulomatosis , polyangiitis or microscopic polyangitis ( pemphigus vulgaris ). if any of these apply to you , tell your doctor or pharmacist before you start taking the medicine , as this may increase the risk of developing a hepatitis infection . your doctor will tell you how long you should take it . it is important that you check that you are not sure . you should not stop taking b
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much blitzima to take you will depend on how you respond to this treatment . you will be given this medicine at the same time each day . if any of the following side effects occur , your doctor will tell you how much to take . the usual dose is a drip ( intravenous infusion ) of medicines . your doctor may adjust the dose to suit your needs . it is important that your doctor tells you how to take it as soon as possible . this is to make sure that the dose is right for you , and that you are given the right dose at the right time of day and on the same day as your chemotherapy , for 3 to 8 hours , depending on how long you are being treated . other medicines and pre - medication may cause side
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are mild to moderate . after treatment , reactions have been fatal . infusion reactions may occur within the first 24 hours after the infusion . fever , chills , shivering , pain at the injection site , blisters / itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing . if you get any of the following symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store in the original package in order to protect from light . blitzima should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of this medicine . these measures will help protect the environment .
what blitzima contains - the active substance is rituximab . each vial contains 10 mg / 100 ml of solution for solution for infusion . the other ingredients are : - 1 vial containing 10 mg or 50 mg or 500 mg of solution . - 10 mg contains sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 , and water for injections . what brissima looks like and contents of the pack bristlyima is a clear , colourless solution for injection . it is available in packs containing 2 vials containing 50 or 1 bottle . not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a type of monoclonal antibody , called interleukin -6 , which is produced by your body . it is used to reduce the inflammation in your body and to reduce symptoms such as pain and swelling in your joints . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the medicine . the damage to the cartilage ( the layer of bone that protects the joints ) is caused by the disease , but it is not known how long , how long you have been given it , or how long it has been given . this is because the medicine is used in adults with moderate to severe active rheumatoid arthritis ( an autoimmune disease ) that has been treated with previous therapies , such as methotrexate , and r
do not use roactemra : - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if this applies to you , you may have an active , severe infection at the time of the infusion . tell your doctor straight away if any of these apply to you or your child . allergic reactions may include chest tightness , wheezing or severe dizziness or light - headedness . swelling of the lips , skin rash , or any other signs of infection or infections . contact your doctor immediately if : you feel unwell . it is important that you do not have to wait for your body ' s ability to fight infections caused by an existing infection . do not
always use roactemra exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to give your doctor or nurse will tell you exactly what to do . the recommended dose is one vial per day . your doctor will give you the intravenous infusion . you will receive the treatment at the same time each day : 8 mg once a day for 4 hours , 4 hours after a drip in the vein ( intravenously ) for 2 hours after your doctor tells you otherwise . if your doctor prescribes you , your doctor may decide to increase the dose , depending on your body weight , it is recommended that you do not take more than 30 minutes , or 12 hours after you receive 30 mg once per day for 8 hours . it is important that you follow the instructions given in this leaflet .
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): allergic reactions ( difficulty with breathing , chest tightness , light - headedness ), rash , itching ( hives ), swelling of the lips , tongue and face . serious infections ( fever , chills ) in the mouth . if you get any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what roactemra contains - the active substance is tocilizumab . each vial contains 4 mg , 80 mg and 20 mg / 10 ml of concentrate . the other ingredients are : - concentrate : 200 mg and 200 mg . - a total of 20 mg or 20 mg of concentrate for injection : 400 mg and / or 20g / 20ml solution : sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogenphosphate dihydrate and water for injections which are not listed in this leaflet . which is a clear , colourless to pale yellow concentrate for concentrate for solution for infusion , this product is available in packs containing 4 , 10 , or 20 vials in a glass vial . not all pack sizes may be marketed
onbrez breezhaler contains the active substance indacaterol , which belongs to a group of medicines called bronchodilators . it works by stimulating the muscles in the walls of the small air passages in the lungs . this helps to control breathing difficulties in patients with a lung disease called chronic obstructive pulmonary disease ( copd ). copd affects the muscles that make breathing difficult . the use of this medicine helps to relax these muscles and help to relax them .
do not take onbrez breezhaler : - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . tell your doctor immediately if : you have heart problems , epilepsy , thyroid gland problems ( thyrotoxicosis ) or diabetes . if any of these apply to you , your doctor may decide to stop treatment . talk to a doctor straight away . your doctor will tell you how to use the medicine you are taking . you should not use this medicine unless you experience tightness of the chest , coughing , wheezing or breathlessness . do not stop using the medicine until your doctor tells you that you have a condition called bronchospasm 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 150 microgram capsule per day . your doctor will tell you how much to inhale . each inhalation dose will be based on your doctor ' s recommendation . do not use more than 300 micrograms per day depending on how you respond to the treatment . you should use your inhaler 24 hours before using onbrez breezhaler . it is important that you use the medicine as soon as possible . if your doctor tells you otherwise , contact your doctor immediately , pharmacist or nurse . inhaling the medicine and capsules ( in blisters ) should be stored in a refrigerator ( at room temperature ). if the medicine is not dissolved , the capsules should be discarded . this pack ( on
what onbrez breezhaler contains - the active substance is indacaterol . each inhaler 150 mg / 150 ml capsule contains the active substances in d . a b . at the end of the capsule , there is no lactose and the capsule is coated with gelatin . the other ingredients are : capsule : 300 mg : the active ingredients are indocaterol ( e171 ) and indecaterol maleate . capsule - containing the capsules , inhaling in the morning and evening . gelatin is a clear , colourless , white to off - white capsules in blisters . they are packaged in a white powder . how to inhale : each capsule contains 150 mg of inhalation . one capsule contains 300 mg inhalers . not all
clopidogrel hcs is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together to form blood clotting . by reducing the amount of platelet forming in your blood , you can reduce the risk of the clots forming , which can lead to thrombosis . if you are not sure , talk to your doctor , pharmacist or nurse before you are given , or have had , for example , thrombi . these are hardened blood vessels ( arteries ) that form a type of thrombus . this is due to hardening of these harden blood vessels or arteries ( atherothromboses ). this is also linked to atherotrombotic events such as stroke , heart attack or death 
do not take clopidogrel hcs : - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a medical condition that is currently causing bleeding , such as a stomach ulcer , bleeding within the brain or severe liver disease . if any of these apply to you , tell your doctor or pharmacist . precautions should be taken to protect yourself and your child ' s health . your doctor will tell you how much , how much to take , and how long you should take . children and adolescents , adolescents and children under 18 years of age , are taking , have recently taken or might take any other medicines . this includes any possible side effects , including , but not limited to , the following 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopidogrel hcs if : you have a condition called ' atrial fibrillation ' or an irregular heartbeat . your doctor will prescribe a dose of 75 mg once a day . if this applies to you , your doctor may prescribe you a higher dose . you may need to take a different dose , depending on the severity of your chest pain , unstable angina , or heart attack . the recommended dose is 300 mg / kg / m2 . do not take more than one tablet , unless your doctor tells you otherwise , as this may increase the risk of a serious event . in case of severe chest pain
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following : fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or eyes , jaundice , bleeding under the skin , red point dots , confusion ( see section 2 ), swelling in the mouth , skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . if any of these occur , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what clopidogrel hcs contains the active substance in each film - coated tablet , 75 mg / ml . the other ingredients are : tablet core : hydrochloride . each tablet contains 2 mg ' s ' in - the - film . o - tablet core: microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . tablets containing : o polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide and talc . macrogol 3000 tablets are supplied in a blister . not all pack sizes may be marketed .
fetcroja contains the active substance cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria and prevent infections . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine , as it is used to treat infections caused by bacteria . other antibiotics do not work as well as other medicines .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your doctor or nurse thinks you may be allergic to other antibiotics ( such as cephalosporins ) or to a severe allergic reaction to certain antibiotics , such as penicillins or carbapenems . severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , or difficulty swallowing or breathing . tell your doctor immediately if : you have ever had any allergic reaction or have recently taken or might take any of these . you should contact your doctor as soon as possible . your doctor will tell you how long you will be treated with 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fetcroja is an infusion ( a drip ) into a vein every 3 to 2 weeks . your doctor will decide how much to give you and how often to give it . if your doctor decides to stop your treatment , tell your doctor straight away . you will be given the medicine at the same time each day . do not take more than once a day , as it may take longer than your doctor tells you to . however , your doctor may decide to increase your dose at any time of the year . this will depend on how long you are given . how often you should give the medicine , with or without food , in order to reduce the risk of infection . it is important that you do not stop receiving f
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following serious side effects you should seek urgent medical treatment : severe allergic reaction , sudden swelling of your lips , face , throat or tongue , a severe rash , or other severe skin reactions , such as difficulty swallowing or breathing . this reaction may be caused by diarrhoea or stools , blood or mucus . treatment with medicines to slow bowel movement . the following side effects have been reported with fetcroja : very common : may affect more than 1 in 10 people . very common side effects ( may affect up to 1 in 100 people ): if any of these side effects affects you , contact your doctor immediately . tell your doctor straight away if
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 milligram of cefiferocol ( as sucrose ), sodium chloride , sodium hydroxide and water for infusion ( see section 2 ) of the tablet . the other ingredients are : tablet core : white powder for solution for injection . pack size : 10 vials .
depocyte is used to treat lymphomatous meningitis ( a condition in which tumour cells attach to membranes in the brain , spinal cord , and other organs of the body . it is used in adults to reduce the number of lymphoma tumour cells . this is a type of cancer that affects more than 1 in 10 people .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking : you have a meningeal infection . severe neurological side effects may occur . if this applies to you , you may experience symptoms of the nervous system such as convulsions , pain , numbness or tingling , blindness or visual disturbances . these symptoms may occur after taking any dexamethasone tablets . you should tell your doctor or pharmacist if any of these effects happen . your doctor will monitor your side effects closely to check for any new side effects . contact your doctor as soon as possible . this includes any possible side effects not listed in this leaflet . other medicines : dep
always use depocyte exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 ml / 5 mg dexamethasone per injection . your doctor will tell you how many doses you should take . you will be given a dose of 5 mg once a day . do not take more than one dose at a time . if any side effects occur , take the next dose as soon as possible . it is important that your doctor tells you to . this is to make sure that the dose is right for you , as it is safe for you to take , is the same as the usual dose . how much to take in the morning and evening , with or without food , it is very important that you do not have any food or drink to drink , drink or snack . de
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects while you are being treated with depocyte : very common ( may affect more than 1 in 10 people ). very common : may affect up to 1 in 100 people . very common (1 in 10 ) if not treated immediately . uncommon (1 in 1 ) 10 , 000 / ml : not known ) adverse events , including nausea , vomiting weakness , confusion , fever headaches , diarrhoea and dizziness . if any of these occur , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep depocyte in the original package in order to protect from light . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of this medicine if you notice severe discolouration , a changed appearance , or a defective container . don ' t throw away any medicines via wastewater . these measures will help protect the environment .
what depocyte contains - the active substance is cytarabine . each vial of suspension contains 10 mg cystabine ( equivalent to 5 mg / ml ). one vial contains 50 milligrams . the other ingredients are : - cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylephtylglycerol , sodium chloride , and water for injections which are not clear , colourless to pale yellow , white to off - white , round , oval - shaped , single injection , in a single vial . not all pack sizes may be marketed .
what bemrist breezhaler contains the active substance is indacaterol . the other ingredients are mometasone furoate , which belongs to a group of medicines called bronchodilators . they work by stimulating the muscles in the lungs , thereby reducing the amount of air in your lungs and preventing the swelling of the airways . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine , ask your doctor or nurse . how bemarist breather works bemmarist breatherer is made up of a mixture of two different types of medicine called corticosteroids ( also called steroids ). the combination of these medicines reduces the swelling and irritation ( inflammation ) in the small airways in the lung . breathing problems have been reported with the use of cortic
do not take bemrist breezhaler : - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have heart problems or an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , low level of potassium in your blood , severe liver problems such as tuberculosis ( tb ) of the lung , or any long - standing or untreated infections . if treatment is not effective , tell your doctor or pharmacist if any of these apply to you . this medicine can cause tightness of the chest , coughing or wheezing . it is also important that you tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use bemrist breezhaler capsules keep the medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label and carton after exp . your doctor will tell you how many capsules to inhale . the medicine will be given to you by a doctor who is experienced in the use of your asthma and / or your symptoms will be checked by your doctor . if your doctor tells you otherwise , your doctor may decide to change the dose , depending on how often you should inhaling the medicine , the inhaler and capsules will be taken . you will need to take the medicine at the same time each day . it is important that you take the capsules as soon as possible 
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . very common ( may affect more than 1 in 10 people ): difficulty breathing , swallowing , swelling of the tongue , lips , or face , skin rash , itching , hives . allergic reaction may affect up to 1 in 100 people . swelling in the tongue and lips ( e . g . face and throat ), angioedema . other side effects have been reported in patients taking bemrist breezhaler . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the capsules in the original blister in order to protect from light . if you have any further questions on the use of this medicine , ask your pharmacist how to use it .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler 125 mg / 62 . 5 ml vial contains 173 mg of ind . the other ingredients are : tablet core : 150 mg indocaterol , 80 mg mother - - father - son - daughter - friend - brother - sister - child - baby - boy - girl - male - female - breast - feeding : the other ingredient is : e . g . tablet : bem breezehaler is available in packs of 125 , 127 . 50 and 173 tablets . tablets are supplied in a glass vial , each containing 150 tablets of in
zyllt contains the active substance clopidogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood . this clumping can lead to blood clotting . these small structures are clumped together by the body , causing the blood to clot , which leads to thrombosis . the active substances in antiplatelets medicinal products are used to reduce the number and size of the blood ( thrombi ) forming in hardened blood vessels ( arteries ). this is called atherothrombosis ( a condition in which there is an increase in the number of atheothrombotic events such as stroke , heart attack or death ). the active ingredient is cytokines ( e . g ., a type of blood coagulation 
do not take zyllt : - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . - you have a medical condition that is currently causing bleeding , such as a stomach ulcer , bleeding within the brain , or severe liver disease . tell your doctor or pharmacist if this applies to you . your doctor will tell you what to do , as it may affect your ability to control bleeding . you may need to stop bleeding if your doctor tells you to . this is because it is important that you follow the advice given to you by your doctor as soon as possible , unless you are not sure , ask your doctor for advice . bleeding may be caused by a medicine condition that can cause internal bleeding
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyllt is used to treat a condition called ' atrial fibrillation ' or an irregular heartbeat . your doctor will prescribe a dose of 75 mg once a day . the recommended dose is one 75 mg tablet . do not take more than your doctor tells you to . severe chest pain , unstable angina , or heart attack 300 mg / ml . you should take the tablet at the same time every day for at least one hour before and during treatment . it is recommended that you take the tablets as soon as you remember . this will help to keep you on the right path to your doctor , pharmacist or nurse . however , if your doctor decides to stop treatment , your doctor may decide to stop , stop or stop 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following : fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or eyes , jaundice , bleeding under the skin , red point dots , confusion ( see section 2 ), swelling in the mouth , skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . this is a serious side effect of zyllt . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ): - skin disorders , e . g . reddish , or swollen skin . these may be signs of skin disorders including
what zyllt contains the active substance is clopidogrel ( as hydrogen sulphate ). each film - coated tablet contains 75 milligrams ( ml ). the other ingredients are lactose , microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil , hypromellose , titanium dioxide , red iron oxide ( e171 ), talc and propylene glycol in the film coating . what the pack the tablet - coating tablets are white to off - white , slightly convex , boxes containing 7 , 14 , 28 , 30 or 50 tablets . not all pack sizes may be marketed .
lamivudine teva is an antiviral medicine that blocks the growth of the hepatitis b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrti ). it is used to treat long term ( chronic ) infection caused by a virus that attacks the liver . if this happens , liver damage will be reduced . lamimavirteva helps to protect the liver from compensated liver disease . treatment is not recommended for patients who have a history of treatment , but it is important that you tell your doctor , pharmacist or nurse if you have ever had any problems with your body ' s immune system , or if your doctor tells you otherwise .
always take lamivudine teva exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . 28 people who have recently taken or might take other similar medicines have reported serious side effects , including liver disease , hepatitis c , or overweight . your doctor will do blood tests to check for signs of your medication . if your doctor tells you to take your medicine , your doctor may tell you to stop your treatment . do not take any medicines after the expiry date which is stated on the carton . you should tell your doctor straight away if : you have any problems with blood samples , any raised liver enzyme levels , which could lead to liver damage . see section 3 for more information on how to take and when to take la
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . lamivudine teva is used to treat your hepatitis b infection . your doctor will tell you what to do if your infection has worsened or your illness is worsening . take your medicine with or without food . swallow the tablet whole with a glass of water . don ' t take more than you should . do not take too many tablets at the same time each day . the recommended dose is 150 mg / ml . it is not recommended that you take more tablets than your doctor tells you to . you should tell your doctor , pharmacist , nurse or nurse . this is to prevent hiv infection , and your doctor may decide to stop your hiv treatment . talk to your doctor before taking
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following side effects while taking lamivudine teva : - other conditions , such as hepatitis b . - side effects after therapy for ' histiolytic b' - tiredness - respiratory tract infections - throat discomfort , headache , stomach discomfort - pain , nausea , vomiting - diarrhoea - increases in liver enzymes that affect the liver . this may be a sign of an increase in the number of cells in the body . these may be signs of increases in the amount of hepatocellular enzymes , causing the liver to produce more hep ' s own enzymes .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in the original package in order to protect from moisture . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is leucine . each film - coated tablet contains 100 mg deluent . the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow and iron oxide red in the tablet coating . what lammiviviririvirivirinivir is available in the pack orange , biconvex film , 32 tablets in aluminium blisters containing 28 , 30 , or 84 tablets containing 100 tablets . not all pack sizes may be marketed .
nespo is an anti - anaemic . your anaemia is a condition in which your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . it works by blocking the natural hormone erythropoietin , which is produced by your kidneys , your bone marrow , and the production of blood cells called darbepoetine alfa . chronic renal failure : if you have symptomatic anemia , you should contact your doctor immediately if your kidney fails . kidney failure is the most common cause of kidney failure . you should tell your doctor straight away if it is not working properly . this is because your kidney does not work properly properly , so it is important that your doctor tells you to . if this happens , it is very important that you take the
do not take nespo ( darbepoetin alfa ) or r - huepo if you have high blood pressure or are allergic to any of the other medicines in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given the medicine . if any of these apply to you , tell your doctor or pharmacist . you may be given medicines to treat sickle cell anaemia ( epileptic fits ( seizures ) , convulsions , seizures , liver disease , drugs to treat the condition . your doctor will tell you what to do if your doctor tells you otherwise . this includes any possible side effects not listed in this leaflet . in this case , you may have an allergy to latex . the needle of the pre - filled suje
always use nespo exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will do blood tests to check your haemoglobin level . the recommended dose is 10 mg once a day . if your doctor tells you to use a dose less than 12 mg , the pre - filled syringe will be injected into a vein ( intravenous ) to treat chronic renal failure . you will receive a single injection under the skin or under a specific area of your body weight ( 0 . 75 kg ) or 0. 45 kg of body weight . regular blood samples will be taken to check how well your anaemia has progressed . it is important to monitor your blood and your blood pressure during your treatment . do not stop your treatment without talking to your doctor or pharmacist .
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported : 471 very common ( may affect more than 10 people ): high blood pressure ( hypertension ) and fluid retention ( oedema ). very common : may affect up to 1 in 100 people : blood clots ( thrombosis ) pain in the area injected rash , redness , and the skin rare (1 in 10 , 000 people ). serious allergic reactions : sudden life - threatening allergic reactions such as anaphylaxis , swelling of the face , lips , mouth , tongue or throat , difficulty in swallowing and breathing ( angioedemo ). uncommon : not known : frequency cannot be estimated from the available data : if you notice any of the following :
keep out of the sight and reach of children . do not use nespo after the expiry date which is stated on the carton and the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the original package in order to protect from light . if you have any further questions on the storage conditions , ask your pharmacist . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 , 500 ml . the other ingredients are : water for injections : sodium phosphate monobasic ( e421 ) sodium chloride , polysorbate 80 . not all pack sizes may be marketed .
macugen is a solution for the treatment of macular degeneration . this disease can cause vision loss or damage to a part of the retina called the macula , which is located in the outermost layer of the eye . in amd , abnormal blood vessels grow in the retina , causing these new blood vessels in the eye to grow . when this happens , it is important to stop the growth of these new cells . if you are not sure , talk to your doctor , pharmacist or nurse before you start treatment , as this medicine is not suitable for you . it is very important that you do not stop the treatment . you should tell your doctor as soon as possible if your doctor tells you to : - your doctor will tell you how long you will be treated , and how long it will take for you to see , feel and smell of the solution . macu
do not use macugen : - if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your doctor suspects that you have an active or suspected infection in your eye , tell your doctor or nurse immediately if the following symptoms occur : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision or increased sensitivity to light or small particles in your vision . your doctor will monitor you closely during the injection . the injection serious allergic reactions have been reported in children and adolescents aged 4 to 18 years of age and above . other medicines and the dose may vary from one dose to another . this includes other medicines not listed in this leaflet .
always use macugen exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one single injection into the eye every 6 to 9 weeks . after the injection , the vitreous part of the eye is removed from the eye . if the injection is not effective , your doctor may prescribe antibiotic eye drops for the treatment of your eyes . your doctor will prescribe some local anaesthetic ( numbing medicine ) to relieve any pain caused by the injection in case you are allergic to antibiotic eyedrops . antibiotic treatment can reduce the risk of eye infection . tell your doctor as soon as possible if your doctor tells you otherwise .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting or rapid pulse , stomach cramps , nausea , vomiting , diarrhoea ( frequency not known ). these side effects may be signs of an infection in the internal portion of the eye . during macugen treatment , the symptoms may be mild to moderate . if you notice any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the original package in order to protect from light . the medicine does not require any special storage conditions .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 ml of solution for injection . the other ingredients are : tablet core : 90 mg sodium chloride , monobasic sodium phosphate monohydrate ( e171 ), dibasic salt : sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections ( see section 2 ). what macugagen looks like and contents of the pack macugegen solution is a single dose pack containing a pouch , a ready - filling vial . it is available in pack sizes ranging from 0 to 25 mg - 0 27 mg , an elastomeric plunger stopper and a pre- attached plunger rod with a plastic
kepivance contains the active substance palifermin . it belongs to a group of substances called escherichia coli ( e . g . epithelial cells ) that are found in the mouth , digestive tract and tissues under the skin . the effect of palifemin is similar to that of other medicines used to treat oral mucositis ( soreness , dryness ) and inflammation of the mouth ( a side effect of treatments to treat your blood cancer ). your doctor will decide if you have a blood cancer that has been treated with chemotherapy , radiotherapy , autologous hematopoietic stem cell transplantation . your doctor may decide whether or not to give you this medicine .
do not take kepivance : - if you are allergic to palifermin or escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents aged 18 years and over . other medicines not recommended : tell your doctor or pharmacist if this applies to you . this medicine is not recommended for use in children under the age of 18 years . if any of these apply to you or your child ' s breast - feeding , or any other medicines you may be taking , have recently taken or might take heparin . you should not take or think that you may need to take other medicines . pregnancy and breast- feeding are not recommended in this age group . it is not known whether you are pregnant or breast
kepivance is used to treat cancer treatment . the recommended dose is 60 mg / kg / m2 . it is given as an intravenous injection into a vein . your doctor will prescribe the dose to you based on your response to the chemotherapy or radiotherapy . you will be given three days of chemotherapy and radiotherapy each day . if you are not sure , ask your doctor , pharmacist or nurse for advice . chemotherapy and radiation therapy may take 24 to 48 hours , depending on how long you are receiving the chemotherapy , radiotherapy and chemotherapy andradiotherapy may take up to 24 hours . however , your doctor may decide to stop the chemotherapy after the chemotherapy has finished . after the radiotherapy is finished , you will receive the chemotherapy at the end of the chemotherapy for at least 48 hours before the chemotherapy is completed .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ) side effects skin rash , itching , redness , pruritus , erythaema , an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever or aching joints ( arthralgia ) altered taste , lipase and amylase levels . if you notice any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg / ml . the other ingredients are : mannitol , sucrose , l - histidine , polysorbate 20 ( e172 ), diluted hydrochloric acid , and water for the mouth and mouth . what ketoxane looks like and contents of the pack ketivance is supplied as a white powder containing 6 vials . not all pack sizes may be marketed .
the active ingredient cinacalcet accordpharma contains calcium and phosphorous . it is used to treat problems with organs called parathyroid glands ( parathyroids ), which are four small glands in the neck , which connect the thyroid gland to the body . the purpose of this medicine is to treat secondary hyperparathyroidism ( serious kidney disease , dialysis ) and waste products . calcium in the blood ( hypercalcaemia ) is a form of paraathyroid cancer in which the body does not produce enough calcium and the body cannot control the amount of calcium that the body can produce . this is due to the fact that it is necessary to remove the gland . in children and adolescents this medicine can be used in adults and adolescents aged 3 to 18 years of age . secondary hyperparo thyroidism is caused by a lack of oxygen . if you have any further questions on
do not take cinacalcet accordpharma : - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . low levels of calcium in your blood . check with your doctor or pharmacist if your blood calcium levels are too low . if this applies to you , your doctor may adjust your dose to meet your needs . tell your doctor straight away if any of these apply to you or your child ' s doctor or nurse . your doctor will check your blood potassium levels before you start taking cinacaca accordpharma for seizures , convulsions or seizures . you may also have liver problems or heart failure . before you are given the medicine , calcium levels can lead to life threatening events or fatal outcomes , low calcium levels may lead to hypocalcaemia .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of cinacalcet accordpharma is one tablet once a day . take the tablets with or without food . you should take regular blood samples during treatment for secondary hyperparathyroidism . your doctor will tell you how many tablets to take . if your doctor tells you to take more than one tablet , take it as soon as you can . do not take more tablets than you should . it is important that you take your tablets at the same time each day , as long as you take them . this will help you to keep track of how long you have taken , and how often you take , the tablets should be swallowed . children and adolescents , aged 3 to 18 years of age , will be given 0 . 20 mg cina
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following : numbness , tingling around the mouth , muscle aches , cramps or seizures . your calcium levels may be too low ( hypocalcaemia ). swelling of the face , lips ,mouth , tongue or throat , difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea or vomiting . these side effects may affect up to 1 in 100 people : dizziness . common : unusual : difficulty in speaking , swallowing , or swallowing ( e . g . nausea , vomiting ). the following side effects have been reported in patients treated with cinacalcet accordpharma , which are not known ( may
what cinacalcet accordpharma contains the active substance in each film - coated tablet , consists of 30 mg , 60 mg and 90 mg . the other ingredients are : tablet core : cellulose , microcrystalline - crospovidone - magnesium stearate ; hypromellose ; titanium dioxide ( e171 ); triacetin ; indigo carmine aluminium lake ; iron oxide yellow . how much to use the active ingredient in the tablet and how many tablets , please tell your doctor or pharmacist if you have any further questions on the use of this product , ask your doctor , pharmacist , or nurse . each tablet contains 30 tablets . they are light green colored , oval shaped , 9.65 x 6.00 mm , biconvex . not all pack sizes may be marketed .
what jentadueto contains the active substance is linagliptin . it belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase -4 inhibitors ), metformin and biguanides , which help to control blood sugar levels in adults with diabetes ( ' type 2 diabetes mellitus '). this medicine is used in combination with insulin . this medicine can be used together with certain other medicines to treat diabetes , such as sulphonylureas , empagliflozin , and insulin , to treat type 2 diabetics .
do not take jentadueto : - if you are allergic to linagliptin or metformin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , if : you have severely reduced kidney function . - you have uncontrolled diabetes . severe hyperglycaemia ( high blood glucose ) can cause nausea , vomiting , diarrhoea and rapid weight loss ( lactic acidosis ). your doctor may decide to change your diet and exercise . your doctor will tell you what to do if your body is not working properly . ketoacidosis is a condition in which your body does not produce enough ' ketone bodies ' ( known as diabetic pre - compa ). symptoms include stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jentadueto is one tablet once a day . your doctor will tell you how many tablets to take . you may take metformin , or individual tablets containing linagliptin . this medicine is used to treat an upset stomach . it is recommended that you take 5 mg linoleic acid ( e . g . 2 , 000 mg / ml ). this medicine can be taken with or without food . do not take more than one tablet at a time . take it as soon as you should if your doctor tells you to take it . however , your doctor may decide to change the dose of this medicine , depending on your health - restricted diet . taking j
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may require immediate medical attention . if you experience any of the following symptoms , talk to your doctor or pharmacist before taking jentadueto : low blood sugar ( hypoglycaemia ) : trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion , hypogycaemia ( frequency not known : uncommon : may affect more than 1 in 10 people ). the most common side effect is sulphonylurea , the combination jentea - insulin . warnings and precautions talk to a doctor , pharmacist or nurse . this includes any possible side effect not listed in this leaflet . you can also report side effects directly via the national reporting system
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the original package in order to protect from light . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what jentadueto contains the active substance is linagliptin . the other ingredients are metformin hydrochloride , which are present in each tablet . each tablet contains : 2 . 5 mg / 850 ml tablet , each 2.5 mg tablet contains 1 , 5 mg of linaligtin ( as 850 mg ) in a glass vial . if you have any further questions on the contents of this leaflet , ask your pharmacist or pharmacist . what if a tablet looks like and contents of each tablet are white to off - white , colourless , opalescent , red , orange , yellow , oval - shaped , round , rectangular , square , and oval shaped tablets . one tablet contains one tablet containing two tablets : one vial contains two tablets of 
edurant contains the active substance rilpivirine , which is used to treat human immunodeficiency virus ( hiv ) infection . it belongs to a group of medicines called non - nucleoside reverse transcriptase inhibitors ( nnrti ). hiv medicines are used for the treatment of hiv in adults , adolescents and children 12 years of age and older who are infected with hiv and are not sure if they are suitable for you . if you are unsure , ask your doctor , pharmacist or nurse .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . the following medicines may be used : carbamazepine ( oxcarbazepine ), phenobarbital , phenytoin , medicines used to treat epilepsy ( seizures ) rifampicin ( e . g . with or without medication for some bacterial infections ( such as tuberculosis ): omeprazole ; lansoprazola , pantoprazole , and rabeprezole ( proton pump inhibitors ). tell your doctor or pharmacist if any of these apply to you . warning
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . do not use edurant after the expiry date which is stated on the label and carton after exp . your doctor will tell you how much to take . children and adolescents ( aged 18 years and over ) the usual dose is 1 tablet of rifabutin . this is a medicine used to treat some bacterial infections . you should not take the tablet without first talking to your doctor , pharmacist or nurse . if your doctor tells you otherwise , your doctor may decide to change the dose you need . it is important that you do not take more tablets than you should . however , if the dose is too high or too low , you should tell your doctor as soon as possible . how much e
like all medicines , this medicine can cause side effects , although not everybody gets them . edurant can cause headache , nausea , difficulty falling asleep , insomnia and dizziness . your routine liver tests may test for transaminase , an increase in cholesterol , pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting or drowsiness , decreased appetite , sleep disorders such as stomach discomfort , depressed mood . this may be a sign of sleep disorders , including stomach discomfort and depression . tell your doctor straight away if you notice any of these . talk to your doctor , pharmacist or nurse as soon as possible . you can also report side effects directly via the national reporting system listed in appendix v .
what edurant contains - the active substance is rilpivirine . each ml of tablet core contains 25 milligrams ( i . e . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . film - coating : hypromellose 2910 , 6 mg , titanium dioxide ( e171 ), macrogol 3000 , triacetin . not all pack sizes may be marketed .
avandamet tablets contain two different medicines , rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . in type 2 diabetics , insulin is not enough to control blood sugar levels . if you are not sure , talk to your doctor , pharmacist or nurse . the two medicines work together to reduce the amount of sugar in your blood . both of these medicines help to control your blood sugar . your doctor may prescribe a sulphonylurea ( a type of insulin used to control diabetes ).
do not take avandamet : - if you are allergic ( hypersensitive ) to rosiglitazone or metformin . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . tell your doctor or pharmacist if : you have had a heart attack , severe angina , heart failure or heart failure in the past . - you have severe breathing difficulties , liver disease , diabetic ketoacidosis , a complication of diabetes , rapid weight loss , nausea , vomiting , kidney disease 107 you are very dehydrated , especially if your doctor tells you to drink more water than you should . your doctor will tell you how long you need to take the tablet . it is important that you take it as soon as possible . this is because it may take longer than usual .
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg of rosiglitazone ( equivalent to 1000 mg of metformin ). this dose should be taken at the same time each day . you should take this dose at the usual time ( between 1 and 8 hours ). the maximum dose is 1 mg / ml . your doctor will tell you how many tablets to take . this dose will be given to you by your doctor , pharmacist or nurse . it is recommended that you take at least 4 times a day , preferably with or without food . if your doctor tells you to take more tablets than you should , take it as soon as you remember . do not take more than 2 hours before your next dose . take your next tablet at regular intervals , with
like all medicines , avandamet can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following allergic reactions : - raised and itchy rash ( hives ) swelling of the face and mouth ( angioedema ). - difficulty in breathing collapse . these symptoms may be caused by a combination of avand amet and lactic acidosis . this is a common side effect of metformin . - severe kidney disease , which can cause symptoms of lacticacidosis , such as rapid breathing and cold . the most common side effects are : rapid breathing , cold and cough . other side effects include : common ( may affect more than 1 in 10 people ): diarrhoea , headache , nausea , vomiting , dizziness ,
avandamet is a medicine that is used to treat a variety of conditions . it is used in adults , adolescents and children aged 12 years and over .
what avandamet contains the active substance is rosiglitazone . the other ingredients are metformin and sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate . each tablet contains 1 mg / ml , 500 mg , 600 mg and 600 mg . one tablet contains 500 mg and 500 mg each , while the other two tablets contain 500 mg or 500 mg of metformine . when taken together with a meal , the other tablet contains 2 tablets . if taken with or without food , it is recommended that the other tablets are : - a glass of water , and - one tablet , or - two tablets , each containing 1 , 000 mg or 1000 mg of rotazone and / or 0 . 1 mcg , metform
clopidogrel mylan belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that prevent blood clotting . this clumping is caused by the use of anti platelet medical products , which reduce the amount of blood that clots . thrombosis is a type of thrombus ( thrombi ) in hardened blood vessels ( arteries ). it is used to reduce the risk of bleeding , stroke , heart attack , and death in patients who have had a history of having a life - threatening event , such as stroke or heart attack or death .
always take clopidogrel mylan exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have a medical condition that is currently causing bleeding , such as a stomach ulcer , bleeding within the brain , or severe liver disease . if any of the above applies to you , tell your doctor straight away . your doctor will tell you exactly what to do , as soon as possible . this includes any possible side effects that may affect your ability to eat or drink alcohol . it is important that you read this leaflet carefully . do not eat alcohol unless your doctor tells you to do so . you must not drink alcohol or drink it unless you have had a drink of alcohol , and / or drink
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopidogrel mylan : you have a condition called ' atrial fibrillation ' or an irregular heartbeat . your doctor will prescribe a dose of 75 mg once a day . if your doctor tells you to take more than the recommended dose , your doctor may increase your dose to suit your needs . you may need to take a double dose to make up for a forgotten dose . take your next dose at the same time each day for severe chest pain , unstable angina , or heart attack . the usual starting dose is 300 mg once daily . do not take too many tablets , unless you have taken more than 75 mg , depending on how long you
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following : fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin , especially around the eyes , jaundice , bleeding under the skin with red point dots , confusion ( see section 2 ), swelling in the mouth , skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . if any of these apply to you , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what clopidogrel mylan contains - the active substance in each film - coated tablet : 75 mg / ml : the other ingredients are : hydrochloride , microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil , polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide and talc . - macrogol 3000 is a clear , colourless , light - coloured tablet . not all pack sizes may be marketed .
doptelet belongs to a group of medicines called thrombopoietin receptor agonists , which are used to treat chronic liver disease in adults with low platelet count . it is used in adults and adolescents to treat a type of chronic , life - threatening , clot - free , bleeding . this is a medical procedure that reduces the number of platelets in the blood . platelets are blood cells that help the blood to coagulate . if you have any questions on the use of this medicine , ask your doctor .
doptelet should not be used : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . blood clots can form in the veins and arteries . - when doping , you may be able to stop the formation of blood . this is especially important for patients with cancer who have taken the contraceptive birth control pill , hormone replacement therapy , have recently had surgery or have been injured . 23 - overweight or have advanced chronic liver disease . children and adolescents do not take this medicine at the same time as other medicines . tell your doctor or pharmacist if any of these apply to you . pregnancy and breast - feeding - do not give this medicine to children under 18 years of age . do
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 5 mg once a day . do not take more doptelet than you should if your doctor tells you to . your doctor will tell you how much to take . take your dose as soon as possible after your planned medical procedure . swallow the tablet whole with a glass of water . don ' t take a double dose to make up for a forgotten dose . this medicine is available in packs of 20 mg , 40 mg or 60 mg once daily . you can take it as long as your platelet counts are being monitored . it is recommended that you take the tablet at the same time each day , depending on how often you should take it . if it is more than one tablet is taken , take it with or without food .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired - may affect up to 1 in 100 people - low red blood cell count ( anaemia ) - blood clot in the portal vein ( blood vessel ) in the liver or intestines - upper abdominal pain , swelling bone pain - muscle aches - fever - other possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains - the active substance is avatrombopag maleate . each film - coated tablet contains 20 ml of the active ingredient . the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e . g . silica , colloidal anhydrous ), magnesium stearate , vinyl alcohol ( e171 ), talc , macrogol 3350 , titanium dioxide , and iron oxide yellow in the tablet core of the pack dopelet 20 mg tablets are pale yellow , round or rounded . they are supplied in one aluminium blister . not all pack sizes may be marketed .
rapiscan belongs to a group of medicines called ' coronary vasodilators '. they work by blocking the flow of blood through the heart arteries , thereby lowering the heart rate , heart rate and muscle contractions . the active substance in the medicine is a radioactive substance called a ' radiopharmaceutical ' . these images are taken using a treadmill to work out how well your heart works . a scan is performed by a doctor who has given you a small amount of radio pharmaceutical product injected into your body , usually in a vein . this allows you to see how your heart is working .
rapiscan is used to treat patients with slow heart rate , high degree heart block , sinus node disease , using a pacemaker to relieve chest pain ( unstable angina ). treatment is not recommended if you have low blood pressure , hypotension , heart failure , or are allergic to regadenoson ( see section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . tell your doctor or nurse if : you have recently had a serious heart problem , such as a heart attack , abnormal heart rhythms or if your heart beat is very fast or uneven . if this happens , your doctor will tell you if it is too slow or too slow . this is because your heartbeat is too fast or uneven . it is important that you do not have to have a pulsemaker . your doctor
rapiscan will be given to you by a doctor who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein containing 400 mg of a 5 ml solution . your weight will be controlled by an injection of sodium chloride 9 , 9 or 5 mg . a radioactive substance ( radiopharmaceutical ) will be added to the solution to make it easier for you to get the right dose . the dose will be adjusted based on your heart rate , blood pressure and the duration of the injection . this will be monitored by your doctor , pharmacist or nurse . you will also be given the dose according to your health , depending on your weight , and the dose you will receive . in addition , your doctor will give you a dose that is appropriate for you . for example , if you have a high dose of
like all medicines , rapiscan can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any of the side effects after the injection . the duration of the injection is 30 minutes . if any treatment is not effective , the following side effects may occur : sudden stopping of the heart , damage to the heart or heart block . this is a disorder of the liver ' s electrical signal . rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face or inability to speak . warnings and precautions talk to a doctor , pharmacist or nurse before you start treatment . these may include : - a stroke or a cerebrovascular accident , an allergic reaction ( rash , wheals / weals ). - diarrhoea , di
viagra contains the active substance sildenafil . it belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . these are substances that are found in blood vessels called penis . the penis is a part of the erection that is sexually stimulated . viagra is used as a treatment for erectile dysfunction ( impotence ) in women who cannot get a sex with a penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . medicines containing nitrates can cause a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( chest pain ). the medicines are given to you by nitric oxide donors ( e . g . amyl nutritide ). if this happens , your doctor may prescribe riociguat . this drug is used in patients with pulmonary arterial hypertension ( high blood pressure in the lungs ) or chronic thromboembolic pulmonary hypertension , which is a condition that can lead to the formation of blood clots ( pde ).
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . take viagra film , coated tablets , or viagra orodispersible tablets . swallow the tablets whole with a glass of water . you can take viagra with or without food . do not take viagra if your erection is not clear or sexually stimulated . your doctor will tell you how to use viagra . if this happens , your doctor may tell you to stop taking viagra without talking to your doctor , pharmacist or nurse . this medicine can cause an increase in side effects ( see section 100 ). do not use this medicine after the expiry date which is stated on the carton .
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any of the side effects after taking viagra . side effects common ( may affect more than 1 in 100 people ) symptoms include sudden wheeziness or difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat , chest pains in a semi - sitting position . nitrates can cause your chest pain . prolonged and sometimes painful erections may affect up to 1 in 1 , 000 people , which can lead to an erectile dysfunction . the most common side effects are : nausea , vomiting , headache , indigestion , nausea and vomiting . these may be signs of an allergic reaction . you should tell your doctor as soon as possible if this happens .
what viagra contains the active substance is sildenafil 25 mg . the other ingredients are : tablet core : the citrate salt , microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake . what viagra looks like and contents of the pack viagra film - coated tablets are a rounded - diamond shape . each tablet contains 25 tablets . they are available in blister packs containing 2 , 4 , 8 or 12 tablets each . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole . it belongs to a group of medicines called dopamine agonists . they work by blocking the activity of certain receptors in the brain . these receptors are involved in the production of nerve impulses that cause the symptoms of primary parkinson ' s disease . levodopa is used to control the progression of the disease in adults . the symptoms are moderate to severe primary restless legs syndrome .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if any of these apply to you , tell your doctor or nurse straight away if : you have any medical conditions that may cause symptoms of kidney disease such as hallucinations ( hearing or feeling things ) or dyskinesia ( abnormal , uncontrolled movements of the limbs ) in patients with advanced parkinson ' s disease ( levodopa ) if dyskinesia is a condition in which you are not able to keep your body and neck straight and upright , or forward flexion of the head and neck . you may experience dystonia ( inability
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 mg once a day for the first week of your first week . your doctor will tell you how much to take and how often to take . you will be given a tablet containing 0 . 088 mg / ml . if your doctor tells you not to take more than 1 tablet , take it as soon as you remember . it is recommended that you take one tablet at the same time each day . this will help to reduce the risk of your symptoms . tablets are available in packs containing 1 tablet at a time , each of which will be divided into two doses . each tablet will be taken in a glass of water . on day 1 , 
like all medicines , this medicine can cause side effects , although not everybody gets them . check with your doctor or pharmacist if you notice any of the following side effects while taking sifrol : very common ( may affect more than 1 in 10 people ): may affect up to 1 in 100 people , 1 in 1 , 000 people and 1 in 10,000 people . parkinson ' s disease side effects include dyskinesia ( abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), urge to behave in an unusual way - hallucinations , hearing or feeling things , confusion , tiredness . if any of these effects occurs , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in app
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 ml of solution , and 0. 35 . 7 mg . the other ingredients are : tablets : tablet core : 1 . 125 mg ; tablet shell : 2 . 25 mg and 1 , 5 . 5 mg of tablet core: mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what the pack sunlessrol looks like and contents of the pack siifrol is a white to off - white , round , oval , opalescent tablet : a clear , colourless , yellow , orange , red , pink , blue , green ,
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye caused by allergic conditions in the eye . the allergic reaction is caused by the presence of some materials ( allergens ) that cause allergic reactions such as itching , redness or swelling on the surface of your eye , which may feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents 6 years of age and older are not allowed to use benzalkonium chloride . if this applies to you , tell your doctor straight away . clinical trials have been conducted to test for the safety and efficacy of the medicine , see section 6 of this leaflet for clinical trials . you may not be able to have a chance of having kidney or liver problems . your doctor may recommend that you do not need to take any other medicines , including other eye drops . pregnancy , breast feeding , or are pregnant or are planning to become pregnant or breast - feeding . this medicine is not recommended for use in children
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much emadine to use the recommended dose is one 3 ml dropper per eye . do not take this medicine after the expiry date which is stated on the label and carton after exp . your doctor will tell you how many drops to use . the usual dose is 1 dropper , followed by 2 droppers . if not used immediately , the dropper should be placed on the eyelid with a clean finger . there is a ' pocket ' between the lid and the eye to keep the drop . it is important that you take the drop as soon as possible . this will help to protect your eyes from light . take the bottle with you , with or without food , at the same time each day . keep the bottle in your hands .
like all medicines , this medicine can cause side effects , although not everybody gets them . check with your doctor or pharmacist if you notice any of the side effects listed in section 6 . common side effects ( may affect more than 10 people ) of the eye : eye pain , itchy eye , eye redness ( uncommon side effects may affect up to 1 in 100 people ). eye problems : corneal disorder , abnormal eye sensation , increased tear production , tired eyes . eye irritation , blurred vision , corneal staining . these may be signs of eye irritation ( e . g . vision ) and corneal stained , which may be a sign of corneal disease . this may be caused by a variety of factors . corneal dysfunction : abnormal eye senssation in the eyes , decreased tear production in the eye which may lead to tired eyes
keep out of the sight and reach of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the blister in order to protect from light . if you notice any signs of infection , contact your doctor immediately .
what emadine contains the active substance is difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride ( e171 ), hypromellose , purified water , hydrochloric acid , and sodium hydroxide . acidity levels and ph levels are determined by the acidity level of the solution and by the pH of the water in the syringe ( see section 2 ' recombinant ') of the tablet is a liquid ( a solution ) in a 5 ml plastic ( drop - container ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam actavis is an antiepileptic medicine . it is a medicine used to treat seizures in adults with epilepsy . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the product . the recommended dose is 16 mg / m2 . children and adolescents : - have recently diagnosed epilepsy , or have recently experienced repeated fits ( seizures ). - if your doctor or nurse tells you that you have been given the medicine , it is important that you tell your doctor as soon as possible , and / or nurse ' s advice , if this applies to you , your doctor will tell you how long you will be given it . this is because it is not known how long it will take for you to take , have had a partial onset seizure ( secondary general
do not take levetiracetam actavis : - if you are allergic to pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . tell your doctor or pharmacist if : you have kidney problems , any slow down in the growth or puberty . - you are being treated with anti - epileptics . your doctor will tell you what to do . you should tell your child ' s doctor if your child has thoughts of harming or killing themselves . this includes any symptoms such as depression or suicidal ideation . other side effects include : abnormal thoughts , feeling irritable , reacting or changes in mood or behaviour . some of the side effects are mild to moderate .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose : 16 mg / ml : 1 , 000 mg : 3,000 mg . your doctor will tell you how much to take and when to take it . you should take the tablet at the same time each day . therapy dose is divided into two doses of 2 doses , which may vary depending on how long you are taking . if your doctor tells you otherwise , your doctor may prescribe a dose that is right for you to take . doses may vary from one dose to another . one dose may be given to you by a doctor , nurse or nurse . treatment dose 17 mg 50 mg 1,000 mg ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : - weakness , light - headed , dizzy or difficulty breathing . - a serious allergic ( anaphylactic ) reaction involving swelling of the face , lips , tongue and throat ( quincke ' s oedema ), flu - like symptoms such as a rash on the face or an extended rash , a high temperature , increased levels of liver enzymes in blood tests , white blood cell ( 56 ) eosinophilia ( enlarged lymph nodes ) or drug reaction . warnings and precautions talk to your doctor or pharmacist before taking levetiracetam actavis . this includes any possible side effects not listed in this leaflet .
what levetiracetam actavis contains - the active substance is levetiractam . each 250 ml vial contains 250 mg / m2 . the other ingredients are crospovidon , povidone , silica colloidal anhydrous , magnesium stearate , and water for injection . not all of the ingredients in this pack are the same as in the case of the other components . - each 500 mg vial is a single - use solution for injection in combination with the other ingredient : tetracycline .
incruse ellipta contains the active substance umeclidinium bromide . it belongs to a group of medicines called bronchodilators . this medicine is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition that affects the lungs , causing breathing difficulties , difficulties in breathing , and tightening of muscles . the use of this medicine helps to tighten the muscles in your lungs so that your breathing difficulties are reduced . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will tell you how to use it . you may experience a sudden attack of breathlessness or wheezing .
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine , as this medicine is not intended for the treatment of asthma . if this applies to you , tell your doctor immediately . your doctor may prescribe this medicine for you : - asthma - heart problems - an eye problem ( narrow - angle glaucoma ), an enlarged prostate , difficulty passing urine , or a blockage in your bladder - severe liver problems , immediate breathing difficulties , tightness of the chest , coughing , wheezing or breathlessness - contact your doctor or pharmacist . do not take this medicine after the expiry date which is stated on the carton .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every 24 hours . do not use incruse ellipta after the expiry date which is stated on the label and carton after exp . your doctor will tell you how much to inhale . symptoms of this medicine may include a sudden attack of breathlessness , wheezing , or cough . you should use a quick - acting reliever inhaler ( such as salbutamol ). your doctor may tell you to stop the inhaling the medicine if it is not working properly . if your doctor tells you to , tell your doctor , pharmacist or nurse . it is important that you use the correct dose of the medicine you are taking . this will help to reduce the risk of an attack
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may affect up to 1 in 100 people . if you experience any of the following symptoms while taking incruse ellipta , tell your doctor straight away : itching skin rash , hives , redness 29 common side effects ( may affect more than 1 in 10 people ): faster heart beat painful , frequent urination , or a urinary tract infection . common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead , inflammation of the skin . these may be signs of inflammation . the following side effects can occur with this medicine : very common : uncommon : rare : not known : frequency cannot be estimated from the available data : increase in the number of people taking this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2c - 8c ). do not freeze . keep the inhaler in the sealed tray in order to protect from light . if not used immediately , store in the original vial in the refrigerator for at least 6 months . after re - inhalation , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incruse ellipta contains - the active substance is umeclidinium bromide . each inhalation dose contains 55 mg umeclinium . the other ingredients are : - a dose for adults 65 years of age and older . - an inhaler containing lactose monohydrate ( see section 2 under ' inhaling powder '). - magnesium stearate ( e171 ). what the incentor looks like and contents of the pack the inhalor is a white to off - white , colourless , clear , round , oval , opalescent , yellow , orange , red , green , and light green mouthpiece cover . it is supplied in a foil laminate tray with a peelable foil lid and a desiccant packet 
nucala contains mepolizumab , a monoclonal antibody , which belongs to a group of proteins called interleukin - 5 . this is a type of protein that is used to treat severe asthma in adults and children 6 years of age and older . severe asthma is caused by the presence of many eosinophils , or white blood cells , in the lungs , that are responsible for the growth and development of this protein . asthmanucala is used for the treatment of asthma attacks . medicines and high dose inhalers are used to control your asthma . these medicines are used in combination with medicines called oral corticosteroids .
do not use nucala : - if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine , as this medicine can cause worsening asthma . 58 asthma - related side effects have been reported in patients with asthma who have had their asthma treated with nucalal . your doctor will check with you if your asthma is stable . do not stop treatment with nuclearala if any of these apply to you . you may be allergic to injection site reactions medicines containing this type ( monoclonal antibodies ) which can cause severe allergic reactions in the body . see section 4 for more information on the possible side effects , including a similar reaction , are listed below . other side effects not listed in this leaflet , you can also report
always use nucala exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection under the skin ( subcutaneous injection ). the usual dose is 12 mg / 100 mg per 1 ml of the pre - filled pen . your doctor will tell you how much to inject . do not inject more than once a day . if your doctor tells you not to , the dose may be increased or decreased . this medicine will be given to you by a doctor , nurse or nurse . it is important that you follow the instructions for the use of this medicine . you will need to use the pen at the same time each day to make sure that you are given the correct dose . in case you have any further questions on the use , ask your doctor ' s advice .
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following side effects while taking nucala : allergic reactions allergic or allergic - like reactions common ( may affect up to 1 in 10 people ) to the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness or feeling lightheaded ( a drop in blood pressure ), swelling of eyelids , face , lips , tongue , mouth hives rash . if any of these occur , contact your doctor immediately . you may experience a reaction to a similar reaction to your dose . this includes any possible side effects not listed in this leaflet . the most common side effects are : very common : may affect more than 1 in 100 people 
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the carton and the pre - filled pen after exp . store in a refrigerator ( 2c - 8c ). do not freeze . after re - opening , store in the original package in order to protect from light . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nucala contains - the active substance is mepolizumab . each vial contains 1 mg / 100 ml . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e171 ), polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nocala 1 mg is available in a pack containing 1 vial or a multipack containing 3 vials each . not all pack sizes may be marketed .
ninlaro is a cancer medicine that contains the active substance ixazomib , a type of ' proteasome inhibitor '. it is used to treat multiple myeloma in adults , adolescents , and children . this medicine is used for cell survival in adult patients who have a tumor of the bone marrow . it works by inhibiting the activity of a protein called proteasomasomes , which are involved in cell survival . myelama cells are produced by a lot of proteins known as protease ' s ' in the cytokines ( e . g . proteases ') in the cell - based proteins . the active substances in the drug work by reducing the number of proteins in the cells that make them more resistant to infection .
do not take ninlaro : - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given the medicine . if any of these apply to you , tell your doctor straight away . you may have bleeding , persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash , liver or kidney problems ( see section 2 ). if your kidney is not working properly , your doctor may decide to stop treatment . your doctor will check that you are getting enough blood cells for your age group of 18 years and older . this is because other medicines are not suitable for children and adolescents . ask your doctor for advice before
ninlaro is used to treat multiple myeloma . this medicine contains the active substance lenalidomide . it is a medicine that contains dexamethasone , which is an anti - inflammatory medicine . if you are not sure , talk to your doctor , pharmacist or nurse before you are given , as this medicine is not for you . your doctor will tell you how much to take and how long to take . the recommended dose is one tablet once a day , twice a week for the first 3 weeks of the first 4 weeks . you will be given one tablet at the same time each day of the week . in the first three weeks , the dose is 25 mg / ml . when you first start taking lenalomide , your doctor may ask you to take it at least 25 days after your first dose
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ), nose bleeds , easily bruise nausea , vomiting , diarrhoea , numbness or tingling , burning of the hands or feet ( peripheral neuropathy ), swelling of the legs or feet , peripheral oedema ), skin rash or itchy around the body . rare side effects may affect up to 1 in 1 , 000 people . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the capsule in the blister in order to protect from light . if the capsule is damaged , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains - the active substance in the capsule is ixazomib . each capsule contains 2 . 3 mg / ml xylitol . the other ingredients are : tablet core : i . e . 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 20 , 21 , 22 , 23 , 30 , 40 , 50 , 60 , 70 , 80 , 90 , 100 , 200 , 400 , 600 , 800 , 0 , 000 , 1 , 500 , 1000 , 300 mg x - 400 mg capsules . capsule shell : gelatin , titanium dioxide 
do not take palforzia : - if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor , pharmacist or nurse before you start treatment . the recommended dose is 4 mg for adults and 17 mg for children . treatment for peanut allergy is based on the presence of peanut ( desensitisation ) in the body . if any of the above applies to you , please tell your doctor or pharmacist . allergic reactions may occur if your child is allergic to food allergies , or if the child is not sure , ask your doctor for advice . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects , you can help provide more information .
do not take palforzia if you are allergic to severe asthma or to any of the other ingredients of your asthma ( listed in section 6 ). if your asthma has a problem swallowing or long term problems with your digestive system , a severe mast cell disorder ( severe or life - threatening anaphylaxis ) within 60 days of starting treatment . talk to your doctor , pharmacist , or nurse before you start . your doctor will tell you how much to take and how long to take . if any of these apply to you , tell your doctor or nurse . warnings and precautions talk to a doctor or pharmacist before you begin treatment , especially if the symptoms of peanut allergy are severe . you should not stop the dose unless your doctor tells you otherwise . the symptoms may be caused by peanut allergy . it is important that your doctor advises you to stop pal
do not take this medicine if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking palforzia . allergic reactions ( anaphylaxis ) are rare ( may affect more than 3 people ). your doctor will determine the best course of treatment for you . initial dose escalation and up - dosing phases will be repeated during these treatment phases . if this is not possible , contact your doctor or pharmacist . your doctor may decide to increase or decrease the dose , depending on the severity of these treatment phase . you may need to change your dose at any time of the day . it is important that you do not have to change the dose on a regular basis . this will help to reduce the risk of desensitisation on the day you are feeling unwell .
like all medicines , this medicine can cause side effects , although not everybody gets them . warnings and precautions talk to your doctor or pharmacist if you notice any of the following side effects while taking palforzia : severe allergic reactions . the reaction may include trouble breathing , throat tightness , feeling offulness , trouble swallowing , speaking - changes in voice , dizziness - fainting - severe stomach cramps , pain , vomiting - diarrhoea , severe flushing and itching of the skin , problems with the stomach and digestive system . if this happens , tell your doctor immediately . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 to 25 ). do not freeze . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is 0 . 5 mg / ml . each sachet contains 1 , 10 or 20 mg of powder . the other ingredients are : microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate , and 100 mg oral powder in capsules . a single - dose blister containing 100 mg of oral powder is provided in a glass vial , opened by a doctor or pharmacist . it is a clear , colourless to off - white , opalescent , open - coloured , oval , round , rectangular , square , or oval shaped , circular , beige oral powder , initial dose escalation ( see section 3 ). it is available in packs containing 3 , 13 , 5 , in single 
zerene contains the active substance benzodiazepine , which belongs to a group of medicinal products called hypnotic actions . it is used to treat sleeping problems after treatment . treatment should be stopped if you have problems sleeping .
do not take zerene - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zeene ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine : - sleep apnoea syndrome ( short periods ). - severe kidney or liver problems ( myasthenia gravis ) - very weak , tired muscles , severe breathing , chest problems . - children and adolescents under 18 years of age and older . talk to a doctor or pharmacist before taking this medicine . undesirable effects may occur when taking any medicine or any medicines . physical dependence may occur during treatment . withdrawal symptoms may include headaches , muscle pain , extreme anxiety or tension . you may experience withdrawal symptoms such as headaches or muscle pain or extreme anxiety , tension
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . you may have difficulty falling asleep . your doctor will tell you how much to take . age 65 : you have mild to moderate liver problems . if your doctor tells you to take less than 5 mg of the capsule , your doctor may decide to increase your dose to 5 mg , depending on how much you are taking . take the capsule as soon as you remember . do not take more than one capsule at a time . this may be due to an overdose . becoming increasingly drowsy , you may be in a coma . talk to your doctor , pharmacist or nurse straight away . it is important that you tell your doctor straight away to make sure that you are getting enough zer
like all medicines , zerene can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any other changes in your health . frequency of side effects 36 common ( may affect more than 1 in 10 people ): very common : may affect up to 1 in 100 people , may affect as little as 1 in 1 , 000 people . may affect less than 10 in 10 ,000 people if not treated immediately . all medicines have side effects similar to those seen in patients treated with drowsiness , memory difficulties , sensations like tingling in the extremities . most of the side effects are mild to moderate . the following side effects have been reported with zelene , which are not known , are common . these include : - irritability , inability to concentrate , difficulty in concentration ,
what zerene contains the active substance is zaleplon . each vial contains 5 mg microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine , titanium dioxide ( e171 ). the other ingredients are : gelatin , titanium dioxide - containing red iron oxide , yellow iron oxide and black iron oxide ( s - 13050 ) - shellac , lecithin , simethicone , and white to off - white - colourless tablets . what zeene looks like and contents of the pack zeroene is a clear , colourless tablet . it is supplied in a glass vial . not all pack sizes may be marketed
